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Abstract 
 
Bunyamwera orthobunyavirus (BUNV) is the prototype for the family Bunyaviridae. 
BUNV has a tripartite RNA genome of negative polarity composed of the large (L), medium 
(M) and small (S) segments. Each segment contains an open reading frame (ORF) flanked by 
untranslated regions (UTRs). The eleven terminal nucleotides are conserved between the three 
segments while the internal regions are unique. The UTRs play an important role in the virus 
life cycle by promoting transcription, replication and encapsidation of the viral genome. 
 
The work presented in this thesis explores UTRs plasticity and examines ways to 
engineere attenuated viruses by modifying only their UTRs. 
Using reverse genetics, mainly two ways of attenuation were explored: rescue of viruses 
either carrying deletions within their 3’ and/or 5’ UTRs in all three segments, or of viruses 
carrying one segment bearing heterologous UTRs. Both approaches resulted in virus 
attenuation in tissue culture, with viruses producing smaller plaques or even no plaques, and 
growing to lower titres than wild-type BUNV. Through serial passage, viruses were shown to 
regain some level of fitness while the mutations introduced in the UTRs proved to be stable. 
Thus, to investigate the mechanism behind fitness recovery, the nucleotide sequence of the 
entire genome of viruses with deletions in their UTRs was determined. Amino acid changes 
were observed in the viral polymerase (L protein) of most mutant viruses and the vast 
majority of the amino acid changes occured in the C-terminal region. The function of this 
domain is unclear to date, however data obtained using a mini-replicon assay suggest that the 
C-terminal domain of the L protein might be involved in UTR recognition. Full genome 
sequencing also allowed the identification of an amino acid mutation within the polymerase 
that resulted in a temperature sensitive phenotype when introduced in an otherwise wild-type 
BUNV.  
 
Thus, it was shown that mutations introduced within the UTR regions of the genome were 
stable through serial passage and resulted in attenuation. Such a strategy could be used in 
combination with mutations of the ORF to design live-attenuated vaccines against serious 
pathogens within the family Bunyaviridae. 
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A. The Bunyaviridae: the viruses and their replication 
1. Classification and taxonomy 
The family Bunyaviridae was formally recognised by the International Committee on the 
Taxonomy of Viruses (ICTV) in 1975 and takes its name from Bunyamwera virus (BUNV) 
the prototype for the group. The family now includes more than 350 named viruses present on 
all continents (with the exception of Antarctica) making it one of the largest families of RNA 
viruses.  
Inclusion in the family Bunyaviridae relies on essential morphologic and biochemical 
criteria: virions are enveloped spherical particles of 80-120 nm diameter containing a tripartite, 
single-stranded RNA genome of negative or ambisense polarity; replication is restricted to the 
cytoplasm; and assembly occurs at the Golgi complex leading to the formation of a lipid 
bilayer envelope that incorporates the two viral glycoproteins. 
Viruses within the family Bunyaviridae are further classified into five genera: 
Orthobunyavirus, Phlebovirus, Nairovirus, Hantavirus and Tospovirus. Historically, viruses 
were classified according to their host range and their antigenic properties; the lack of 
serological cross reactivity between viruses was used to differentiate genera. 
Orthobunyaviruses, phleboviruses, nairoviruses and tospoviruses are arthropod-borne viruses 
mainly transmitted by mosquitoes, phlebotomine flies, ticks and thrips. Hantaviruses are 
rodent-borne viruses transmitted via aerosolised excreta or bite. Viruses in the family infect 
vertebrates with the exception of the tospoviruses that infect plants. Most recently, molecular 
data have had a major impact on virus classification and viruses are assigned to a specific 
genus according to the size of their genome and proteins, the sequence of the conserved 
terminal nucleotides on genome segments, and their gene expression strategy.  
Efforts to classify viruses into species are never ending and results in a constant revision 
of the catalogue of viruses within the family Bunyaviridae. According to the ICTV 9th report 
(Plyusnin et al., 2011), the genus Orthobunyavirus comprises 18 serogroups (defined through 
extensive serological studies of complement fixation, neutralisation and haemagglutination 
inhibition assays) and is further divided into 48 species (and 3 tentative species) and includes 
over 170 viruses. Still according to the ICTV 9th report, the genus Hantavirus comprises 23 
species, the genus Phlebovirus comprises 9 species including 37 viruses while 33 viruses are 
tentative species, the genus Nairovirus comprises 7 species and the genus Tospovirus 
comprises 8 species and 16 tentative species. Moreover, seven grouped (19 viruses) and 21 
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ungrouped viruses might be members of the family Bunyaviridae but are not yet recognised as 
species and have not been assigned to a genus due to a lack of biochemical and genetic 
characterisation. 
 
Genus/Virus Host: disease Vector Distribution 
Orthobunyavirus    
  Akabane virus Cattle: abortion and congenital 
defects 
Midge Africa, Asia, Australia 
  La Crosse virus Human: fever Mosquito North America 
  Oropouche Human: encephalitis Midge South America 
Phleboviruses    
  Rift Valley fever virus Human: encephalitis, 
haemorrhagic fever, retinitis 
Domestic ruminants: abortion, 
haemorrhage, necrotic hepatitis 
Mosquito Africa 
  Sandfly fever virus Human: fever Sandfly Europe, Africa, Asia 
Nairovirus    
  Crimean-Congo 
hemorrhagic fever 
Human: haemorrhagic fever, 
20-80% fatality 
Tick Africa, Eastern Europe, 
Asia 
  Nairobi sheep disease virus  Sheep, goats: fever 
haemorrhagic gastroenteritis, 
abortion 
Tick Europe, Africa, Asia 
Hantavirus    
  Hantaan virus Human: severe HFRS, 5-15% 
fatality 
Field mouse Eastern Europe 
  Puumala virus Human: mild HFRS, 0.1% 
fatality 
Bank vole Western Europe 
  Sin Nombre virus Human: hantavirus pulmonary 
syndrome, 40% fatality 
Deer mouse North America 
Tospovirus    
  Tomato spotted wilt virus >650 plant species Thrips Worldwide 
Table 1-1: Most notable virus members of the family Bunyaviridae. 
 
2. Maintenance in nature and associated diseases 
a) Genus Orthobunyavirus  
The genus Orthobunyavirus and the family Bunyaviridae take their name from 
Bunyamwera virus (BUNV), the prototype bunyavirus which was isolated from mosquitoes of 
Aedes species in the Semliki Forest in Uganda (Smithburn et al., 1946). BUNV has been 
isolated from humans in several regions of Sub-Saharan Africa and infection is thought to 
cause an acute febrile illness. More than 30 viruses within the genus have been associated 
with human diseases.  
In North America, the leading cause of arboviral encephalitis is the result of infection 
with two members of the California serogroup, La Crosse virus (LACV) which infects 
children, and Jamestown Canyon virus (JCV) which causes disease mainly in adults 
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(McJunkin et al., 2001). LACV is mainly transmitted by Aedes triseriatus mosquitoes and 
chipmunks are its main natural vertebrate reservoir. Infection in chipmunks is asymptomatic 
but the viremia reaches titres that are sufficient to infect a feeding mosquito. Thus, chipmunks 
are considered the amplifying host while humans are considered a dead-end host. Indeed, 
blood viremia in human is too low to infect feeding mosquitoes. After a viremic blood meal, 
the epithelial cells of the mosquito midguts are infected by ingested viruses (Beaty et al., 
1982). As a result of replication, virus particles are released from the basal lamina and 
disseminated across the body. Among infected tissue, the salivary glands and ovaries play 
determinant roles in spread of the virus and its maintenance in nature respectively (Reese et 
al., 2010). Replication in the salivary glands allows transmission of the viruses from the 
female mosquito to the vertebrate host during feeding, while replication in the ovaries was 
shown to result in the vertical transmission of the virus from a female mosquito to its 
offspring. The virus was shown to overwinter in infected eggs, and infected males are thought 
to propagate the virus in mosquito populations through venereal transmission.  
In Brazil, Oropouche fever, caused by Oropouche virus (OROV), is the second most 
common arboviral infection after Dengue fever. OROV is transmitted by culicoid midges and 
unusually for a member of the orthobunyavirus, viremia in human is sufficient to infect 
midges after biting. In recent years, OROV has been recognised as a major public health 
problem not only in Brazil but across Central and South America (Azevedo et al., 2007).  
Viruses within the genus also cause important disease in livestock: Cache Valley virus, in 
North America, Schmallenberg virus (SBV) in Europe (Hoffmann et al., 2012) and both Aino 
virus and Akabane virus (AKAV) in Australia and Asia (Kim et al., 2011; Tsuda et al., 2004) 
are responsible for abortions and congenital abnormalities in cattle, sheep and goats. 
b) Genus Phlebovirus 
Viruses within the genus Phlebovirus are mainly transmitted by phlebotomine sandflies, 
hence the name of the genus but there is exceptions, i.e Rift Valley fever virus (RVFV), 
which is the type species, is transmitted by mosquitoes of the species Aedes and Culex, while 
a newly emerged virus, Huaiyangshan virus or severe fever with thrombocytopenia syndrome 
virus (SFTSV), is associated with ticks (Yu et al., 2011; Zhang et al., 2011). 
RVFV was isolated in the Great Rift Valley in Kenya during the early 30s. Of the many 
phleboviruses isolated, RVFV has the most dramatic impact on human health and livestock. 
Infection in humans manifests in most cases with a mild febrile illness, but can be more 
serious and develops toward encephalitis, retinitis and hepatitis associated with haemorrhagic 
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fever. Historically, mortality rate was low (around 0.5%), however in recent years it has 
increased to up to 10%. In susceptible animals, like sheep, infection results in fever, hepatitis 
and in pregnant animals often leads to abortion of the foetus. Mortality rates in newborn lamb 
may reach 100% but animals become more resistant with age (Boshra et al., 2011; Ikegami & 
Makino, 2011; Pepin et al., 2010). 
c) Genus Nairovirus 
Nairoviruses are maintained in nature in their respective tick host. They can persist in tick 
populations throughout the various life stages and can be passed onto the offspring through 
vertical transmission. The vertebrate host only plays an amplifying role. Two members of the 
genus are of particular interest: Crimean-Congo haemorrhagic fever virus (CCHFV) and 
Nairobi sheep disease virus (NSDV). CCHF is found in Africa, Asia and Europe and is 
asymptomatic in a variety of livestock and wild herbivores. However, infection in humans 
often results in severe haemorrhagic fever (Whitehouse, 2004). NSDV is present in Africa 
and Asia and causes acute haemorrhagic gastroenteritis in sheep and goats with over 90% 
mortality rate (Marczinke, 2002). 
d) Genus Hantavirus 
The genus Hantavirus takes its name from the Hantan River in South Korea where the 
type species, Hantaan virus (HTNV), was discovered (Lee et al., 1978). Contrary to other 
genera, there is no known arthropod vector for hantaviruses. They are maintained in nature in 
rodents and insectivores. Horizontal transmission among rodents is thought to result from 
exposure to infectious excreta and saliva. While infection of the natural reservoir is mainly 
asymptomatic, infection in humans can develop into haemorrhagic fever with renal syndrome 
(HFRS) or hantavirus pulmonary syndrome (HPV). Old World hantaviruses, i.e. Hantaan 
(HTNV), Seoul (SEOV) and Puumala (PUUV) viruses are associated with HFRS in Europe 
and Asia, while New World hantaviruses, i.e. Sin Nombre (SNV), Andes (ANDV) and Black 
Creek Canal (BCCV) viruses are associated with HPS in the Americas. The ecology and 
pathology of hantaviruses have been reviewed recently by Jonsson and al. (Jonsson et al., 
2010). 
e) Genus Tospovirus 
The genus Tospovirus take its name from tomato spotted wilt virus (TSWV) which was 
thought to be the only member of the family for a long time. Other members have been 
discovered recently but have been less studied. TSWV infects a wide variety of plants 
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worldwide. Its threat to agriculture is important as infected crops include peanuts, tobacco, 
potatoes, peppers, and tomatoes. TSWV is transmitted by 13 different thrips species in which 
it can replicate. Formation of virus particles through the process of assembly and budding is 
not required for virus propagation inside the plant, and cell-to-cell spread is mediated by the 
NSm protein. Transmission from plant to thrips is also particle-free, but only thrips larvae, not 
adults, can get infected through ingestion of plant sap containing free vRNPs (Whitfield et al., 
2005). Transmission from thrips to plants requires the formation of virion particles through 
the process of assembly and budding (Sin, 2005). Vertical transmission of tospoviruses in 
thrips has not been reported. 
3. Virion structure 
a) Morphology 
When observed by electron microscopy, virus particles appear pleomorphic or spherical, 
80 to 120 nm in diameter, and display projections of surface glycoproteins of 5 to 10 nm that 
are embedded in a lipid bilayer envelop 5 to 7 nm thick.  
Techniques such as cryo-electron microscopy allow an accurate determination of particle 
sizes while preserving their integrity. La Crosse orthobunyavirus (LACV) particles were 
reported to be 75 to 115 nm in diameter (Figure 1-1-A) (Talmon et al., 1987), Tula hantavirus 
(TLV) particles show a mean diameter of 135 nm (Figure 1-1-B) (Huiskonen et al., 2010) 
while Rift Valley fever phlebovirus (RVFV) had a mean diameter of 105 nm (Figure 1-1-C) 
(Huiskonen et al., 2009).  
The spikes, visible on the outside of the particles, are mostly formed by heterodimers of 
the two glycoproteins; indeed biochemical analysis showed that the two glycoproteins were 
present in equimolar amount in LACV (Obijeski et al., 1976a). The glycoprotein pattern on 
the particle surface differs within the family Bunyaviridae. Virions in the genus 
Orthobunyavirus show small disorganised knob-like structures. The lack of organisation in 
the pattern is also observed for virions in the genera Nairovirus and Tospovirus. The spikes of 
virions in the genus Hantavirus are thought to contain four heterodimers arranged in a grid-
like structure but without forming a distinctive pattern (Huiskonen et al., 2010). Evidence for 
an organised pattern of the glycoproteins is so far unique to virions in the genus Phlebovirus: 
the glycoproteins form round and closely packed units organised in an icosahedral symmetry 
(Freiberg et al., 2008; Huiskonen et al., 2009). 
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Figure 1-1: Electron micrograph of negatively stained particles. 
Cryo-electron micrograph of La Crosse virus (A) Tula virus (B) and Rift Valley fever virus (C). Bars 
represent 100 nm. Pictures are respectively taken from Talmon et al. (1987), Huiskonen et al. (2010) 
and Huiskonen et al. (2009). 
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b) Biochemical and physical properties 
The biochemical composition of virions varies slightly between viruses, and the chemical 
content of UUKV was estimated to be 2% of RNA, 58% protein, 33% lipid and 7% 
carbohydrate (Obijeski & Murphy, 1977). 
Virion particle buoyant density in sucrose is 1.16-1.18 g/cm3, and in CsCl is 1.20-1.21 
g/cm3. Sedimentation ranges from 400 to 500 S. Virions are sensitive to heat, formaldehyde, 
lipid solvents and non-ionic detergents. The last two remove the lipid envelop resulting in the 
loss of infectivity, at least in arthropod and mammalian hosts (Obijeski & Murphy, 1977). 
4. Genome structure and organisation 
a) Structure of the viral genome 
The viral genome is composed of three single-stranded genome segments named large (L), 
medium (M) and small (S) according to their sizes in nucleotide (nt). The lengths of each 
segment vary greatly between genera (Table 1-2): the L segment of orthobunyaviruses, 
hantaviruses and phleboviruses is around 6.5 kb, that of tospoviruses is around 8.9 kb, while 
the L segment of nairoviruses is 12.2 kb; less variation is observed for the M segment, with 
the shortest being 3.6 kb for hantaviruses and the longest being 4.8 kb for tospoviruses; the S 
segment of orthobunyaviruses is 1 kb long, while hantaviruses, nairoviruses and 
phleboviruses S segments are around 1.7 kb and tospoviruses is 2.9 kb. 
The coding regions are flanked by unstranslated regions (UTRs) whose size and sequence 
vary greatly but as a general rule the 3’ UTR is shorter than the 5’ UTR. The very terminal 
nucleotides at both the 3’ and 5’ UTRs are conserved on all three segments for viruses that 
belong to the same genus. These conserved sequences are complementary and result in a non-
covalent base-pairing of the extremities forming a panhandle structure. Electron microscopy 
of RNA extracted from virions provided evidence for the circularisation of the viral RNA 
(Figure 1-2) (Hewlett et al., 1977; Obijeski et al., 1976b). The UTRs play an important role in 
the virus life cycle, have been well characterised, and more details can be found in section 1-
C. 
Each viral genome segment complexes with numerous copies of the nucleocapsid (N) 
protein and few copies of the RNA-dependant RNA-polymerase (RdRp) to form individual 
ribonucleoprotein complex (RNP). At least one of each of the L, M and S nucleocapsid must 
be packaged into a virus particle to confer infectivity (Figure 1-3). 
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RNA segment Genus 
 
Orthobunyavirus Phlebovirus Nairovirus Hantavirus Tospovirus 
L 6.9 6.4 12.2 6.5 8.9 
M 4.5 3.5 4.9 3.6 4.8 
S 1 1.7 1.7 1.7 2.9 
Table 1-2: Pattern of sizes of viral RNA segments in Bunyaviridae genera. 
Sizes are given in kb. Adapted from (Elliott & Blakqori, 2011) 
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Figure 1-2: Electron micrograph of LACV nucleocapsids. 
Nucleocapsids were obtained by cesium chloride equilibrium gradient centrifugation (x177,000). 
Taken from Obijeski and al. (Obijeski et al., 1976b). 
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Figure 1-3: Representation of an orthobunyavirus virion.  
The surface spikes are formed by the two glycoproteins Gc (green) and Gn (purple) that are inserted 
into the viral envelop as dimers. Each helical RNP is formed by one of the three segments of vRNA 
(L: large, M: medium and S: small) encapsidated by the nucleocapsid protein (orange) and associated 
with the polymerase (red). 
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b) Coding strategies 
All viruses within the family Bunyaviridae encode four structural proteins: the RdRp on 
the L segment, the envelope glycoproteins Gn and Gc on the M segment and the nucleocapsid 
protein on the S segment which sizes vary greatly (Table 1-3). Some viruses within the genera 
Orthobunyavirus, Phlebovirus and Tospovirus also encode for two non-structural (NS) 
proteins, NSm and NSs, on their M and S segments respectively, while some hantaviruses 
code only for the NSs protein (Jääskeläinen et al., 2007; Vera-Otarola et al., 2011). Structural 
proteins are translated from mRNAs transcribed from the genomic RNA while mRNAs for 
the NS proteins are transcribed from either the genomic RNA or the antigenomic RNA 
corresponding to the 5’ half of the genomic RNA. Therefore, viruses within the family 
Bunyaviridae use either a negative-sense coding strategy only or a combination of negative-
sense and ambisense coding strategies (Figure 1-4).  
The L segments of viruses in all genera encode the L protein in the negative-sense 
orientation and so far there is no evidence for any other ORF present in either the genomic or 
antigenomic RNAs. 
The M segments encode the two glycoproteins Gn and Gc in the negative sense 
orientation. When present, NSm, is also encoded in the negative sense orientation with the 
exception of tospoviruses which encode their NSm in the ambisense orientation. No evidence 
of an ORF for NSm was described for viruses in the genera Hantavirus. In the case of 
phleboviruses, NSm is present in the mosquito-borne phlebovirus RVFV but absent in the 
tick-borne UUKV and SFTSV. The presence of NSm has recently been reported for the 
nairovirus CCHFV (Altamura et al., 2007). 
The S segments of nairoviruses, some hantaviruses and orthobunyaviruses within the Tete 
and Anopheles A and B serogroups encode only the N protein in a negative sense orientation 
while viruses within the genera Phlebovirus, Tospovirus and some Orthobunyavirus also 
encode the NSs protein. Orthobunyaviruses and hantaviruses encode their NSs protein in an 
overlapping reading frame in the negative sense orientation but phleboviruses and 
tospoviruses use an ambisense strategy and encode their NSs protein in the positive-sense 
RNA. 
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Protein Genus 
 
Orthobunyavirus Phlebovirus Nairovirus Hantavirus Tospovirus 
L 259-263 238-241 459 246-247 330-332 
Gn 29-41 50-70 30-45 68-76 46-58 
Gc 108-120 55-75 72-84 52-58 72-78 
NSm 15-18 none, 14 or 78 78-115 none 34 
S 19-26 24-30 48-54 48-54 29 
NSs 10-13 29-31 none none or 7-12 52 
Table 1-3: Pattern of sizes of viral proteins in Bunyaviridae genera. 
Sizes are given in kDa. Adapted from (Plyusnin et al., 2011) 
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Figure 1-4: Coding strategy of the L, M and S segments for the prototype virus of each genus in 
the family Bunyaviridae. 
The L, M and S segment are represented for the type species of each genus. Naked black lines 
represent genomic RNA in the viral sense orientation (3’ to 5’) with the length in nucleotides given 
above. The thick black lines represent mRNA, the squares symbolise the 5’ cap structures and arrows 
symbolise the 3’ end. Coloured boxes represent the protein products with their name and size in kDa. 
Abbreviations: BUNV, Bunyamwera virus; HNTV, Hantaan virus; DUGV, Dugbe virus, RVFV, Rift 
Valley fever virus, TSWV, tomato spotted wilt virus. Adapted from (Plyusnin et al., 2011). 
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5. Viral genes products 
a) L segment product 
The RNA-dependant RNA-polymerase proteins of Bunyaviridae are encoded in a 
negative-sense orientation and their sizes range from 238 kDa for phleboviruses to 460 kDa 
for tospoviruses. Little homology is observed between the L proteins of viruses belonging to 
different genera but amino acid sequence alignment reveals the presence of conserved motifs 
(Aquino et al., 2003; Jin & Elliott, 1991; Müller et al., 1994; Reguera et al., 2010).  
Four domains, identified as the ‘polymerase module’ (Poch et al., 1989), are present 
within all RdRp and were named motifs A to D. Two additional motifs were described for the 
polymerases of bunyaviruses and arenaviruses: one preceding motif A was termed pre-motif 
A and the one following motif D was termed motif E (Müller et al., 1994). The different 
polymerase modules are located roughly in the middle of the bunyavirus polymerases and 
their critical role for polymerase activity was demonstrated by mutagenesis of conserved 
amino acids within these motifs (Jin & Elliott, 1992). Using a recombinant vaccinia virus 
expressing BUNV L protein, Jin et al. showed that the L protein was capable of performing 
both transcriptase and replicase activities, therefore synthesising both genome and 
antigenome species from transfected RNPs (Jin & Elliott, 1991; 1993b). It was also shown 
that the positive-sense RNA synthesised by the recombinant L protein contained host-cell 
derived sequences at their 5’ extremity suggesting that the endonuclease activity resides 
within the L protein (Jin & Elliott, 1993b). Indeed, like orthomyxoviruses, bunyavirus 
polymerases use the mechanism of ‘cap-snatching’ to synthesise their mRNA. For influenza 
viruses, the endonuclease domain resides in the PA subunit and is formed by the residues PD-
D(D/E)xK, characteristic of the nuclease superfamily (Dias et al., 2009). These highly 
conserved residues are present in the N-terminal region of bunyavirus polymerases and 
endonuclease activity has been recently reported for LACV (Reguera et al., 2010). The 
presence of the endonuclease domain at the N-terminal of the LACV polymerase was further 
supported by crystallisation data obtained for residues 1-183 and its comparison with the 
structure of the PA subunit endonuclease domain (Dias et al., 2009; Reguera et al., 2010; 
Yuan et al., 2009).  
A full crystal structure of the bunyavirus polymerase is not yet available and no functions 
have been identified for the C-terminal domain of the protein. The N-terminal domain of 
bunyaviruses fulfils the same function than the PA subunit of influenza virus and the middle 
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part of the polymerase can be compared to the PB1 subunit (Reguera et al., 2010). By analogy 
it was suggested that the C-terminal domain could fulfil the same function than the PB2 
subunit, which contain the mRNA cap-binding domain (Guilligay et al., 2008), but to date 
there is no evidence for this. 
The localisation of the L protein in infected cells was mainly studied for TULV thought 
fusion to a green fluorescent protein (GFP) and for BUNV and RVFV through introduction of 
the V5 epitope within the C-terminal region of the protein (Brennan et al., 2011a; Kukkonen 
et al., 2004; Shi & Elliott, 2009). In both study, the L proteins were located in the cytoplasm 
and formed a punctuated pattern at the nuclear periphery. This pattern suggests the association 
of the protein with intracellular membrane structure. 
b) M segment products 
(i) The glycoproteins 
The M segment serves as template for the synthesis of the two envelope glycoproteins 
(GP). Historically, the GPs were named G1 and G2 according to their migration profile in 
SDS-PAGE gel. However, as it appeared that the functions of the GPs across the different 
genera correlate better with their position on the segment than with their size they were 
renamed Gn and Gc (Lappin et al., 1994). The two GPs are translated as a polyprotein 
precursor and their names Gn and Gc reflect their position within this precursor at either the 
amino terminus or the carboxy terminus. Cleavage of the polyprotein precursor is thought to 
occur cotranslationally as no evidence for the full-length protein in infected cells has been 
found  (Fazakerley et al., 1988). The mechanism of cleavage is unknown for most 
bunyaviruses but both Gn and Gc were found to be preceded by signal sequences that could 
result in cleavage by host cell signalase (Fazakerley et al., 1988). For HTNV, a pentapeptide 
motif, WAASA, preceding the Gc protein was identified as the cleavage site (Löber et al., 
2001). After cleavage, the GPs sizes range from 35 to 72 kDa with Gn and Gc of similar sizes, 
except for viruses within the genus Orthobunyavirus that display a marked size difference 
with Gn, around 32 kDa, and Gc, around 110 kDa.  
Bunyavirus GPs are class I membrane proteins, which implies that they span the 
membrane only once and have their amino terminus exposed at the virion surface. The Gn and 
Gc proteins of all viruses are glycosylated on asparagine residues. In addition, their cysteine 
content reaches about 5 %. Both N-glycans and disulphide bond formed between cysteine are 
important for protein folding and trafficking (Persson & Pettersson, 1991; Shi et al., 2005; Shi 
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& Elliott, 2004). In the ER, Gn and Gc form heterodimers which are then transported to the 
Golgi. The Golgi targeting/retention signal has been mapped to the trans-membrane domain 
of Gn in Bunyamwera virus and Gc require the chaperone-like action of Gn to be targeted to 
the Golgi (Shi et al., 2004). Correct targeting of the GPs is crucial for virus assembly and 
budding and thus for infectivity. 
(ii) NSm protein 
The M segment gene products differ among genera. Hantaviruses produce only Gn and 
Gc while some viruses in the four other genera also code for the non-strutural protein NSm. 
Orthobunyaviruses produce NSm from the same polyprotein precursor than Gn and Gc. 
Cleavage is likely to rely on furin-like enzymes and results in the production of 11-14 kDa 
protein. The role of NSm during orthobunyavirus infection is not well understood but it was 
suggested that its N-terminal region plays a role in virion assembly at the Golgi membrane 
(Shi et al., 2006).  
NSm is also expressed from the same mRNA as Gn and Gc in mosquito-borne 
phleboviruses, RVFV, but is absent from tick-borne phleboviruses, UUKV. Again, the role of 
NSm during infection is not well characterised but its presence is dispensable as it is possible 
to rescue virus lacking this protein (Bird et al., 2008).  
The M segment of tospoviruses utilises an ambisense strategy to encode its NSm protein. 
The result is a protein of around 34 kDa which has several characteristics of proteins involved 
in movement within infected plants. Indeed, the TWSV NSm protein is expressed at the early 
stage of infection, can bind RNA and was shown to allow virus movement across cell walls 
(Li et al., 2009). 
c) S segment products 
(i) The nucleocapsid protein 
Among the family Bunyaviridae, nucleocapsid (N) protein sizes varies from around 25 
kDa (ortho-, phlebo- and tospo-virus) to around 50 kDa (hanta- and nairo-virus). Little 
sequence homology is observed between viruses in different genera but the N protein 
functions’ appeared to be similar across all genera in the family. 
The N protein is the most abundant protein in infected cells and virion. This abundance 
reflects its important roles in virus replication: its main role is to protect viral genomic and 
anti-genomic RNAs from degradation by forming the viral RNPs, but it also interacts with the 
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L protein, the GPs and itself.  
The N-N interactions have been extensively studied for viruses in the genus Hantavirus: 
residues at both the amino and carboxy termini are involved in the formation of trimers 
(Kaukinen et al., 2003). For Tula hantavirus (TULV), oligomerisation of N protein involves 
interaction between charged residues present in the N-terminal coiled coil domain (Alminaite 
et al., 2008; Alminaite et al., 2006) as well as residues 393-398 at the C-terminal end 
(Kaukinen et al., 2004). These data are supported by similar findings for other viruses within 
the genus, i.e. SNV, Andes virus and HTNV (Alfadhli, 2002; Kaukinen et al., 2005; Wang et 
al., 2008). In the case of BUNV, deletion of portions of the N- and C-terminal domains 
inhibits oligomerisation of the N protein. These data suggest a head-to-head and tail-to-tail 
multimerisation model where the oligomer is formed by addition of N protein one by one 
(Leonard et al., 2005). In contrast to hantaviruses, a central region of BUNV N protein also 
appeared to be involved in N-N interaction (Eifan & Elliott, 2009). 
In addition to protein interaction, the N protein is involved in RNA binding. For both 
hantaviruses and bunyaviruses, the N protein interacts preferentially with the 5’ end of the 
RNA (Osborne & Elliott, 2000; Severson et al., 2001). While the RNA binding site of HTNV 
mapped to the central region of the protein (Severson et al., 2005; Xu et al., 2002), recent 
mutational analysis of BUNV N protein showed the critical role of the amino acid (aa) at 
position R94 (Walter et al., 2011). In the same study, Walter et al. showed that amino acid at 
position R40 along with L50 facilitate RNA binding. 
(ii) NSs protein 
Members of the Tospovirus and Phlebovirus as well as some members of the 
Orthobunyavirus and Hantavirus genera produce a non-structural protein NSs. Viruses within 
the family Bunyaviridae have developed two different strategies to encode their NSs protein: 
(a) the NSs of orthobunya- and hantaviruses (both around 10 kDa) is translated from an 
overlapping ORF in the same mRNA as the N protein; this mechanism involves ribosome 
leaky scanning (Vera-Otarola et al., 2011); and (b) the NSs of phlebo- and tospoviruses (up to 
50 kDa) is translated from a separate ORF encoded in the ambisense orientation.  
The NSs of RVFV accumulates in the nucleus of infected cell where it forms filamentous 
structures (Struthers & Swanepoel, 1982; Yadani et al., 2004). Hantavirus NSs protein have a 
cytoplasmic localisation, for TULV it is found in perinuclear inclusions (Virtanen et al., 
2009) while ANDV NSs was found in granules distributed throughout the cytoplasm (Vera-
Otarola et al., 2011). Immunofluorescence analysis with a plasmid-expressed FLAG-tagged 
Chapter 1: Introduction  The Bunyaviridae 
 
19 
 
protein showed that BUNV NSs could both localise in the nucleus and form cytoplasmic 
inclusion (Thomas et al., 2004). 
No sequence homology is observed between the NSs protein across genera and, even 
within the same genus, sequences are poorly conserved. However, with the advent of reverse 
genetics, functional analysis revealed that they play very similar roles. The NSs’ of the 
different genera appear to be multifunctional proteins involved in virus replication and host 
cell interaction. In a mini-replicon assay, the absence of NSs enhanced reporter activity for 
both BUNV and LACV, while overexpression of NSs inhibits mini-replicon activity 
(Blakqori, 2003; Weber et al., 2001). This characteristic of NSs seems to be conserved, at 
least across the orthobunyaviruses, as the same results were observed for Guaroa and Lumbo 
viruses (Weber et al., 2001) and suggests that NSs has a negative influence on the replicative 
activity of the viral polymerase. The relevance of this inhibitory effect observed in the mini-
replicon assay is not fully understood. NSs was found to be a non-essential protein for virus 
replication in tissue culture as a NSs deleted version of BUNV, LACV and AKAV was 
successfully rescued (Blakqori & Weber, 2005; Bridgen et al., 2001; Ogawa et al., 2007a; 
Ogawa et al., 2007b). Nevertheless, viruses lacking NSs expression were attenuated in 
interferon-competent cell lines compared to wild-type virus. Thus, NSs was identified as a 
virulence factor and an antagonist of the IFN system (Blakqori et al., 2007). The NSs protein 
of the phlebovirus RVFV has also been extensively studied: results obtained with clone 13, an 
isolate that contains a large, in-frame deletion of the NSs ORF, showed NSs to be a good IFN 
production inhibitor (Bouloy et al., 2001). The role of NSs during RVFV infection was later 
studied using rescued viruses lacking the NSs ORF as a whole (Billecocq et al., 2004; Bird et 
al., 2008). 
The role of NSs in regulating the host cell IFN response, as well as its contribution to the 
general host-cell protein shut-off observed at times, will be discussed later (see section 1-A-7).  
6. Viral life cycle in mammalian cells 
The bunyavirus replication cycle takes place exclusively in the cytoplasm and can be 
divided in four major steps: (1) attachment and entry of the virion, followed by release of the 
RNPs into the cytoplasm; (2) primary transcription and translation; (3) amplification of the 
viral genome; and (4) assembly, budding and release of newly formed particles.  
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a) Attachment and entry 
To deliver their genomes into the host cell cytoplasm bunyaviruses utilise mechanisms 
common to most enveloped viruses. The first step consists in the interaction of the viral 
attachment protein with a cell surface receptor, followed by internalisation of the virion and 
release of the RNPs into the cytoplasm (Figure 1-5).  
Gn and/or Gc seem to be involved in virus attachment. The presence of neutralising sites 
on both Gn and Gc proteins of phleboviruses and hantaviruses suggest that they both play a 
role in virus attachment (Arikawa et al., 1989). It appears that Gc is the major attachment 
protein for orthobunyaviruses in mammalian and mosquito cells (Hacker et al., 1995; 
Plassmeyer et al., 2005) while studies with the orthobunyavirus LACV suggested that Gn 
could mediate attachment in mosquito cells (Ludwig, 1989; 1991). Similar results were 
reported for TWSV, where Gn could mediate attachment in thrips (Whitfield et al., 2004). 
The cellular protein(s) mediating virus attachment are poorly characterised. To date, they 
have been identified only for viruses within the genera Hantavirus and Phlebovirus. 
Hantavirus attachment to epithelial cells is mediated by β3 and β1 integrins (Gavrilovskaya et 
al., 1999; Gavrilovskaya et al., 1998). Interestingly, the tropism for either β3 or β1 integrins 
was linked to the severity of the resulting disease and were respectively linked with high or 
low pathogenicity (Gavrilovskaya et al., 2002). For HTNV and PUUV, two other cellular 
proteins have been shown to play a role in virus-cell interaction: DAF/CD55, a GPI-anchored 
protein and gC1qR/p32, a glycoprotein interacting with C1q (Choi et al., 2008; Krautkramer 
& Zeier, 2008). For the phleboviruses RVFV and UUKV a recent study by Lozach et al. has 
established the role of DC-SIGN as a receptor for viral entry (Lozach et al., 2011). DC-SIGN 
is a C type lectin that binds mannose N-glycan through its carbohydrate recognition domain, 
relevant with the observation that both Gn and Gc are glycosylated. 
After attachment, virus particles need to be internalised through endocytosis. The 
hantavirus HTNV, orthobunyavirus OROV and nairovirus CCHF have been shown to be 
internalised through the well characterised clathrin-dependant endocytosis pathway (Jin et al., 
2002; Santos et al., 2008; Simon et al., 2009) while the phlebovirus UUKV utilises a clathrin 
independent route for internalisation (Lozach et al., 2010). Following endocytosis, virus 
particles localise in the early, then late, endosomes and acidification of the vesicle is thought 
to promote fusion of the viral Gn and/or Gc protein with the cellular membrane. A model 
where Gc mediates the fusion between viral and vesicle membranes is supported by different 
experiments demonstrating its ability to promote cell-to-cell fusion at low pH 
Chapter 1: Introduction  The Bunyaviridae 
 
21 
 
 
 
Figure 1-5: Entry and uncoating of Hantaan virus particles. 
(1) The glycoproteins of HTNV bind to the β3 and/or β1 integrins. (2) Receptor binding trigger the 
formation of a clathrin-coated vesicle that is cleaved from the cell membrane by dynamin. (3) The 
vesicle is addressed to the early endosome. (4-5) Maturation from early to late endosome, during 
which the pH changes from neutral to acidic, allows fusion of the viral membrane with the endosomal 
membrane and release of the RNPs into the cytoplasm. 
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(Filone et al., 2006; Ogino et al., 2004; Plassmeyer et al., 2005; Plassmeyer et al., 2007). For 
UUKV, a low pH was shown to induce conformational changes of Gc and these changes are 
thought to be involved in fusion (Overby et al., 2008). The role of Gn is not well 
characterised but truncation of the cytoplasmic tail of BUNV Gn resulted in a defect in 
membrane fusion suggesting that Gn also plays a role in the fusion process (Shi et al., 2007). 
b) Transcription and translation 
In the cytoplasm of infected cells, uncoating of the viral genome leads to primary 
transcription of the negative sense viral RNA and production of mRNA. The viral L and N 
proteins are necessary and sufficient to perform transcription, and only RNPs but not naked 
RNA can serve as templates (Dunn et al., 1995). The role of the N protein in transcription was 
shown for BUNV using site directed mutagenesis in a mini-replicon system or virus context 
(Eifan & Elliott, 2009; Walter et al., 2011) and studies on HTNV implicate that N fulfils the 
function of an RNA chaperone protein and facilitates both the dissociation of the panhandle 
and the unwinding of the RNA strand (Mir, 2005; Mir & Panganiban, 2006). 
Transcription initiation in segmented negative strand RNA viruses is unique and relies on 
the mechanism of ‘cap-snatching’. ‘Cap-snatching’ is the processes by which viruses cleave 
the capped 5’ ends of host mRNAs to use them as primers for viral mRNA synthesis. The 
endonuclease activity necessary to achieve cleavage of the capped primers has been 
associated with the L protein (Jin & Elliott, 1991; Reguera et al., 2010). Unlike influenza 
viruses that hijack newly produced mRNAs in the nucleus, the bunyaviruses L protein targets 
mature mRNAs in the cytoplasm. The N protein is suggested to be involved in the cap-
snatching processes during Sin Nombre hantavirus transcription. Mir et al. (2008) showed that 
N binds to and sequesters cellular 5’ mRNA caps in cytoplasmic foci (processing bodies or P 
bodies), therefore creating a pool of primers directly available to initiate mRNA synthesis 
(Figure 1-6) (Mir et al., 2008).  
For segments using a simple negative-sense coding strategy, mRNAs resulting from the 
transcription of the L and M segment are 40 nt shorter than their cognate segment while S 
mRNAs are 100 nt shorter than the S segment (Bouloy et al., 1990; Jin & Elliott, 1993b). 
Unlike cellular mRNAs, viral mRNAs are not polyadenylated (Abraham & Pattnaik, 1983; 
Vera-Otarola et al., 2010). In the case of segments with an ambisense strategy, transcription 
termination signals are present in the intergenic regions. Signals promoting transcription 
initiation and termination have been identified for BUNV S segment and will be discussed 
later (see section 1-C-3).  
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The transcriptase activity of the L protein results in elongation of the mRNA transcripts. 
A feature unique to viruses within the family Bunyaviridae is the obligatory coupling of 
transcription elongation with translation, i.e. where translation initiates before mRNA 
synthesis is completed (Figure 1-6). Indeed, in the absence of coupled protein synthesis, 
premature transcription termination was observed both in vitro and in vivo. A proposed 
reason was the possibility that, in the absence of ribosomal bonding, the nascent mRNA can 
hybridize to its template causing the polymerase to stall. This would result in an impaired 
transcriptase activity and lead to the production of short transcripts (Barr, 2007; Bellocq & 
Kolakofsky, 1987; Mir et al., 2008; Vialat & Bouloy, 1992). Thus, in bunyaviruses, 
transcription and translation are interdependent. The S and L mRNAs are translated on free 
ribosomes, while the M mRNAs are translated on membrane-bound ribosomes. 
c) Replication 
In order to replicate the negative sense genome, a positive sense antigenome must be 
synthesised first. Compared to mRNAs, antigenome RNA molecules possess exact 3’ and 5’ 
ends and are encapsidated to serve as template to produce exact genome copies (Figure 1-7).  
The switch from cap-dependant initiation resulting in transcription to cap-independent 
initiation resulting in replication is not fully understood. Availability of the N protein seems 
to be involved in the process. Indeed, during replication, the RNA products are encapsidated 
rather than translated and it has been shown for other RNA viruses (i.e rhabdoviruses) that co-
encapsidation of the transcript serves as an anti-termination signal. Moreover, it was shown 
recently that introducing mutations within the amino acid sequence of the N protein had 
different impacts on transcription and replication. Eifan et al. demonstrated that some BUNV 
N protein mutants were replication defective but transcription competent while other were 
replication competent but transcription defective (Eifan & Elliott, 2009). These observations 
suggest that the N protein is involved in the synthesis of the different RNA species.  
Studies of cap-independent transcription in hantaviruses reveal the presence of a 
monophosphate at the 5’ end of the genome. To account for this observation, a prime-and-
realign mechanism was proposed. In this model, replication would initiate with pppG 
alignment with the third nucleotide and after the synthesis of few nucleotides, the polymerase 
would slip back and realign the transcript with the template (Garcin et al., 1995a). More 
details about the prime-and-realign model can be found in section 1-C-3. 
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Figure 1-6: Model for cap-snatching, transcription initiation and obligatory coupled translation. 
After cleavage by the polymerase, the host capped-mRNAs bind to the N protein and are sequestered 
in the P bodies. To initiate viral transcription the RdRp uses the 5’ caps from the pool formed in the P 
bodies. Translation occurs concomitantly to transcription and allows the RdRp to recognise the 
termination signal. Adapted from Mir and al. (2008) and Barr and al. (2007). 
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Figure 1-7: Bunyavirus transcription and replication strategies for negative-sense genome (A) 
and ambisense genome (B). 
The N protein is represented by orange circles; the black lines represent RNA; 5’ cap are represented 
by black squares; protein are represented by blue hexagons. 
 
Chapter 1: Introduction  The Bunyaviridae 
 
26 
 
d) Assembly and egress 
Maturation of the virus particles from assembly to budding happens at the Golgi smooth 
membrane. This is a common feature for bunyaviruses but it is unusual compared to other 
negative sense RNA viruses that bud from the plasma membrane. Budding from the plasma 
membrane has been reported for the hantaviruses SNV and BCCV, and for the phlebovirus 
RVFV but this remains a rare event (Ravkov et al., 1997). 
As morphogenesis occurs at the Golgi complex, viral proteins and RNPs have to localise 
around the Golgi area. Electron-microscopic (EM) studies of BUNV have shown that 
infection induces the formation of a ‘viral factory’ composed by units of Golgi stacks, 
mitochondria, and components of the rough endoplasmic reticulum that are linked together by 
tubular structures (Salanueva et al., 2003). Based on these detailed EM analysis and study of 
viral protein localisation, trafficking and interaction, a model was proposed for BUNV 
morphogenesis (Fontana et al., 2008). In this model (Figure 1-8), the viral factories are 
composed of unique tubular structures with a globular head at one end and open to the 
cytoplasm at the other end. The viral-induced tube is composed of Golgi membranes and its 
head is associated with the ER and mitochondria and contains several cellular proteins such as 
translation elongation factor 2, ribosomal proteins, actin and myosin I. Disruption of the actin 
filament using specific drugs affects both tube formation and function, resulting in impaired 
viral morphogenesis. It was proposed that replication occurs mainly within the globular head 
where viral proteins N and L were located, and then the RNPs would be transported along the 
tube to the assembly site using actomyosin-based motors. The viral protein NSm also appears 
to play an important role within the tube; its presence is essential for tube formation and it 
was suggested that NSm plays the role of a scaffolding protein. Moreover, NSm was shown to 
interact with both N and the glycoproteins (Shi et al., 2006), suggesting that NSm could 
facilitate transport of the RNPs from the replication to the assembly site. This role of matrix-
like protein is supported by the presence of NSm in immature intracellular viral intermediates 
but not in extracellular mature virions. The RNPs travel along the tube until they reach the 
cytoplasm where they bind to the glycoproteins anchored in the nearby Golgi membrane. The 
CT domain of both Gn and Gc is required for virus assembly (Shi et al., 2007). Following 
interaction of the RNPs a virus particle is formed by budding into the Golgi cisternae. The 
virus particle is then transported to the cell surface via the exocytic pathway. During transport, 
the virus particles mature and NSm is not present in the virion released at the cell surface. 
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Figure 1-8: Model for assembly in viral factory and egress. 
Viral tubules assemble using actin and polymerised NSm as scaffold. The reticulous endoplasmic 
reticulum (RER) and the mitochondria (mi) provide cellular factors needed for replication and 
transcription. The viral polymerase and the N protein concentrate in the globular head. (1) Replication 
occurs in the globular head and nascent vRNAs are encapsidated to form RNPs. (2) Actinomyosin 
motors transport the RNPs toward the cytoplasm. (3) The viral RNPs then attach to the cytoplasmic 
domain of the glycoproteins Gc and Gn. (4) Budding from the Golgi membrane lead to the release of a 
vesicle containing the immature virus particle (light grey). (5) The mature virus particle (dark grey) is 
released at the cell surface through the exocytic pathway. Adapted from Fontana and al. (2008). 
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7. Effect of bunyavirus infection on the host-cell 
a) Inhibition of host-cell protein synthesis 
In mammalian cells, orthobunyaviruses and some phleboviruses were found to cause 
partial or complete shut-off of host cell protein synthesis. Interference with host cell protein 
production can occur at transcriptional and/or translational level. Most studies focussed on 
effect on transcription but a recent study showed that BUNV also interferes with translation. 
Thus, orthobunyaviruses inhibit both transcription and translation of cellular mRNAs. 
(i) Inhibition of transcription 
In eukaryotic cells, transcription of mRNAs is performed by the DNA-dependant RNA-
polymerase II (RNAPII). The C-terminal domain (CTD) of RNAPII is composed of 52 
repeats of the heptapeptide YSPTSPS whose phosphorylation status changes as elongation 
progresses. The initiation step require phosphorylation of serine 5 (Ser5) by Cdk7, a 
component of the CAK (Cdk activating kinase) subunit of transcription initiation factor IIH 
(TFIIH) while phosphorylation of serine 2 (Ser2) by Cdk9, a subunit of the positive 
transcriptional elongation factor b (P-TEFb) is required for mRNA elongation and termination. 
The combined action of the kinases Cdk7 and Cdk9 and of their associated phosphatase, 
Ssu72 and Rtr1, and Fcp1, respectively results in a gradient of CTD phosphorylation with 
Ser5-P being more prevalent when the complex is at the 5’ end of the DNA template and 
Ser2-P prevailing when the complex is at the 3’ end of the DNA (Buratowski, 2009; Kuehner 
et al., 2011). 
BUNV was shown to inhibit phosphorylation of RNAPII on Ser2 (Thomas et al., 2004). 
However, cells infected with a NSs-deficient BUNV displayed a normal phosphorylation 
pattern on Ser2, leading to the conclusion that BUNV NSs is necessary and sufficient to 
inhibit RNAPII activity. Later, BUNV NSs was found to interact with MED8, a component of 
the head domain of the Mediator complex (Leonard et al., 2006). Mediator activates 
transcription initiation by acting as a bridge between DNA, transcription factors and RNAPII 
(Conaway & Conaway, 2011; Conaway et al., 2005). The interaction of NSs with MED8 is 
thought to destabilise the initiation complex resulting in reduced mRNAs synthesis. A recent 
study by Verbruggen and al. (2011), demonstrated that LACV NSs specifically inhibits 
mRNAs transcription by targeting RNAPII for degradation by the proteasome (Verbruggen et 
al., 2011). The phlebovirus RVFV disrupts RNAPII function through a third mechanism. 
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RVFV NSs was shown to bind to p44, a component of the core of the TFIIH complex. The 
interaction between p44 and XPD is important to ensure correct phosphorylation of the CAK 
substrates which include RNAPII (Le May et al., 2004).  
Orthobunyaviruses and phleboviruses have evolved a mechanism that directly inhibit 
host-cell transcription and thus cellular factors necessary for transcription of the viral genome 
by the viral polymerase are available without competition. 
(ii) Inhibition of translation 
Efficient translation of eukaryotic mRNA relies on the presence of a 5’ 7-methyguanosine 
cap and a 3’ poly(A) tail and the formation of a stem-loop structure. In this model, the cap-
binding complex, formed by eIF4G, 4E and 4A, bind to the 5’ cap and to the poly(A) binding 
protein (PABP), creating a bridge between the 5’ and the 3’ end of the mRNA (Klann & 
Dever, 2004; Sachs et al., 1997). The circularised mRNA then interacts with the 43S pre-
initiation complex composed mainly by the ribosome subunit 40S, eIF2α and the methionyl-
transfer RNA. Following scanning of the ribosome to the AUG, the 60S subunit of the 
ribosome is recruited and translation can start. 
Contrary to transcription, during which viruses do not rely on the host-cell machinery, 
translation of viral proteins utilises the host-cell translational complex and thus has to 
compete with cellular mRNA. BUNV have evolved a mechanism to inhibit translation of 
poly(A) mRNA by sequestering the PABP in the nucleus (Blakqori et al., 2009). The exact 
mechanism leading to relocalisation of PABP is not fully understood but it seems to involve 
both N and NSs proteins and potentially the viral polymerase as well.  
BUNV do not have poly(A) mRNA and therefore translation of viral mRNA occurs in a 
PABP-independent manner. The role of the UTRs in enhancing translation will be discussed 
later (section 1-C-3). 
b) Evasion of the innate immune system 
The innate immune system is the first line of defence against microbial infections and 
instead of targeting specific antigens it recognises pathogen-associated molecular patterns 
(PAMPs). Binding of PAMPs to their cognate pattern recognition receptor (PRR) activates a 
cascade of events leading to production of type I IFN (also called IFNα/β) and induces an 
anti-viral state. RNA viruses trigger the IFN response via activation of cytoplasmic PRRs, 
such as the helicases RIG-1 (retinoic acid inducible gene-1) and MDA5 (melanoma 
differentiation-associated protein 5) which are respectively triggered by 5’ triphosphate group 
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and small dsRNA or large dsRNA structures. Upon activation they interact with the 
mitochondrial membrane protein MAVS and induce a signalling cascade that leads to 
phosphorylation of the transcription factors IRF (IFN regulatory facto) 3 and 7, NF-κB 
(nuclear factor kappa-light-chain-enhancer of activated B cells), and AP-1 (activator protein 
1). After translocation to the nucleus, the transcription factors enhance IFNα/β gene 
expression (Figure 1-9-left). Secreted IFNα/β acts in an autocrine or paracrine manner by 
binding to the type I IFN receptor (IFNAR) on the cell surface. This interaction triggers the 
JAK/STAT signalling cascade which leads to expression of IFN stimulated genes (ISGs). 
Among the many ISGs expressed, the three most important and well-studied are PKR (protein 
kinase R), the 2’-5’ oligoadenylate synthase (2’5’OAS)/RNaseL system and the protein Mx. 
PKR phosphorylates the elongation translation initiation factor eIF2α which results in a 
general protein synthesis shut-off and activation of 2’5’ OAS which in turn activates RNaseL 
which cleaves all ssRNAs (Figure 1-9-right) (Goodbourn & Randall, 2009; Hale et al., 2008; 
Weber & Haller, 2007). MxA is a strictly IFN-induced protein and many viruses within the 
family Bunyaviridae, including LACV, RVFV, PUUV, HTNV and CCHF, are sensitive to it. 
During LACV infection, MxA was shown to sequester N in perinuclear inclusions making it 
unavailable for viral replication (Kochs, 2002).  
Orthobunyaviruses mainly inhibit the innate immune response through a general block of 
host-cell transcription and translation mediated by the NSs protein. However, RVFV NSs 
protein was shown to have a direct action on IFN production by interacting with SAP30 
(Sin3A associated protein 30) which is a subunit of the Sin3A corepressor complex (Le May 
et al., 2008). Hantaviruses and nairoviruses do not express the NSs protein and induce a very 
weak host-cell protein shut-off, if any. However, CCHF nairovirus interferes with the innate 
immune system via the ovarian tumor (OTU) domain present on the L segment. OTU 
domains are proteases that have the ability to hydrolyse ubiquitin conjugates. The 
deconjugating activity of CCHFV OTU domain results in the inhibition of both the NF-κB 
pathway and the antiviral effect of ISG15 (Frias-Staheli et al., 2007). The activation of NF-κB 
by TNFα and its translocation to the nucleus were shown to be affected by the N protein of 
the hantaviruses HTNV, SEOV and Dobrava (Taylor et al., 2009). 
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Figure 1-9: Simplified type I IFN response signalling. 
Left panel: Activation of the PRRs RIG-1 and MDA5 leads to the phosphorylation of the transcription 
factors IRF-3 and NF-κB. Once in the nucleus, IRF-3 and NF-κB promote the transcription of IFNα/β. 
Right panel: binding of IFNα/β on the IFN receptor triggers expression of the ISGs PKR and RNaseL, 
resulting in a general host-cell protein shut-off. Adapted from Weber et Haller. (2007) and Goodborn 
et Randall (2009). 
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c) Modulation of apoptosis 
Cells that are damaged or are no longer needed can be disposed of through programed cell 
death, or apoptosis. A variety of intrinsic and extrinsic stimuli, like oxidative stress, UV, or 
microbial infections, are sensed by extra-cellular receptor (i.e. Fas receptor) or intracellular 
sentinels in the cytoplasm (i.e. Bcl-2) and the nucleus (i.e. p53). They trigger apoptotic 
signalling pathways that lead to the activation of proteases of the caspase family and 
nucleases (Galluzzi et al., 2008; Shi, 2002; Taylor et al., 2008). 
Viruses can modulate the apoptosis signalling pathway and have either a pro- or anti-
apoptotic influence. In insect cells, in which bunyaviruses establish a persistent infection 
therefore replicating in a non-lytic manner, no evidence of apoptosis induction was found. 
However, in their mammalian host, LACV, OROV, AKAV and Aino virus were found to 
induce apoptosis (Acrani et al., 2010; Lim et al., 2005). LACV NSs was found to induce 
apoptosis in a Reaper-like manner. Reaper is a Drosophila protein involved in regulating 
caspase activity and can cause apoptosis (Steller, 2008). Sequence similarities were found 
between Reaper and LACV NSs as well as similarities in their functions: they both induce 
release of cytochrome c by the mitochondria and they bind to Scythe, therefore inhibiting its 
anti-apoptotic function (Colon-Ramos, 2003). BUNV NSs was shown to have the opposite 
effect on apoptosis. Indeed, a virus lacking NSs expression induced apoptosis more quickly 
compared to wt virus. The anti-apoptotic effect of BUNV NSs is thought to be an effect of the 
general block on IRF-3 observed during infection. IRF-3 not only inhibits transcription but is 
also involved in pro-apoptotic activities (Kohl et al., 2003).  
Despite the ability of different bunyaviruses to inhibit or promote programed cell death, it 
appears that in most cases virus titres were not affected by apoptosis, suggesting that it is not 
important in the virus life cycle. It seems likely that the effect on apoptosis observed during 
bunyavirus infection is due to collateral damages more than real targeting.  
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B. Reverse genetics of negative sense RNA viruses 
1. History of reverse genetics 
In RNA virology, the term reverse genetics designates the ability to use recombinant 
DNA (or cloned DNA) to reconstitute a viral genome. This technique allows the possibility to 
directly manipulate the viral genome by targeted mutagenesis, thus facilitating the study of 
the relation between genotype and phenotype both in vitro and in vivo. Three types of reverse 
genetics systems have been established: (1) mini-replicon systems where a virus-like genome 
consisting of a reporter gene flanked by viral regulatory regions is co-transfected into tissue 
culture cells with plasmids expressing the viral proteins necessary for replication; (2) virus-
like particle (VLP) assays, extension of the mini-replicon assay, with the addition of 
expression-plasmids for viral glycoproteins that allow packaging and transfer of the reporter 
gene; and (3) rescue systems that generate infectious virus particles that may contain specific 
genetic modifications. 
Rescue or recovery of infectious viral particles is easier for positive sense RNA viruses 
than for negative sense RNA viruses. Indeed, transfection of cDNA is sufficient to achieve 
expression of the viral genome. Hence, the first RNA virus generated by transfection of 
cDNA into E. coli was the bacteriophage Qβ (Taniguchi et al., 1978). A few years later, 
poliovirus was recovered following transfection of mammalian cells with a plasmid 
containing a cDNA copy of the viral genome (Racaniello & Baltimore, 1981). Reverse 
genetics for many positive strand RNA viruses followed. 
Rescue of negative strand RNA viruses appeared to be more challenging, as neither their 
genome nor antigenome is sufficient to initiate viral replication. Indeed, the minimal 
infectious unit is an intact RNP formed by the encapsidated genomic or antigenomic RNA 
coupled with the RdRp. The first step toward the rescue of a NSV was taken by Luytjes et al 
in 1989 when they managed to successfully reconstitute influenza RNPs in vitro (Luytjes et 
al., 1989). They used a mini-genome comprising the CAT (chloramphenicol acetyl 
transferase) gene in the negative sense flanked by the UTRs of the influenza A virus NS gene 
which was transcribed in vitro. RNPs were formed by combining the mini-genome with the 
viral proteins NP, PA, PB1 and PB2 which were then transfected into cells that were infected 
with an helper virus. In this system, the reporter gene was amplified, expressed and packaged 
into virus particles. Despite this success, it was only ten years later that the first influenza 
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virus was rescued entirely from cDNA (Fodor et al., 1999; Neumann et al., 1999). In the 
meantime, rescue of other NSV was successful. Rabies virus was the first non-segmented 
NSV to be successfully rescued from cDNA and this success was due to the innovative idea to 
transfect a plasmid that contains the viral genome in the positive sense orientation i.e. the 
antigenome (Schnell et al., 1994). In the footsteps of RV rescue, groups working on other 
non-segmented NSV adapted this method to successfully rescue VSV (Whelan et al., 1995), 
measles virus (Radecke et al., 1995) and Sendai virus (Garcin et al., 1995b) among others. 
In their system, Schnell et al. (1994) use a T7 promoter to promote transcription of the 
viral genome from the cDNA by the bacteriophage T7 DNA-dependant RNA-polymerase 
(T7RNAP). Using the T7RNAP has advantages: it can be expressed in a broad range of cell 
lines and not only mammalian cell lines, and it localises in the cytoplasm where most NSV 
replicate. However, the T7RNAP has to be supplied in trans using either a recombinant 
vaccinia virus, transfection of an expression plasmid, or by a transgenic cell line 
constitutively expressing it. The use of T7RNAP also has limitations: transcription initiation 
is most efficient on template starting with a guanoside and transcription termination is not 
precise (Kuzmine et al., 2003; Milligan et al., 1987). The addition of an extra G at the 5’ end 
of the viral template will ensure high transcriptional level but might result in decrease 
recognition by the viral polymerase. The presence of authentic 5’ and 3’ end can be achieved 
by the use of self-trimming ribozymes. The cellular DNA-dependant RNA-polymerase I 
(RNAPI) can achieve more precise transcription, but its promoter sequences are species 
specific, restricting the choice of cell lines and the RNAPI is localised in the nucleus. This 
nuclear localisation might have an impact on post-transcriptional modification of the viral 
transcript.  
Rescue of segmented NSV proved more challenging and the number of available systems 
is still limited. Difficulties come from the number of plasmid having to be transfected as well 
as achieving the correct ratio between each plasmid to mimic natural infection. The first 
successful rescue of a segmented NSV was reported for BUNV by Bridgen and Elliott in 
1996 (Bridgen & Elliott, 1996). This system required the transfection of six plasmids (three 
genome plasmids and three support plasmids) but a few years later, Lowen et al. developed a 
system where only the three genome plasmids were required (Lowen et al., 2004). Both 
systems will be described in details in section 1-B-2-c. 
Three years later, a completely different system, using both RNAPI and RNAPII, was 
used to rescue influenza viruses from cDNA. Two groups achieved it in the same year using a 
similar approach: the cDNA of each viral segment was cloned under control of the human 
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RNAPI promoter while the expressing plasmid for the three polymerase subunits and the 
nucleoprotein were cloned under the RNAPII promoter. (Fodor et al., 1999; Neumann et al., 
1999). The main difference lies in the termination signal used to terminate the antigenome 
transcript: when Neumann et al. used a mouse RNAPI terminator, Fodor et al. choose the 
hepatitis delta virus ribozyme. The 12-plasmid rescue system was further simplified to a 8-
plamid rescue system by Hoffman et al. (2000). To achieve production of infectious influenza 
virus from only 8 transfected plasmids a bidirectional pol I-pol II transcription system was 
engineered: the viral cDNA was inserted in the negative-sense orientation between the 
RNAPI promoter and terminator sequence, then this cassette was inserted in the positive-
sense orientation between the RNAPII promoter and poly(A) signal. Thus, both mRNA and 
genomic RNA are transcribed from the same plasmid (Hoffmann & Webster, 2000).  
Over the recent years, efficiency of the existing rescue systems has been improved and 
more and more system became available for segmented NSV (Table 1-4). 
 
Virus Promoter system Proteins supplied in trans Reference  
BUNV T7RNAP L, N, Gn and Gc (Bridgen & Elliott, 1996) 
none (Lowen et al., 2004) 
LACV T7RNAP none (Blakqori & Weber, 2005) 
Influenza A 
hRNAPI (gen) 
MLP (sp) 
PA, PB1, PB2 and NP (Fodor et al., 1999) 
hRNAPI (gen)  
CMV (sp) 
PA, PB1, PB2 and NP (Neumann et al., 1999) 
Bidirectional hRNAPI-
hRNAPII 
none (Hoffmann & Webster, 2000) 
Influenza B Bidirectional hRNAPI-hRNAPII 
none (Hoffmann, 2002) 
LCMV T7RNAP (gen) RNAPII (sp) 
L, NP and GP (Sanchez, 2006) 
RVFV 
T7RNAP L, N, Gn and Gc (Ikegami et al., 2006) 
mRNAPI (gen)  
T7RNAP (sp) 
L and N (Billecocq et al., 2008) 
T7RNAP none (Bird et al., 2008) 
AKAV mRNAPI (gen)  CMV (sp) 
L, N, Gn and Gc (Ogawa et al., 2007b) 
Influenza C hRNAPI (gen)  HMG (sp) 
PB2, PB1, P3 and NP (Crescenzo-Chaigne & van 
der Werf, 2007) 
Lassa virus T7RNAP none (Albarino et al., 2011) 
JUNV RNAPI (gen) RNAPII (sp) 
L and NP (Emonet et al., 2011) 
Table 1-4: Non exhaustive list of NSV rescue systems. 
Abbreviation: T7RNAP (T7 DNA-dependant RNA-polymerase), mRNAPI (murine DNA-dependant 
RNA-polymerase I), hRNAPI (human DNA-dependant RNA-polymerase I), CMV (cytomegalovirus), 
HMG (mouse hydroxymethylglutaryl-coenzyme A reductase), gen (genome), sp (support plasmids). 
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2. Reverse genetics of bunyaviruses and their 
applications 
a) The mini-replicon system 
Mini-replicon systems have been established for the orthobunyaviruses BUNV, LACV 
and AKAV (Blakqori, 2003; Dunn et al., 1995; Ogawa et al., 2007b). Either RNAPI for 
LACV and AKAV or T7RNAP for BUNV ensure the transcription of the virus-like 
antigenome. In the BUNV system, the virus-like cDNA contains the ORF of a reporter gene 
(i.e. CAT or Renilla luciferase) flanked by the viral UTRs. This construct is under the control 
of the T7RNAP promoter and terminator sequences, and the sequence of the hepatitis δ 
ribozyme placed downstream of the BUNV 3’ UTR guarantees the exact end. Protein-
expressing plasmids (or support plasmids) contain a viral ORF under the control of the 
T7RNAP promoter and allow expression of the viral proteins required for transcription and 
replication. In all systems, expression of the reporter gene requires the presence of the N and 
L proteins, sustaining the concept that only RNPs and not naked RNA serve as template for 
transcription and replication by the polymerase. Addition of the NSs protein to the system 
proved to have an inhibitory effect on expression of the reporter gene (Blakqori, 2003; Weber 
et al., 2001).  
Mini-replicon systems have also been established for RVFV but contrasting effects of the 
NSs protein have been reported: Ikegami et al. (2005) shown that NSs enhanced mini-replicon 
activity while two different groups observed an inhibitory effect (Bouloy & Weber, 2010; 
Brennan et al., 2011a; Ikegami et al., 2005). The development of mini-replicon systems for 
hantaviruses and nairovirus proved more difficult giving high background of reporter gene 
activity (Bergeron et al., 2009; Flick et al., 2003; Zhang et al., 2008). 
Mini-replicon systems are a crucial step toward the successful rescue of an infectious 
virus from cDNA. They also are a powerful tool to assess the activity of the N and L proteins 
as well as the functionality of the UTRs. 
b) VLPs assays 
VLPs assays are an extension of mini-replicon assays where, by providing expression 
plasmids for the GP, Gn and Gc, the mini-replicon genome can be packaged into infectious 
virus-like particles. VLPs can infect new cell but are unable to spread or produce progeny 
virus: in the initial transfection the genome expressing plasmid for the L and N segment are 
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provided but the GP are only provided as expressing plasmids. VLPs have been used to 
studied genome packaging both at the protein and genome sequence level (Eifan & Elliott, 
2009; Overby et al., 2006; Shi et al., 2009; Shi et al., 2007). Interestingly, purified VLPs of 
the phlebovirus RVFV were shown to trigger a protective immune response in mice (Näslund 
et al., 2009), such a potential for vaccine engineering has not been reported for members of 
the Orthobunyavirus.  
c) The rescue system 
When BUNV was first recovered from cDNA in 1996 the procedure was demanding and 
the system inefficient. However, it was a breakthrough. In this system, Hela cells were first 
infected with a recombinant vaccinia virus which expresses T7RNAP in the cell cytoplasm. 
Then cell were transfected with the three support plasmids that encode for all the viral 
proteins. After a period of incubation, the three plasmids encoding the full length L, M and S 
antigenomes were transfected. These plasmids were similar to the mini-genome (described 
previously) with a viral ORF in the place of the reporter gene. In order to isolate BUNV from 
vaccinia virus, supernatant from the transfected cells was passaged onto C6/36 Aedes 
albopictus cells (in which vaccinia virus does not replicate) and released BUNV was plaque 
purified on BHK-21 cells (Bridgen & Elliott, 1996). The procedure typically yielded 10-100 
plaques per 107 cells transfected.  
The efficiency of the system was progressively improved. The first step was the creation 
of a BHK-derived cell line constitutively expressing the T7RNAP, BSR T7/5 cells (Buchholz 
et al., 1999). These cells could be transfected with a mixture of the three support plasmids and 
the three transcription plasmids and this new system routinely yielded 106-107 pfu per dish of 
wt BUNV. The system was further simplified by reducing the number of transfected plasmids 
from six to five, using only support plasmids for N and L proteins. Lowen et al. (2004) 
reduced the number of plasmids to just the three that encode the viral antigenomic RNA 
(Lowen et al., 2004). This protocol routinely yields 106-107 pfu/ml of wt BUNV.  
The T7RNAP three plasmid based system was successfully applied to rescue LACV 
(Blakqori & Weber, 2005) and the phlebovirus RVFV (Ikegami et al., 2006). Surprisingly, for 
LACV, the addition of support plasmids in the transfection mix abolishes virus rescue. The 
RNAPI based rescue of AKAV required the transfection of the support plasmids for the N and 
L proteins (Ogawa et al., 2007b). The need of five plasmids was also observed for RVFV 
when the RNAPI promoter was used (Billecocq et al., 2008). The reason behind this 
difference is not fully understood but might be explain by different transcriptional levels or 
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difference between the T7 and RNAPI transcript.  
Reverse genetics provide a powerful tool to explore bunyavirus gene function and viral 
replication. This technology has been extensively used to characterise the role of NSs during 
the life cycle of many viruses including BUNV (Streitenfeld et al., 2003; Weber et al., 2002), 
RVFV (Billecocq et al., 2004), and LACV (Blakqori et al., 2007). The role of the other NS 
protein, NSm, in apoptosis (Won et al., 2007) and virus assembly (Shi et al., 2006) was also 
studied using genetically modified RVFV and BUNV respectively. The facility to manipulate 
the genome also allows for the fusion of markers like the V5-tag or the fluorescent protein 
eGFP to different viral proteins. Hence, cellular localisation of the viral proteins can be 
defined using confocal microscopy (Brennan et al., 2011a; Shi & Elliott, 2009) or live-cell 
imaging (Shi et al., 2010). Recently, reverse genetics has been applied to engineer attenuated 
viruses that could have vaccine potential. Lowen et al. showed that manipulation of just the 
UTRs results in virus attenuation in both tissue culture and mice but further studies are 
necessary to determine their vaccine potential (Lowen et al., 2005), while a recombinant 
RVFV virus lacking both NSs and NSm ORFs was shown to confer protective immunity in 
mice and sheep (Bird et al., 2012; Bird et al., 2008).  
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C. Untranslated regions of negative and ambisense 
RNA viruses 
1. General organisation of negative and ambisense RNA 
virus UTRs 
RNA virus genomes are flanked by non-coding regions that play an important role in 
virus life cycle. These regions contain signals that are necessary and sufficient to drive viral 
RNA and protein synthesis, as well as nucleocapsid formation and virion assembly. 
 
The genome of non-segmented negative strand viruses (order Mononegavirales) is 
characterised by a 3’ leader and 5’ trailer sequence at the termini, and each gene is separated 
by an intergenic sequence. Sequences forming the leader (Le), trailer (Tr) and intergenic 
region (IGR) are not transcribed. In addition to the leader, trailer and intergenic sequence, the 
3’ and 5’ end of each gene contain highly conserved gene start and gene end sequences that 
are transcribed but not translated and are therefore referred as UTRs. 
For vesicular stomatitis virus (VSV), the prototype for the genus Rhabdovirus, the leader 
and trailer are 47 nt long with the 25 most extreme nucleotides being complementary. The 
complementarity decreases further from the termini. Each gene is flanked by conserved 
nucleotides that are respectively UUGUC and AUAC. Gene end and gene start sequence are 
separated by only two nucleotides forming the intergenic region (Barr et al., 2002; Rose, 
1980). 
The genome organisation of Ebola virus (genus Filovirus) is more complex than that of 
VSV. Indeed, EBV genome is larger and encodes more genes than VSV genome. The 3’ 
leader and 5’ trailer sequence are highly conserved and present a high degree of 
complementarity that allows formation of a stem-loop structure (Sanchez et al., 2001). 
Untranslated regions preceding and following each ORF are unusually long. Thus the start 
codon for the first protein is at nucleotide position 470 while the stop codon of the last protein 
is located 742 nt upstream of the very end (Weik et al., 2005). Two consecutive genes are 
either separated by an intergenic region or the 5 conserved nucleotides of the transcription 
stop signal of the upstream gene also serve as the transcription start signal of the downstream 
one (Neumann et al., 2009). 
Chapter 1: Introduction  Functions of the UTRs  
 
40 
 
 
Viruses within the family Arenaviridae have a two-segmented genome and both the large 
(L) and the small (S) segments use an ambisense coding strategy. The first 19 nt of the 3’ 
UTR are conserved between the L and S segment and among family members. Despite two 
mismatches, the 5’ terminal 19 nt are mostly complementary to the 3’ terminus and are tought 
to base-pair to form a panhandle structure. The 3’ and 5’ UTRs of the L and S segment are 
respectively 32-100 nt and 22-65 nt long. On both segments, the intergenic region, that 
separates the ORFs, are 59 to 217 nt and are predicted to form one to three hairpin structures 
(reviewed in (Buchmeier et al., 2001)). 
 
Viruses within the family Orthomyxoviridae possess a segmented genome of negative 
polarity that generally carries short UTRs. The UTRs of influenza A viruses have been best 
characterised and are 20 to 45 nt long at the 3’ genomic end while the 5’ UTR is 19 to 57 nt 
long. The first 12 to 13 nt at the 3’ and 5’ ends of the genomic RNA respectively are partially 
complementary and are conserved between the eight segments and between strains.  
2. Anatomy of bunyavirus UTRs 
Members of the Bunyaviridae have a tri-segmented genome that exhibits 
complementarity and conservation of the termini among viruses in the same genus but not 
between viruses in different genera (Table 1-5). The inverted complementarity of the 3’ and 5’ 
UTRs allows base-pairing of the termini and formation of a panhandle structure characteristic 
of segmented negative-sense RNA viruses. Both the length of the UTRs and the extent of 
complementarity vary for each segment and between genera. As a general rule, the genomic 3’ 
UTR is shorter than the 5’ UTR of a given segment.  
 
Genus 3’ terminus 5’ terminus  
Orthobunyavirus UCAUCACAUGA… …UCGUGUGAUGA 
Hantavirus AUCAUCAUCUG… …AUGAUGAU 
Nairovirus AGAGUUUCU… …AGAAACUCU 
Phlebovirus UGUGUUUC… …GAAACACA 
Tospovirus UCUCGUUAG… …CUAACGAGA 
Table 1-5: Consensus 3’ and 5’ terminal sequences of genomic sense RNAs. 
The terminal sequences are written in the genomic 3’ to 5’ sense. 
 
For viruses within the genus Orthobunyavirus, the terminal 11 nt of each segment are 
conserved between all serogroups and inversely complementary, with the exception of a G-U 
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mismatch at position 9. They are followed by short segment-specific sequences (3 to 4 nt) that 
are conserved between virus of the same serogroup. Thereafter, UTRs are highly variable both 
in sequence and length. Indeed, while the length of the coding region is conserved within a 
serogroup, the length of the UTRs varies greatly even among viruses in the same serogroup, 
e.g. in Bunyamwera serogroup, the N ORF is 699 nt, whereas the S 3’ UTR varies from 27 to 
85 nt and the S 5’ UTR varies from 169 nt to 226 nt. Differences between serogroups are even 
greater with some viruses having very shorter UTRs, e.g. OROV has a S 5’ UTR of only 14 nt 
and a S 3’ UTR of only 44 nt (Table 1-6).  
For the family prototype, BUNV, the 3’ and 5’ UTR of the L and M segments are about 
50 and 100 nt respectively, while UTRs of the S segment are longer with 85 and 174 nt. 
Similar to all orthobunyaviruses, the first 11 nt of each end are complementary (except the G-
U pair at position 9) and complementarity is extended 4 nt for the L and S segment and 3 nt 
for the M segment. Further imperfect complementarity is observed within the segment-
specific sequences up to 30 nt (Figure 1-10). 
 
 L  M  S 
 3’ 5’  3’ 5’  3’ 5’ 
AKAV 30 82  22 81  33 123 
BUNV 50 108  56 100  85 174 
INKV 43 61  52 122  72 206 
JCV 58 108  52 123  72 256 
LACV 61 127  61 140  81 195 
TAHV 61 125  61 107  78 192 
OROV 43 50  31 91  44 14 
Table 1-6: Length in nucleotide of the 3’ and 5’ UTRs of the three segments of different 
orthobunyaviruses. 
Nucleotide sequences accession numbers are given in Table 2-1. 
 
The phlebovirus S segment and the tospoviruses M and S segments use an ambisense 
strategy to code their proteins. While their 3’ and 5’ UTR bear the same characteristic as those 
of other bunyaviruses, they also possess an intergenic region. This intergenic region is 
predicted to form a hairpin structure similar to the one observed for arenaviruses. 
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Figure 1-10: Extended nucleotide complementarity of BUNV termini. 
The first 11 nt (left of the red line) are conserved between all three segment and within the genus 
Orthobunyavirus. The following three or four nt (highlighted in yellow) are conserved for each 
segment within the Bunyamwera serogroup. The remaining nt are unique to each BUNV segment. 
Adapted from (Elliott et al., 1991). 
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3. UTR functions during the virus life cycle 
a) Promoter elements 
For non-segmented negative sense viruses (order Mononegavirales), the genomic 3’ end 
(Le) has to promote both transcription and replication while the antigenomic 3’ end 
(complementary to the trailer, TrC) serves as a promoter for replication only. Using reverse 
genetics and mini-genome assays, two structures of replication promoters have been 
described: first, a replication promoter that is compact and entirely located within the Le/TrC 
sequences, as shown for rhaboviruses and pneumoviruses (Fearns et al., 2000; Li & Pattnaik, 
1999; McGivern et al., 2005); second, a replication promoter that is composed of two distinct 
domains separated by a spacer region, shown to be a natural feature of paramyxoviruses 
(Marcos et al., 2005; Tapparel et al., 1998), and reported for some filoviruses (Weik et al., 
2005). Bi-partite promoters comprise around 30 nt in the Le/TrC region (the first 12 nt of 
which are conserved) and a second element present in the 3’ UTR of the first gene or the 5’ 
UTR of the last gene.  
For VSV, the first 15 nt of both the Le and the TrC were identified as the minimal 
promoter for replication, and the level of replication was shown to increase with the extent of 
complementarity of the extremities (Whelan & Wertz, 1999b). However, transcriptional 
activity relies on specific sequence elements within the Le region and increasing the 
complementarity between the termini decreases the efficiency of transcription. Besides nt 19 
to 46 in the Le region being important, the promoter for transcription also requires four non-
transcribed nucleotides at the junction between Le and the first gene, as well as sequences in 
the gene start signal (Li & Pattnaik, 1999; Whelan & Wertz, 1999b). Thus, replication and 
transcription promoters are formed by overlapping sequences but are distinct enough to 
promote either replication starting at the +1 genomic position or transcription starting at the 
first gene start signal (Whelan & Wertz, 2002). This model with two distinct initiation sites is 
supported by findings showing the existence of two different polymerase complexes 
(Qanungo et al., 2004). The replicase complex is formed by the viral L, P and N proteins, 
while the transcriptase complex is formed by the viral L and P proteins associated with three 
host factors (Elongation Factor 1-α, Guanylyltransferase and Heat Shock Protein 60). 
Qanungo et al. (2004) then showed that the replicase and transcriptase complexes, as they 
defined them, initiate synthesis at the exact 3’ genomic termini or at the first gene start signal 
respectively. Transcription can only initiate at the first 3’ gene start resulting in an obligatory 
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sequential transcription of the gene in the order they appear from the 3’ genomic end to the 5’ 
(Abraham & Banerjee, 1976; Ball & White, 1976). At each gene junction, the polymerase 
halts for few minutes and in 70-80% of cases reinitiates on the downstream gene. This 
phenomenon results in a gradient in mRNA synthesis also called transcriptional attenuation 
and is a common feature of non-segmented RNA viruses (Barr et al., 2002). 
 
Different to viruses with non-segmented genome, those with segmented genomes, both 
negative or ambisense coding strategy, can regulate the replication and transcription of each 
strand separately. However, essential sequences at both the 3’ and 5’ genomic termini are 
conserved between each strand and only the following internal sequences are segment specific.  
The mechanisms regulating transcription and replication of influenza A viruses have been 
well characterised. The association of the PA, PB1 and PB2 subunits forms the polymerase 
complex. During transcription initiation, the PB1 subunit binds to the stem-tetraloop at the 5’ 
terminus of the genome (Figure 1-11-A). Rao et al. (2003) showed that it was the identity of 
the nt at position 2, 3, 8 and 9 that was important in template activity rather than their ability 
to base-pair (Rao et al., 2003). This interaction triggers the activation of the cap-binding site 
of the PB2 subunit and also the PB1 binding site for the 3’ terminus (Figure 1-11-B, C) (Li et 
al., 1998; Li et al., 2001). Then, nt 11-13 of the 5’ end and nt 10-12 of the 3’ end base-pair 
and enhance the endonuclease activity of PA (Dias et al., 2009; Yuan et al., 2009). Cleavage 
of host-cell mRNAs occurs preferentially after a CA sequence (Geerts-Dimitriadou et al., 
2011) and transcription starts at the penultimate nucleotide of the 3’ termini. Addition of the 
first nucleotide triggers the release of both the cap and the 3’ end of the vRNA and then 
elongation can proceed (Figure 1-11-D). The switch from transcription to replication is not 
fully understood but it must occur at or before initiation. Indeed, replication requires the 
polymerase complex to switch from primed to un-primed RNA synthesis. Recent studies 
seem to indicate that NP might influence polymerase activity by altering the structure of the 
promoter by binding to it (Newcomb et al., 2008). Other studies describe that high levels of 
capped mRNA were in favour of transcription while high level of viral polymerase combined 
to the 5’ end of vRNA promote replication (Olson et al., 2010; Perez et al., 2010). Replication 
of the negative-sense viral genome requires an intermediate RNA species, the positive-sense 
antigenome. Two different initiation mechanisms have been proposed for each step (Figure 
1-12). The synthesis of the antigenome would start with the dinucleotide pppApG at the 3’ 
extremity of the viral genome (Deng et al., 2006) while synthesis of the vRNA from the 
antigenome would start internally at positions 4 and 5 with the same dinucleotide pppApG. 
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Figure 1-11: Model for influenza cap-snatching and transcription initiation. 
(A) Binding of the 5’ end of the vRNA to the PB1 subunit activates the cap-binding site of PB2 (B) 
The host cell mRNA is cleaved by the endonuclease activity of the PA subunit, preferentially after a 
CA sequence. (C) The 3’ end of the vRNA is recruited and base-pair with the 5’ end, solid lines 
indicates base-pairing required for initiation and dotted lines denote base-pairing that enhance 
initiation. The 3’ A of the cap RNA is supposed to bind to the 3’ U of the vRNA, then addition of the 
first GTP caused release of both the capped structure from PB2 and the 3’ end from PB1. (D) The 5’ 
end of the vRNA remain bound to PB1 during the transcription process. Adapted from Rao and al. 
(2003). 
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Figure 1-12: Model for influenza replication initiation. 
(A) Synthesis of antigenome (cRNA) start at the very last nt at the 3’ end of the vRNA template with 
ATP and the addition of the second nt trigger elongation of the transcript. (B) Synthesis of the vRNA 
from the antigenome also starts with the dinucleotide AG but at position 4 and 5 of the template. The 
two nt are then translocated backward to realign with the 3’ end. Adapted from (Deng et al., 2006; 
Zhang et al., 2010) 
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After initiation on the antigenome, the polymerase would stop at the following U, allowing a 
slip back and thus realignment with the exact 3’ terminus (Zhang et al., 2010). Transcription 
can then proceed. 
 
A unique feature of segmented negative-sense viruses is the use of a cap-snatching 
mechanism to initiate mRNA synthesis. This process has been well characterised for 
influenza viruses but less so for bunyaviruses. A recent study of LACV L protein identified 
the endonuclease domain responsible for the cleavage of host-cell mRNA but whether or not 
the UTRs are involved in the process was not investigated (Reguera et al., 2010). Thus, 
similar to influenza virus, replication of the bunyaviruses genome requires a switch from 
primer dependant to primer independent RNA synthesis. The mechanism behind the switch is 
not well characterised either, but few studies seems to point toward a role of the N protein as 
described for other negative-sense RNA viruses. A recent study by Eifan et al. (2009) showed 
that mutations introduced within the N protein affect transcriptional and replicational 
activities differentially suggesting that different regions of the N protein are involved in the 
synthesis of the different RNA species (Eifan & Elliott, 2009).  
Transcription and replication of BUNV genome relies on the cooperation of the 3’ and 5’ 
termini to promote RNA synthesis, and both nucleotide identity and complementarity are 
critical (Barr et al., 2003; Barr & Wertz, 2004; Kohl et al., 2004). Indeed, when the ORF is 
flanked by non cognate UTRs (i.e. S 3’ and M 5’ UTR), the template is both transcription and 
replication deficient (Barr & Wertz, 2004; Kohl et al., 2004). However, restoration of 
complementarity between nt 12 and 15 (or nt 12 and 16) within the variable complementary 
region restored RNA synthesis. Introduction of nucleotide complementary within the internal 
regions of the UTRs has minor effects on RNA synthesis efficiency. Thus the core promoter 
for transcription and replication is present within the extreme 16 nt of the 3’ and 5’ genomic 
termini. A study by Barr et al. (2005) using direct labelling of synthesised RNAs showed that 
the terminal 25 nt were sufficient to promote transcription and confirmed that the antigenomic 
3’ UTR of strictly negative-sense S segment was unable to promote transcription (Barr & 
Wertz, 2005). In order to identify the transcriptional promoter, the differences between the 
first 25 nt of the 3’ genomic and antigenomic UTR were investigated. Between the two 
promoter regions, nine nt differences exist: a conserved mismatch in the panhandle at position 
9, and nt at positions 16 to 25 display little homology. While the identity and base-pairing 
ability of the distal nucleotides was shown to play little role in transcription, identity but not 
the base-pairing ability of the nt at position 9 is crucial. An U at position 9 of the 3’ UTR is 
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critical for transcriptional activity of the template. 
The mechanism of transcription initiation is not well understood. It appears that cleavage 
of the host mRNA often occurs after a preferred sequence reflecting the need for limited base-
pairing with the viral genome (Garcin et al., 1995a; Jin & Elliott, 1993a). For BUNV, the 3’ 
end of the viral genome matches the 5’ end of the scavenged host cellular RNA. Following 
this observation, Jin et al. (1993) proposed that after synthesis of two or three nucleotides, the 
polymerase slips backward on the template, leading to the reiteration of the 5’ terminal 
sequences (Jin & Elliott, 1993a). A similar mechanism was proposed by Garcin et al. (1995) 
for HTNV, and was named ‘prime-and-realign’ (Figure 1-13-A). In this model, host 
oligonucleotides with a terminal G anneal to the C at position +3 of the viral template. 
Synthesis of the nascent mRNA would halt after a few nucleotides and the polymerase would 
realign the transcript with the start of the template by slipping backward. The terminal 
sequence of HTNV is constituted by three AUC triplets and deletion of one or two of the 
triplets is frequently observed suggesting that the priming can happen at the second or third C 
nt and that the polymerase only slips back two nucleotides (Garcin et al., 1995a). The same 
‘prime-and-realign’ mechanism was postulated for initiation of replication for HTNV (Figure 
1-13-B). Indeed, de novo RNA synthesis should generate a 5’ triphosphorylated end; however 
a monophosphorylated U residue is present at the 5’ end of HTNV antigenomic RNAs. Based 
on the ‘prime-and-realign’ mechanism theory, after initiation at position +3 with pppG, the 
polymerase would slip back and position the priming G at position -1 compared to the 
template. The overhanging pppG would be removed by nucleolytic activity of the polymerase, 
leaving a monophosphorylated U at the 5’ end of the antigenome (Spiropoulou, 2011). 
b) Encapsidation signals 
Encapsidation of both genomic and antigenomic species by the nucleocapsid protein is a 
common feature of negative and ambisense RNA viruses. This process is concomitant with 
RNA synthesis, and for this reason, encapsidation signals must reside within the 5’ end of 
each RNA species. 
 
The N protein of VSV was shown to interact preferentially with positive-sense leader 
RNAs over other RNA species in a sequence-specific manner (Blumberg, 1983). The first 14 
nt at the 5’ end were sufficient to promote encapsication, and Blumberg et al. (1983) 
postulated that a stretch of A residues at every third position from the 5’ end of both genomic 
and antigenomic RNAs was responsible for the selective encapsidation of these RNAs in vitro.  
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Figure 1-13: Prime-and-realign model for hantavirus transcription and replication initiation. 
(A) The host 5’ cap primes with a G residue at position +3 of the viral template. After a short 
extension, the polymerase slips backwards 2 nt to realign the transcript, then elongation can proceed. 
(B) Replication is primed with a GTP at position +3 of the viral template. After a short extension, the 
polymerase slips backwards 2 nt, positioning the initial G at position -1. A cleavage mechanism results 
in the presence of a monophosphorylated U at the start of the transcript. Elongation can then proceed. 
Adapted from Spiropoulou (2011).  
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The role of an A-rich region in the encapsidation signal was also reported for rabies virus by 
Yang et al. (1998): they demonstrated that the N protein bind to nt 20-30 in the positive-sense 
RNA leader region (Yang et al., 1998). This motif is also present in the trailer region of the 
genomic RNA, however, neither terminus presents the pattern of A residues at every third 
position. In contrast, the nucleocapsid protein of influenza viruses appears to bind single-
stranded RNA without any sequence specificity (Yamanaka et al., 1990). 
 
Encapsidation signals of bunyaviridae have been mainly studied for BUNV and some 
hantaviruses. Using competitive binding assays, the N protein of BUNV was shown to 
interact preferentially with the 5’ terminal 32 nt of the viral S genome. This region was 
predicted to form a stem-loop structure that seems to be required for efficient encapsidation 
(Kohl et al., 2004; Osborne & Elliott, 2000). The results obtained by Ogg et al. with JCV, a 
virus closely related to BUNV, seem to support this notion. Indeed, the N protein of JCV bind 
to the 5’ end of the genomic viral RNA, and the 3’ end of both the genomic or antigenomic 
RNA are not involved (Ogg & Patterson, 2007). Moreover, introducing the sequence of the 5’ 
end into a non-viral background induced the ability of the non-viral RNA to bind the N 
protein. Similar results were observed by Severson et al. for Hantaan virus: encapsidation of 
the S segment RNA by the N protein depended on a specific sequence present in the 5’ 
terminal 39 nt (Severson et al., 2001). This region was also predicted to form a stem-loop 
structure. In contrast, data for SNV suggest that the panhandle formation due to 
complementarity of the 3’ and 5’ ends constitutes the RNA-N binding domain (Mir, 2005; 
Mir & Panganiban, 2004). 
c) Transcription termination signals 
Contrary to replication, transcription terminates upstream of the end of the template. For 
non-segmented NSV, transcription termination of an upstream gene is a pre-requisite for 
transcription initiation of the downstream gene, making transcription termination essential for 
expression of all the viral proteins. For segmented NSV transcription termination is thought to 
prevent base-pairing of the 5’-3’ ends that would prevent translation. Transcription 
termination plays an important role in the virus life cycle and, when identified, specific 
signals were located in the intergenic regions or in the genomic 5’ UTR.  
 
During VSV transcription, approximately 97% of the mRNA being synthesised terminate 
at the gene junction, indicating that the RdRp recognises termination signals efficiently (Barr 
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et al., 2002). As a result, a 100 to 300 nt poly(A) tail is added at the 3’ end of the nascent 
transcript. The intergenic junction of VSV is composed of 23 nt: the strictly conserved 11 nt 
sequences 3’ AUACUUUUUUU 5’ (found at the end of each gene), followed by the 2 nt-long 
non-transcribed intergenic sequence 3’ G/CA 5’ and the well conserved 10 nt gene start 
sequence 3’ UUGUCNNUAG 5’ (Rose, 1980). The gene start sequence is not required for 
efficient transcription termination, indicating that downstream mRNA initiation is not 
involved in transcription termination. The role played by the gene end and intergenic 
dinucleotide in termination was mainly studied using bicistronic mini-genome templates. The 
IGR was found to play a role as a physical barrier between the U-rich gene end sequence and 
the U that begins the gene start sequence. Indeed, the IGR is necessary to signal transcription 
termination but any two nucleotides will be efficient (Barr et al., 1997b; Hwang et al., 1998). 
In contrast, the nucleotide identity of the conserved tetranucleotide 3’ AUAC 5’ was 
important. The alteration of either nucleotides reduced termination efficiency with an 
increased effect from 3’ to 5’, with alteration of the C residue resulting in the production of 
read-through transcripts only (Barr et al., 1997a). However, the nucleotide identity of these 
four nucleotides had no impact on the formation of the poly(A) tail. The seven U residues 
were found to promote the addition of 100 to 300 A residues through a mechanism know as 
reiterative transcription. Moreover, shortening or interrupting the U7 tract abolishes 
termination (Barr et al., 1997a). Reiterative transcription or stuttering of the polymerase was 
shown to be induced by the AU-rich tetranucleotide upstream of the U7 tract while a GC-rich 
sequence abolished termination producing read-through transcripts (Barr & Wertz, 2001). 
 
Members of the family Arenaviridae possess a two segmented ambisense genome. Each 
of the L and S segments code for two mRNA, one is transcribed from the 3’ genomic end and 
the other from the 3’ antigenomic end. The two ORFs are separated by an IGR that does not 
contain a poly-U sequence, and accordingly mRNAs are not polyadenylated. However, the 
termination of all four mRNAs has been mapped to occur within the IGR, preferentially at a 
putative stem-loop structure. For LCMV, the preferred site for transcription termination 
appears to be the distal side of the hairpin downstream of the coding sequence (Meyer & 
Southern, 1993). The importance of the IGR in transcription termination was also shown 
using mini-genome assays where it proved essential for the synthesis of mRNAs (Pinschewer 
et al., 2005). Similar results were reported for other members of the family supporting a 
structure-dependant model for transcription termination. Indeed, Lopez et al. (2007) used the 
reverse genetic system to show that a single, highly stable hairpin was sufficient to signal 
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termination of mRNAs synthesis by Tacaribe virus (López & Franze-Fernández, 2007). The 
stem-loop structure at the 3’ end, as well as signalling termination, could play a role in 
stabilising the mRNA and protecting it against exonuclease digestion. 
 
Influenza virus mRNAs are polyadenylated, and like non-segmented NSV, transcription 
termination occurs at a 5 to 7 nt long U sequence located 17 nt upstream of the 5’ end of the 
viral RNA. According to the model for influenza A virus transcription termination (reviewed 
in (Fodor, 2001)), the poly(A) tail is synthesised by stuttering of the polymerase or reiterative 
copying of the U stretch. Direct evidence that the U tract is involved in the formation of the 
poly(A) tail was obtained by Poon et al (1999): they showed that replacing the U tract by an A 
tract result in the synthesis of a polyuridilated RNA both in vitro and in vivo and that 
interrupting the U tract abolishes polyadenylation (Poon et al., 1999). The mechanism of 
stuttering is thought to be induced by steric hindrance. Indeed, the 5’ end of the viral template 
is bound to the PB1 subunit of the polymerase throughout the transcription process, therefore 
the loop formed by the remaining template gets shorter and shorter. When the polymerase 
reaches the U stretch, the length of the remaining template provides a physical barrier to 
elongation causing stuttering and formation of the poly(A) tail (Figure 1-14) (Poon et al., 
1998; Pritlove et al., 1999).  
For members of the Bunyaviridae, mRNAs synthesised from gene segments with a simple 
negative sense coding strategy are generally truncated at their 3’ end: their synthesis 
terminates about 40 nt (L and M segments) or 100 nt (S segment) before the end of the 
genomic template (Bouloy et al., 1990; Eshita, 1985; Jin & Elliott, 1993a; Patterson & 
Kolakofsky, 1984). Although most negative-strand RNA viruses use a U tract to signal 
transcription termination via polyadenylation of the transcript, the presence of a poly(A) tail 
has not been identified on most mRNA within the family (Abraham & Pattnaik, 1983; 
Blakqori et al., 2009; Vera-Otarola et al., 2010).  
The presence of a U tract signalling termination transcription was reported for the M 
segment of Sin Nombre hantavirus (Hutchinson, 1996). In this study, a U8 repeat was 
identified as responsible for the synthesis of a poly(A) tail on the nascent GP transcript. This 
U tract is highly conserved among hantaviruses suggesting that other virus in this genus might 
use an U repeat to signal transcription termination. However, there is no such evidence to date. 
In the same study, Hutchinson et al. (1996), identified a C-rich motif CCCACCC responsible 
for transcription termination of the S segment mRNA. This sequence is also conserved in 
related hantaviruses. The signals for transcription termination of other members of the 
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Figure 1-14: Model of transcription termination and polyadenylation in influenza virus. 
After initiation and for the duration of the transcription process the 5’ end of the template remains 
bound to the polymerase. As a consequence, near the end of the template the polymerase provide a 
physical barrier and cannot move forward any further. This results in stuttering of the polymerase on 
the U stretch and formation of the poly(A) tail. Adapted from Fodor et al. (2001). 
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Bunyaviridae have only been identified recently. 
For phlebovirus RVFV, a specific sequence 3’ CGUCG 5’ within the 5’ UTR of the M 
segment was identified as the signal for transcription termination, leading to the synthesis of a 
mRNA 112 nt shorter than its genomic RNA template (Albarino et al., 2007; Collett, 1986; 
Ikegami et al., 2007). Concerning the L segment, Albarino et al. (2007) and Ikegami et al. 
(2007), did not agree on the identification of a termination signal. Albarino et al. showed that 
the L mRNA terminated as a run-off transcript, while Ikegami et al. showed that the L mRNA 
was 20 to 40 nt shorter than the genomic template and terminated near a stem-loop structure. 
Using RACE analysis, Lara et al. (2011) found than synthesis of L mRNA terminated 28 to 
29 nt before the 5’ genomic end and that termination occurred 1 to 2 nt upstream of a 3’ 
CGAUG 5’ sequence (Lara et al., 2011).  
Mutagenesis analysis of the BUNV S segment in a mini-genome assay revealed the 
presence of two transcription termination signals (Barr et al., 2006). A 33 nt region of the 5’ 
UTR was found to efficiently signal transcription termination and within this region, a 6 nt 
sequence 3’ GUCGAC 5’ was found to play a major role while other nucleotides possess 
minor signalling activity. Abrogating signalling ability of this region revealed the presence of 
a different transcription termination signal 32 nt downstream. This region is 9 nt-long and 
contains a pentanucleotide sequence 3’ UGUCG 5’ that is also present in the 33 nt region. 
This two termination signals were found to act independently of each other. Similar GU-rich 
sequences were identified in other orthobunyaviruses suggesting they might play a role in 
transcription termination throughout the genus. Such sequences have also been identified in 
BUNV L segment but not in BUNV M segment. However, experimental mapping of L and M 
mRNA termination has yet to be reported.  
Phlebovirus S segment and tospovirus M and S segments use an ambisense coding 
strategy and transcription termination occurs within the IGR. For members of the tospoviridae, 
termination is thought to involve secondary structure formation in the IGR. Similar to 
Arenaviridae, transcription termination was mapped to occur at the end of a stem-loop 
structure (Kormelink, 2011). However, detailed mapping of N and NSs mRNA termination of 
the phleboviruses RVFV, SFSV and TOSV by Albarino et al. (2007) showed that the 3’ end 
of these mRNA contain most of the IGR and overlap each other, making the involvement of 
secondary structure unlikely. The same study revealed that termination occurred at the same 
termination signal as in the M segment: 3’ C1-3GUCG/A 5’ and this motif is present in both 
the genomic and antigenomic sense RNAs (Albarino et al., 2007).  
Chapter 1: Introduction  Functions of the UTRs  
 
55 
 
d) Translation enhancer 
Translation of host cell mRNA requires the presence of both a 5’ cap and a 3’ poly(A) tail 
to recruit the translational initiation complex. In this complex, PABP, eIF4G, eIF4E and 
eIF4A form a bridge between the mRNA extremities. The resulting circularisation of the 
mRNA can recruit the ribosomal complex (Jackson et al., 2010; Klann & Dever, 2004).  
Bunyavirus mRNAs possess a 5’ cap but lack the 3’ poly(A) tail. However, they are 
efficiently translated by the host-cell machinery. Thus, they must have evolved a poly(A) tail-
independent mechanism to translate their mRNAs. The positive-strand RNA virus, Dengue 
virus (DENV) presents mRNAs with the same characteristics as those of bunyaviruses, their 5’ 
end is capped and their 3’ end is not polyadenylated. A study by Chiu et al. (2005) 
demonstrated that DENV 3’ UTR has translational regulatory properties similar to those of a 
poly(A) tail. This enhancing effect relies on specific sequences, or translation-enhancing 
elements (TEE) that are present within the 3’ UTR (Chiu et al., 2005). Recently, the 
mechanism by which BUNV hijacks the host-cell machinery to translate its own mRNAs has 
been partially elucidated by Blakqori et al. (2009). In this study, the authors showed that the S 
segment 3’ UTR displays translation-enhancing effects that are similar to those observed for 
DENV (Blakqori et al., 2009). They also showed that the 3’ UTR can enhance translation 
activity without the support of any viral protein and achieves this by interacting either directly 
with the translation factor eIF4G or via other cellular proteins. The basis for the TEE action 
seems to rely on structural conformation of the 3’ UTR, however a more detailed structure to 
function analysis is needed to fully understand the mechanism that allow the S segment 3’ 
UTR to enhance translation of non-polyadenylated mRNAs.  
e) Packaging signals 
The packaging of the viral genome into virions is a fundamental step in the virus life 
cycle. This process requires the specific incorporation of the viral RNA genome while other 
RNA species are excluded. Packaging by RNA viruses is mediated by both cis-acting and 
trans-acting signals present in their genome. 
 
For viruses with non-segmented genomes, packaging of one genome copy is sufficient to 
generate an infectious particle. For members of both the Paramyxoviridae and Rhabdoviridae, 
cis-acting signals present in the terminal non-coding region were found to mediate efficient 
packaging. Using mini-replicon assays, Whelan et Wertz (1999) mapped the precise signal 
responsible for VSV RNPs packaging. Studying packaging behaviour of template with 
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different terminal combinations (wt, 3’ copyback, 5’ copyback and inverted), they found that 
the Tr, when located at the 5’ end of the genome, contained signals necessary and sufficient 
for assembly, while neither the Le nor the LeC were required (Whelan & Wertz, 1999a). 
Detailed mutational analysis of the Tr region identified the 29 terminal nucleotides as 
essential but also identified sequences playing a minor role in packaging. These findings are 
consistent with the observation that naturally occurring DI particles contain the Tr and TrC 
sequences at their 3’ and 5’ ends, but were not reported in 3’ copyback DIs (Pattnaik et al., 
1995).  
Naturally occurring DI particles were also reported for rabies virus, and were also 
exclusively of the 5’ copyback variety. However, using reverse genetics, Finke et 
Conzelmann (1997) recovered a virus with an ambisense recombinant genome where the Tr 
sequence was replaced by the LeC sequence. During replication of wt RV in infected cells, 
genome and antigenome are synthesised with a ratio of 49:1, while the ambisense RV 
synthesised equal amount of both RNA species (ratio of 1:1). These differences in ratio were 
conserved in virus particles, indicating that there is no specific mechanism directing 
incorporation of genomic or antigenomic RNPs into virions (Finke & Conzelmann, 1997). 
 
The segmented genome of some RNA viruses poses a unique problem to genome 
packaging: to produce infectious particles, at least one of each segment must be incorporate 
into virions. Two models that could explain this mechanism were postulated. In a random 
model, each segment possess a common packaging signal that distinguishes the viral genome 
from other RNA species present in the cell, but each viral segment competes for a common 
niche. Thus, the probability of successfully packaging a full viral genome decreased with the 
number of segments present in the particle. An example of random packaging is provided by 
the infectious bursal disease virus (IBDV) that has a two-segmented dsRNA genome. Luque 
and al. (2009) have identified six different natural populations that differ only by the number 
of genome inside the viral capsid. Functional analysis of each population revealed that 
polyploidy correlates with a higher particle to infectivity ratio (Luque et al., 2009). In a 
specific packaging model, each genome segment is individually targeted for assembly to form 
particles containing a single copy of each genome segment. The three-segmented dsRNA 
bacteriophage Φ6 is an extreme case of segment-specific packaging with a particle to pfu ratio 
close to 1 (Mindich, 2004).  
Assembly mechanisms regulating packaging of the eight segments of influenza A virus 
have been extensively studied. The segment–specific packaging model best fits the data 
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obtained so far. Among the evidence, the presence of each genome segment in equimolar ratio 
in virion preparation, despite their ratios being different in infected cells, do not match the 
random packaging model (Bergmann & Muster, 1995; Hatada et al., 1989). Electron 
microscopy (EM) studies showed that most virion particles are composed of eight segments 
organised into a ‘7+1’ array of seven RNPs surrounding a central RNP (Fournier et al., 2012; 
Harris et al., 2006; Hutchinson et al., 2008; Noda et al., 2006; Yamaguchi et al., 2008). Using 
a mathematical method, it was calculated that random assembly of eight segments would 
generate a particle-to-pfu ratio of 1:416 (Bancroft & Parslow, 2002; Hutchinson et al., 2008; 
Marsh et al., 2007). This prediction does not match the observed 1/10-1/100 proportion of 
infectious influenza particles, and therefore discredited a complete random packaging model. 
However, the observe ratio for influenza is far from the ratio of 1 seen as a result of almost 
perfect segment-specific packaging of the bacteriophage Φ6 segments, suggesting that there is 
a certain degree of imprecision in the mechanism. Evidence for some flexibility has been 
shown, using the reverse genetic system to replace the viral ORF with a reporter gene. UTRs 
of segments 4, 5, 6 and 8 were able to compete for packaging, however in a segment-
independent manner (Hutchinson et al., 2010). To sustain the segment-specific packaging 
model, both signals common to all segments and segment-specific ones need to be identified. 
Many recent studies using reporter genes or mutated viral genomes combined with data 
obtained through the analysis of naturally occurring DI particles led to the conclusion that two 
types of signals were required. The first signal, that serves to discriminate vRNA from other 
RNA species, is common to each segment and is contained in the 12-13 nt at both the 3’ and 5’ 
end of the genome. The second signal is specific to each segment; it is adjacent to the 
conserved sequence, spans the UTR and extends into the coding region (Fujii et al., 2005; 
Fujii et al., 2003; Gog et al., 2007; Hutchinson et al., 2008; Liang et al., 2005; Liang et al., 
2008; Marsh et al., 2007; Marsh et al., 2008; Watanabe et al., 2003).  
 
Similar to influenza A virus, bunyaviruses seems to package their three-segmented 
genome using an imperfect segment-specific model. Indeed, for SSHV, the three RNA 
species present in virions were not in exact molar equivalence, in favour of a random 
packaging model (Gentsch, 1977). However, assessment of the particle-to-pfu ratio of BUNV 
gave value around 5. This relatively low value suggest some degree of specificity during 
genome packaging (Lowen et al., 2005). Using UUKV and BUNV mini-genome assays, 
packaging signals were mapped to the UTRs (Flick et al., 2004; Kohl et al., 2006). Flick and 
al. (2004) compared the efficiency with which each genome was packaged and showed that 
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mini-genomes flanked by the L segment were maintain over passage while those flanked with 
either the S or M UTRs were rapidly lost. In a study on BUNV, Kohl et al. (2006) identified 
nt 20 to 33 of the 3’ and 5’ UTRs as important for genome packaging in a mini-genome assay 
and noticed that transfection of cDNA lacking this region in the M segment along with wt L 
and S cDNA result in rescue failure. Early studies of DI particles generated during BUNV 
infection showed that, similar to influenza, the DIs were composed of the UTRs and truncated 
ORF. DI particles were mainly reported for the L segment (Patel & Elliott, 1992). However, 
unlike for influenza virus, involvement of the coding region in genome packaging appeared 
unlikely. Indeed, the addition of coding sequence in the mini-replicon system failed to 
increase the packaging efficiency of the S segment (Kohl et al., 2006). Influences of coding 
region on packaging of the L and M segments were not reported. A recent study by Terasaki 
et al. (2011) on packaging of RVFV suggested the existence of co-packaging mechanism 
promoting virion assembly through intermolecular interaction between segments (Terasaki et 
al., 2011). Using the mini-genome in VLPs assays, they showed that the M RNA was 
required for the efficient packaging of the L RNA and important for the co-packaging of the S 
RNA. However, such a central role of the M segment in packaging of RVFV infectious 
particle is debatable. Indeed, in a later study by Brennan and al. (2011), a two-segmented 
RVFV was rescued: this virus lacks the entire M segment as the coding sequence for the GPs 
was inserted in the place of the NSs coding sequence (Brennan et al., 2011b). Interestingly, 
the same study showed that a segment containing the coding sequence for eGFP flanked by 
the M UTR was maintained through serial passage despite the absence of selection pressure 
and conferred a growth advantage to the two-segmented virus. Taken together, results from 
Terasaki and al. (2011) and Brennan and al. (2011), suggested that the M segment is 
specifically packaged and that it might facilitate the co-packaging of the L and S segment into 
virion particles. 
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D. RNA virus evolution 
1. Defining evolution 
Charles Darwin described evolutionary change as ‘descent with modification’ meaning 
that the process of evolution is a succession of events leading to a change in the genetic 
material of a population from one generation to the next. Despite viruses being self-
replicating entities, they undergo evolutionary changes and are thus subject to the laws of 
evolution. Indeed, modifications in the genetic population occur through the accumulation of 
natural variations (mutations, recombination, and reassortment detailed below) on which 
natural selection acts upon. Virus populations are particularly susceptible to genetic drift 
during host-host transmission where only a very small percentage of the population, and thus 
only a sample of all the available genotypes, cross from one host to the other. This is also 
called the ‘bottleneck effect’.  
This chapter will focus on the mechanisms that introduce natural variations within the 
genome of RNA viruses, the role they play in virus evolution and how they can influence the 
way we design vaccines and new drugs. 
2. Recombination as a mechanism for viral emergence 
RNA viruses display considerable genome plasticity and two mechanistically different 
genetic exchanges processes can be described: (1) copy-choice (or RNA) recombination 
results in the formation of a chimeric genome when the polymerase switches between two 
templates of different origin; (2) reassortment is the process by which viruses with segmented 
genome can exchange entire genomic segment during packaging (Simon-Loriere & Holmes, 
2011). Despite the fundamental differences between RNA recombination and reassortment, 
both processes require the same host cell to be infected with two or more viruses.  
Evidence of RNA recombination was obtained for many RNA virus families and is 
thought to have an impact on viral emergence, virulence, evasion of the immune system and 
adaptation to new host. However, the frequency of recombination events varies greatly among 
viruses. The rate of RNA recombination appears to be frequent among retroviruses (Mansky, 
1998) but is only occasional in positive ssRNA viruses, with the exception of coronaviruses 
(Tolou et al., 2001) and is rare in negative ssRNA viruses (Chare, 2003). There are a few 
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cases where recombination proved to result in emergence of a new virus. In the late 80s, Hahn 
et al. (1988) solved the puzzle posed by the New World alphavirus western equine 
encephalitis virus (WEEV). Indeed, WEEV causes encephalitis, a known feature of New 
World alphaviruses, but was serologically related to an Old World alphaviruses which do not 
cause encephalitis. Using sequence analysis, they showed that WEEV had arisen from 
recombination between the New World alphavirus eastern equine encephalitis (EEEV) and an 
Old World alphavirus Sindbis-like virus (Hahn et al., 1988). Another example of 
recombination leading to emergence of a new virus was described by Jackwood et al. (2010), 
where the turkey coronavirus (TCoV) was similar to infectious bronchitis virus (IBV) with 
the exception of the spike glycoprotein gene. The origin of the spike gene in TCoV is 
unknown (Jackwood et al., 2010). 
Segmented RNA viruses have the possibility to exchange genomic segments and such 
events seem rather frequent. During large outbreaks of haemorrhagic fever caused by RVFV 
in Africa, some cases were found to be caused by the orthobunyavirus Ngari virus (Gerrard et 
al., 2004). Sequence analysis of this virus showed that the L and S segment originated from 
BUNV while Batai virus was later identified as the donor for the M segment (Briese et al., 
2006). Emergence of new influenza A viruses through the process of genome reassortment is 
well established and the latest H1N1 pandemic in 2009 is a good example. The virus 
responsible for this outbreak was due to a reassortment of two swine viruses which 
themselves where the product of reassortment between different avian, human and swine 
viruses from both Europe and America (Christman et al., 2011). 
3. Mutation rate and the notion of quasispecies 
To replicate their genomes, RNA viruses rely on a viral enzyme, the RNA-dependant 
RNA-polymerase which copies the genome with a relatively low fidelity. This intrinsic error 
prone enzyme, combined with the absence of repair mechanisms, results in a high mutation 
rate. Indeed, for ssRNA viruses the mutation rate is around 10-4 mutations per site per 
replication which corresponds to the introduction of one mutation per genome per replication 
cycle (Drake & Holland, 1999; Duffy et al., 2008; Sanjuán et al., 2010). Thus, genome 
replication results in the generation of a cloud of mutants leading to the idea that viruses exist 
as quasispecies. The quasispecies theory was first formulated by Eigen in the 70s. Nowadays 
it refers to a virus population that does not consist of a unique genotype but as a collection of 
sequences genetically linked by mutations (Figure 1-15) (Holmes, 2009; Lauring & Andino, 
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2010; Ojosnegros et al., 2011). 
In RNA virus populations, the high mutation rate is coupled with a huge number of 
entities subjected to the process of evolution. With regard to the quasispecies theory, 
individual variants depend on the fitness of others in the population and the population 
evolves as a whole to average its fitness. The fitness of a population can be defined by its 
replicative capacity compared to a population of reference sequences in a given environment, 
or sequence space. A population with a high fitness occupies a high and narrow peak in the 
fitness landscape, while a less fit population occupies a lower but wider peak. At a low 
mutation rate, the fittest population will out-compete the other. However, at a high mutation 
rate the fittest population is trapped in sequence space and mutations lead to a dramatic 
decrease of fitness. On the other hand, mutations in the flatter population lead to a less 
dramatic loss in fitness as the variants can move through sequence space while remaining 
close to their maximum fitness (Figure 1-16). This phenomenon lead to the concept of 
‘survival of the flattest’ where less fit but more robust populations have the advantage 
(Codoñer et al., 2006; Lauring & Andino, 2010; Wilke et al., 2001; Wilke, 2005). Flatter 
populations are in a stable state and despite the high mutation rate they remain at equilibrium. 
The quasispecies theory and the concept that evolution occurs through a mutation-selection 
process supposes that populations will always tend to reach the equilibrium distribution (Bull 
et al., 2005). If the mutation rate increases beyond a limit, the equilibrium will be disrupted, 
leading to fundamental changes in population genetics. As a result, the population structure 
will break down and the population will disperse in sequence space. These events characterise 
the concept of ‘error threshold’. Using different mathematical models, the ‘error threshold’ 
concept was shown to be relevant for finite populations when present in a high-dimensional 
sequence space and takes into account lethal mutations (Biebricher & Eigen, 2005; Takeuchi 
& Hogeweg, 2007).  
RNA virus populations are thought to replicate at a mutation rate very close to the error 
threshold. Yet, most mutations are detrimental. In a directed mutagenesis experiment of the 
VSV genome, Sanjuan (2004) determined that 40% of mutations introduced at random would 
have a lethal effect and 30% would be deleterious, only 5% would be beneficial and 25% are 
neutral (Sanjuan, 2004). Thus, even a slight increase in the mutation rate can lead to 
mutational meltdown where the master sequence is lost, and results in extinction of the 
population. However, error threshold and extinction threshold are two different concepts. 
Indeed, mutational meltdown that follows the cross of the error threshold reflects a genetic 
shift whereas population extinction is a reduction of the absolute population size. Thus, 
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Figure 1-15: Model for generation of quasispecies during virus replication. 
Virus replicate with a high mutation rate and mutations accumulate at each round of replication 
(concentric circles). In this tree, each branch indicates two variants linked by a point mutation. This 
two dimensional representation is an oversimplification of the intra connectivity of quasispecies as 
sequence space is multidimensional with many branches between variants. Taken from Lauring et al. 
(2010). 
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Figure 1-16: Occupation of the fitness landscape and survival of the flattest. 
At low mutation rate, variants will be relatively stable and accumulate near the top of the fitness peak, 
hence population A (in yellow) will easily outcompete population B (in blue). At high mutation rate, 
variants spread along their corresponding peak. Most variants in population A will locate below their 
fitness value while variants in population B remain near their optimum fitness. As a consequence, the 
flatter population B will outcompete the fitter population A. Adapted from Wilke et al. (2001). 
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extinction threshold can be reached independently of the error threshold (Bull et al., 2005; 
Bull et al., 2007; Manrubia et al., 2010).  
4. Implications for vaccine engineering and drug design 
Vaccination is the most effective way to prevent viral diseases and vaccines currently 
available for general use are either inactivated or live-attenuated. Inactivated vaccines are 
prepared from viruses produced in tissue culture and subjected to inactivation via a chemical 
process or the use of detergents. They present little or no risk (Brown, 2001). Live-attenuated 
vaccines are produced according to the Jennerian approach (Pérez-Schael et al., 1997) or 
through the selection of mutants after serial passage in an unnatural host (Beyer et al., 2002; 
Theiler & Smtih, 1937). Compared to inactivated vaccines, live-attenuated ones trigger all the 
components of the immune system resulting in effective and long-lasting immunity. However, 
live-attenuated vaccines can regain some level of virulence through acquisition of mutations 
or, for segmented viruses, genomic reassortment (Chumakov et al., 1992; Murphy & Chanock, 
2001).  
Recent studies on live-attenuated vaccines have addressed both the issue of mutation 
accumulations and reassortment. Vignuzzi et al. (2008) based their approach on the 
quasispecies theory and the possible link between mutation rate, population dynamics and 
virulence. In their study on poliovirus, they engineering high-fidelity polymerases therefore 
decreasing the quasispecies diversity by limiting the number of mutations accumulated per 
genome per replication cycle. High-replication-fidelity viruses were shown to be attenuated in 
mice and to induce poliovirus-specific neutralising antibodies. Immunisation also proved to 
confer long-lasting protection against challenge with lethal doses of wt poliovirus (Vignuzzi 
et al., 2008). The reassortment issue has always been a concern for live-attenuated influenza 
vaccines. It is well-known that influenza A and influenza B viruses do not reassort and Hai et 
al. (2011) exploited this property to design a chimeric vaccine. The chimeric hemagglutinin 
RNA segment contains the UTRs of an attenuated influenza B virus flanking the ectodomain 
of the hemagglutinin ORF of different influenza A subtypes (H1, H3 and H5). Each 
recombinant virus was attenuated both in vitro and in vivo and mice immunised with these 
viruses proved to be protected when challenged with a lethal dose of influenza A wt virus 
(Hai et al., 2011).  
 
Considering that RNA viruses replicate near the error threshold, it was speculated that 
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using chemicals to increase the mutation rate could drive the population to cross the error 
threshold and enter lethal mutagenesis (Anderson et al., 2004). This strategy has been applied 
successfully to treat some RNA virus infections. For example, the antiviral effect of ribavirin 
(a purine-base RNA analogue) during poliovirus infection was shown to be exerted through 
lethal mutagenesis. Crotty et al. (2001) were able to establish a correlation between the slight 
increase in mutation rate induced by ribavirin and the reduction in virus viability (Crotty et al., 
2001). The same effect of ribavirin was observed by Severson et al. (2003) during Hantavirus 
infection (Severson et al., 2003). However, the possibility, that increasing the mutation rate 
might as well increase the probability to create drug-resistant variants, must be assessed. 
Indeed, viruses could evolve mechanisms to escape nucleoside effect by excluding the drug 
from the active site. The quasispecies theory suggests that viruses could also achieve 
resistance by moving to a flatter region of the sequence space. Work on foot-and-mouth 
disease virus (FMDV) using combination therapy is encouraging. Pariente et al. used a 
combination of mutagenic base analogues and antiviral inhibitor, and obtained promising 
results establishing the entry into error catastrophe as a valid strategy to treat viral infections 
(Pariente et al., 2003; Pariente et al., 2005; Pariente et al., 2001). 
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E. Aims 
The general aim of this project was to explore BUNV genome plasticity through 
modification of the UTRs while keeping virus attenuation as a leitmotiv. Specifically I 
engaged in three different paths: 
(1) I looked into the possibility of creating a two segmented BUNV using an S segment 
with an ambisense coding strategy. 
(2) I investigated the possible role of the segment-specific sequences within the UTRs 
during virus replication by creating segments bearing heterologous UTRs, 
(3) I pushed the limits of virus viability to define the minimal UTRs still able to support 
virus replication. 
Among these three projects, the last was given priority becoming the main focus of this 
thesis, and was extended beyond the simple determination of the minimal UTRs. After rescue, 
grossly attenuated viruses with shortened UTRs were serially passaged. It was speculated that 
they would maintain their deleted UTRs while partially regaining fitness. Thus, the plan was 
to investigate the mechanisms behind the regain of fitness. 
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A. Materials 
1. Eukaryotic cell lines  
A549-NPro is a cell line derived from adenocarcinomic human alveolar basal epithelial 
cells. A549-NPro cells express the NPro protein of BVDV (bovine viral diarrhea virus) that 
abolishes interferon-β production through targeting of IRF-3 to degradation by the 
proteasome (Hilton et al., 2006). They were maintained in DMEM medium supplemented 
with 10% FCS and 2 µg/ml puromycin. 
 
A549-V is a cell line derived from adenocarcinomic human alveolar basal epithelial cells. 
A549-V cells express the V protein of SV5 (simian virus 5) that blocks type I IFN signalling 
through the targeted degradation of STAT1 and limits the induction of IFN-β in response to 
dsRNA (Didcock et al., 1999; Poole, 2002). They were maintained in DMEM medium 
supplemented with 10% FCS and 2 µg/ml puromycin. 
 
BHK-21 clone 13 is a cell line derived from baby hamster kidney (MacPherson & Stocker, 
1962) and was maintained in GMEM medium supplemented with 10 % NCS and 10 % TPB. 
 
BSR T7/5 is a cell line derived from BHK-21 and stably expressing T7 RNA polymerase 
(Buchholz et al., 1999). They were maintained in GMEM medium supplemented with 10 % 
FCS, 10 % TPB and G418-SO4 at 1 mg/ml. 
 
HuH-7 is a differentiated hepatocyte cell line derived from cellular carcinoma cells that 
was originally taken from a liver tumour in a 57-year-old Japanese male in 1982 
(Nakabayashi et al., 1982). They were maintained in DMEM medium supplemented with 
10% FCS and 0.1mM non-essential amino acids. 
 
Vero E6 is a cell line derived from an African green monkey kidney cell line and was 
maintained in DMEM supplemented with 10% FBS. 
 
C6/36 cells (Igarashi, 1978), derived from the mosquito Aedes albopictus, were 
maintained in Leibowitz-15 medium supplemented with 10% FBS and 10% TPB. 
Chapter 2: Materials and methods  Materials 
69 
 
 
XTC-2 amphibian cell line, derived from Xenopus laevis, were maintained in in 
Leibowitz-15 medium supplemented with 10% FBS and 10% TPB (Watret et al., 1984). 
 
Mammalian cell lines were maintained at 37°C in a humid atmosphere with 5% CO2. 
Xenopus and mosquitoes cell line was maintained at 28° with no CO2. 
2. Competent bacterial cells 
E. coli JM109: endA1, recA1, gyrA96, thi-1, hsdR17 (rK-, mK+), relA1, supE44, ∆(lac-
proAB), [F’, traD36, proAB, lac/qZ∆M15]. 
 
JM109 cells were grown at 37°C either on plates or in suspension.  
3. Plasmids 
a) pTM1 series 
The backbone pTM1 contains a bacteriophage T7 promoter followed by an 
encephalomyocarditis internal ribosome entry site (IRES), and was originally supplied by B. 
Moss (Moss et al., 1990).  
pTM1-BUNL, pTM1-BUNM and pTM1-BUNS contain respectively the coding sequence 
for the BUNV L, Gn/NSm/Gc and N/NSs proteins downstream of the T7 promoter (Weber et 
al., 2001). These plasmids allow the expression of the viral proteins. They were provided by 
RM Elliott. 
pTM1-FF-Luc contains the sequence for the firefly luciferase gene cloned downstream of 
the T7 promoter (Weber et al., 2001). 
b) pT7ribo series 
The backbone pT7ribo contains a bacteriophage T7 promoter, followed by StuI and SmaI 
restriction enzyme sites, the hepatitis δ ribozyme sequence and the T7 terminator sequence 
(Dunn et al., 1995). 
pT7riboBUNL(+), pT7riboBUNM(+) and pT7riboBUNS(+) contain respectively the full 
sequence of the BUNV L, M and S segment cloned between the T7 promoter and the hepatitis 
δ ribozyme in the positive sense orientation (Figure 2-1). These plasmids allow the expression 
of antigenome RNA segments with two non-viral G residues at the 5’ end and an authentic 3’ 
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end (Bridgen & Elliott, 1996). They were provided by RM Elliott. The pT7riboBUNL(+) use 
in this thesis has been modify to contain a restriction site for XhoI. The two nucleotides 
change at position 3146 (GC) and 3149 (AG) do not lead to any amino acid changes. 
Compared to the GenBank database, this plasmid also contains 1 nt change at position 6340 
(TC) resulting in the corresponding amino acid changing from V to A. 
The plasmid pT7riboBUNM(+) used in this study contains 7 nt changes compared to the 
sequence in the GenBank database: between nt 410-420, AGGAAGAAGGAA resulting in 
RKKE substitution; at nt 1429, GA resulting in RK substitution; at nt 2638, CG, 
resulting in PL substitution; at nt 3359, TC, resulting in no amino acid change; and at nt 
4008, AG, resulting in RG substitution.  
pT7riboBUNMdelMscI(+) was constructed from pT7riboBUNM. Briefly, an internal 
region of the M coding sequence from pT7riboBUNM(+) was deleted using the restriction 
enzyme MscI. Within the M coding sequence, MscI cuts at nucleotide positions 254 and 3161. 
After digestion, products were purified on an agarose gel and the fragment of 4939 nt, 
corresponding to the vector and the extremities of the M segment was ligated to create 
pT7riboBUNMdelMscI. 
pT7riboBUNLREN(-), pT7riboBUNMREN(-) and pT7riboBUNREN(-) contain BUNV 5’ 
UTR, the Renilla luciferase gene in the negative sense, and the homologous BUNV 3’ UTR, 
cloned between the T7 promoter and hepatitis δ ribozyme. These plasmids were provided by 
RM Elliott. 
pT7riboBUNMLM(+), pT7riboBUNSLS(+), pT7riboBUNLML(+), pT7riboBUNSMS(+), 
pT7riboBUNLSL(+) and pT7riboBUNMSM(+) plasmids were provided by RM Elliott. Each 
construct name follows the same pattern, where the letter after BUN denote the segment of 
origin of the 3’ UTR, the middle letter the origin of the ORF and the last letter the origin of 
the 5’ UTR.  
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Figure 2-1: Schematic of pT7riboBUNS(+) plasmid. 
The BUNV S segment is cloned in the positive sense orientation between the T7 promoter and 
terminator sequences. The presence of the hepatitis δ ribozyme downstream of the 5’ UTR insures an 
authentic end.  
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4. Virus sequence accession numbers 
Virus name Segment Accession number 
Akabane virus L NC_009894 
 M NC_009895 
 S NC_009896 
Bunyamwera virus L NC_001925 
 M NC_001926 
 S NC_001927 
Inkoo virus L EU789573 
 M U88059 
 S U74137 
Jamestown Canyon virus L HM007355 
 M HM007354 
 S HM007353 
La Crosse virus L NC_004108 
 M NC_004109 
 S NC_004110 
Schmallenberg virus L HE649912 
 M HE649913 
 S HE649914 
Tahyna virus L HM243137 
 M HM243138 
 S HM243139 
Oropouche virus L NC_005776 
 M NC_005775 
 S NC_005777 
Table 2-1: Nucleotide sequences accession numbers. 
5. Synthetic oligonucleotides 
a) Primers used for the L segment 
NAME  SEQUENCE 5' - 3' 
L3'14- AGGAGTACACTACTCCTATA 
L3'24- TTCTATATGTAGGAGTACAC 
L3'34- TTTTTAAATTTTCTATATGTAGGAG 
L3'39- TTATATTTTTAAATTTTCTAT 
L3'44- ACTGGTTATATTTTTAAATTTTCTATA 
L3'7 CACTACTCCTATAGTGAGTC 
L5'100+ TTCATTGGTTTATTTAATTGGACAT 
L5'14+ AGGAGCACACTACTGGGT 
L5'24+ TTTCTTATGTAGGAGCACACT 
L5'31+ GTACAATTTTCTTATGTAGGAGCA 
L5'38+ CAAAAAAGTACAATTTTCTTATGTAG 
L5'45+ CAGCATTCAAAAAAGTACAATTT 
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L5'65+ CTATGTGGCAAAAATGATAACAG 
L5'85+ AATTGGACATTCCAAAAGCACTA 
L5'92+ TTTATTTAATTGGACATTCCAAAAGC 
LORF- TCAGAAAAAGGTAAATAGAGAC 
LORF+ ATGGAGGACCAAGCTTATGA 
Qc-M-G3397A-For GTCCAAATTAAAAAAAACTGGCTCCAGGGC 
Qc-M-G3397A-Rev GCCCTGGAGCCAGTTTTTTTTAATTTGGAC 
Qc-M-G5877A-For GGTATAACAAAATGGTTCCTATCTGTCCAGTTG 
Qc-M-G5877A-Rev CAACTGGACAGATAGGAACCATTTTGTTATACC 
Qc-N-C6329T-For GTTAGTTTCAGCAGGGGTAGATGAGATCAAAGAAG 
Qc-N-C6329T-Rev CTTCTTTGATCTCATCTACCCCTGCTGAAACTAAC 
Qc-N-G4894C-For GGGGCTGATCCTATACAATTGGAAAAAGATC 
Qc-N-G4894C-Rev GATCTTTTTCCAATTGTATAGGATCAGCCCC 
Qc-N-G5438A-For CCTCTATTATTTAAACTCAAAGTTTTAACTC 
Qc-N-G5438A-Rev GAGTTAAAACTTTGAGTTTAAATAATAGAGG 
Qc-T-A407G-For CCAGTGATGTCTGAATTGGGTGTAGATACAGAAATAGC 
Qc-T-A407G-Rev GCTATTTCTGTATCTACACCCAATTCAGACATCACTGG 
Qc-T-A4827C-For GAAATATGAAACTTATTCCCCATTCCCCTGC 
Qc-T-A4827C-Rev GCAGGGGAATGGGGAATAAGTTTCATATTTC 
Table 2-2: Sequence of the oligonucleotides used for BUNV L segment. 
 
b) Primers used for the M segment 
NAME  SEQUENCE 5' - 3' 
M3'11- AGTACACATCTCCTATAGTGA 
M3'22- GATGTATCGGTAGTACACTAC 
M3'33- GAAAGGTTTGTGATGTATCGG 
M3'44- GATGTGTCTCTGAAAGGTTTG 
M5'20+ GTTATCGGTAGCACACTACT 
M5'40+ TCAAAAAACAAGGCTGTTTT 
M5'60+ ATTCATATTGACACATTGTG 
M5'80+ CATTGTTAAATACATTCAAA 
MORF- TCACTTTTGCTTAATTTCTT 
MORF+ ATGAGAATTCTAATACTGCTT 
Table 2-3: Sequence of the oligonucleotides used for BUNV M segment. 
 
c) Primers used for the ambisense segment 
NAME  SEQUENCE 5' - 3' 
BsmBI-MORF+ AAAGCGGCCGCTCACTTTTGCTTAATTTCTTGCAA 
NotI-MORF- CAAAAGTACTGCTGGTGTTAGCAGCGACATCATGAAATTCCAA
CTC 
Qc-AmbiM-NSs1-For CCACTGGGCTTAGTTATGACCACATACGAATC 
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Qc-AmbiM-NSs1-Rev GATTCGTATGTGGTCATAACTAAGCCCAGTGG 
Qc-AmbiM-NSs5-For GAGTTGGAATTTCATGATGTCGCTGCTAACACCAGCAGTACTT
TTG 
Qc-AmbiM-NSs5-Rev CAAAAGTACTGCTGGTGTTAGCAGCGACATCATGAAATTCCAA
CTC 
Table 2-4: Sequence of the oligonucleotides used for BUNV ambisense segment. 
 
d) Primers used for Renila luciferase segment 
NAME  SEQUENCE 5' - 3' 
NruI-Ren(-)ORF/TAC- TCGCGATGACTTCGAAAGTTTATG 
Ren L39+ TTATATTTTTAAATTTTCTATATGTAGGAG 
Ren L44+ ACTGGTTATATTTTTAAATTTTCTATATGT 
Ren L45- CAGCATTCAAAAAAGTACAATTTTCTT 
Ren L65- CTATGTGGCAAAAATGATAACAGCATTCAAAAA 
Ren L85- AATTGGACATTCCAAAAGGCACTATGT 
Ren M33+ GAAAGGTTTGTGATGTATCGGTAGTACACTACTGGG 
Ren M40- TCAAAAAACAAGGCTGTTTTGTTATCG 
Ren S112- CAACCCACAAAATAACAGCTGCTT 
Ren S65+ TCTGTTGGATTTAATAGCACAGCGATT 
StuI-Ren(-)ORF/TTA+ AGGCCTTATTGTTCATTTTTGAGAACT 
Table 2-5: Sequences of oligonucleotides used for the Renilla constructs. 
 
6. Enzymes  
a) Restriction enzymes 
From Promega: BamHI, BsmBI, BsrGI, ClaI, EagI, EcoRI, NcoI, NotI, PstI, SapI, SphI, 
XhoI. 
From Fermentas: MscI 
From New England BioLabs: BamHI, KpnI-HF NheI-HF, PmeI, PstI-HF, SphI-HF, SalI-
HF. 
b) Modifying enzymes 
From Promega: CiAP, m-mlv Reverse Transcriptase, RNasin, SAP, T4 DNA ligase, T4 
polynucleotide kinase 
From Fermentas: DpnI 
From Novagen: KOD Hot Start polymerase  
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7. Antibodies 
a) Primary antibodies 
Polyclonal anti-BUN N, bleed 593 was raised in rabbit and provided by RM Elliott. It was 
used at the dilution 1/1000 in Western blotting assays. 
Monoclonal anti-tubulin was raised in mouse and was use at the dilution 1/10 000 in 
Western Blotting assays, from Sigma. 
Polyclonal anti-BUNGn/Gc, M742 was raised in rabbit and provided by RM Elliott. It 
was used at the dilution used at 1/100 in immunofluorescence assays. 
b) Secondary antibodies 
anti-Rabbit IgG HRP-linked, raised in goat was purchased from Cell Signalling 
Technology and use at the dilution 1/5000 in Western Blot. 
anti-Mouse IgG (whole molecule) HRP-linked, raised in goat, was purchased from Sigma 
and used at the dilution 1/3000 in Western Blot. 
anti-Mouse IgG (whole molecule) TRITC conjugate (T5393) was purchased from Sigma 
and used at the dilution 1/64 in immunofluorescence assays. 
8. Radiochemicals 
TRAN35S-Label No-Thaw Metabolic Labelling Reagent was purchased from MPbio. It 
contains >70% 35S-L-methionine and ~10% 35S-L-custein at a concentration of 10 mCi/ml 
(~370MBq/ml) and with a specific activity of >1000 Ci/mmol (~37.0 TBq/mmol). 
9. Reagents and chemicals  
• Cell culture, transfection and virus manipulation 
Avicel RC/CL, Microcrystalline cellulose & Sodium carboxymethylcellulose NFP, BP 
was purchased from FMC. 
 
FCS (Foetal Calf Serum) was purchase from LONZA. 
 
G418 sulphate was purchased from Sigma and used at a final concentration 1mg/ml only 
during routine maintenance. 
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GMEM (Glasgow Minimum Essential Medium) was purchased from Gibco. 
 
Lipofectamine 2000 was purchased from Invitrogen. 
 
MEM (Minimum Essential Medium) and 2X MEM were purchased from Gibco. 
 
10x Neutral Red: PBS, 0.6% Neutral Red (w/v). Filtered. 
 
Opti-MEM (Opti – Minimum Essential Medium) was purchased from Gibco. 
 
NCS (Newborn Calf Serum) was purchase from PAA. 
 
TPB (Tryptose Phosphate Broth) was made in house. 
 
• Bacterial culture 
Ampicillin Sodium was purchased from Formedium. 
 
L-broth: 10 g NaCl, 10 g Bactopeptone, 5 g yeast extract per litre. Autoclaved. 
 
LB agar: L-broth containing 1.5% (w/v) agar. Autoclaved. 
 
• Protein analysis 
Benzonase was purchased from Novagen 
 
Blocking buffer: PBS, 5% skimmed milk, 0.1% Tween 20 
 
Formaldehyde: 4% formaldehyde (v/v) in PBS 
 
Gel fix: 50 % methanol, 10 % acetic acid, 40 % H2O (v/v) 
 
MES SDS running buffer (20x) was purchased from Invitrogen. 
 
Nitrocellulose membrane: Hybond-c extra was purchased from Amersham. 
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NU-PAGE SDS gel, 4 – 12% Bis-Tris, 10 or 12 wells (Invitrogen) 
 
Protein disruption buffer: 50 mM Tris-HCl, 10% glycerol, 2% SDS, 0.2% BPB, 100mM 
DTT (added fresh) and 125 U/ml benzonase  
 
SuperSignal West Pico Chemiluminescent Substrate was purchased from Thermo 
Scientific. 
 
Transfer buffer was purchased from Invitrogen. 
 
• DNA analysis 
Agarose, molecular grade was purchased from Bioline. 
 
DNA loading buffer (Promega)  
 
dNTPs, MgSO4 and KOD buffer from Novagen 
 
Ethidium bromide solution, Molecular grade (Promega) 
 
10x Tris-acetic acid-EDTA (TAE): 400 mM Tris base (w/v), 12% acetic acid (v/v), 0.1 
mM EDTA (w/v), up to 1L in de-ionised water. 
 
• RNA preparation and Northern blotting 
Antibody buffer: 2 µl of anti-digoxigenin-AP Fab fragment from Roche (1/10000, 
centrifuge at 12 000 rpm for 5 min at 4ºC and pipette at the top) in 2ml 10X Blocking buffer 
and 18 ml Maleic acid buffer 
 
10X Blocking buffer: 1 g Blocking reagent (Roche) diluted in 10 ml Maleic acid buffer 
 
CDP-Star, ready-to-use from Roche 
 
Detection buffer: 0.1 M Tris, 0.1 M NaCl, pH 9.5 
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50% formamide hybridization buffer: 50% deionised formamide (Ambion); 5×SSC; 0.1% 
(w/v) n-lauroyl-sarcosine; 0.02% (w/v) SDS; 2% (v/v) blocking solution  
 
loading dye (RNA): 25% (w/v) Ficoll 400; 0.4% (w/v) BPB; 0.4% (w/v) xylene cyanol 
 
Maleic acid buffer: 0.1 M maleic acid, 0.15 M NaCl, pH 7.5 
 
membrane Amersham Hybond-N+ was purchased from GE Healthcare. 
 
10x RNA loading dye: 50 nM Tris-HCl, pH 7.6, 0.25% BPB (v/v), 60% glycerol (v/v) 
RNaseZAP was purchased from Ambion 
 
Sodium DodecylSulphate (SDS): 10% w/v in dH2O 
 
20× SSC: 3 M NaCl, 0.3 M sodium citrate, pH 7.0 
 
TRIzol Reagent (Invitrogen): a mono-phasic solution of phenol and guanidine 
isothiocyanate 
 
washing buffer: 0.1 M maleic acid, 0.15 M NaCl, 0.3% (v/v) Tween-20, pH 7.5 
 
• Immunodetection 
Blocking buffer: PBS, 5% skimmed milk 
 
Permeabilising solution: PBS, 0.5% Triton X-100 (Sigma) 
 
TrueBlue Peroxidase Substrate was purchased from KPL 
 
• Miscellaneous 
Acetylated BSA was purchased from Promega 
 
Giemsa’s stain solution was purchased from BDH Chemical. 
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PBS (5X): 300 mM Na2HPO4, 85 mM NaH2PO4, 0.34 M NaCl in H2O. Adjust to pH 7.4. 
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B. Methods 
1. Maintenance of eukaryotic cells 
Mammalian cell lines were routinely passaged every three or four days in large (175 cm2) 
or medium (75 cm2) flasks. For passaging, the cell monolayer was first rinsed with PBS, and 
then 1 ml or 0.5 ml of 1X Trypsine was added for a large or medium flask respectively. The 
cells were incubated with the Trypsine at room temperature until they detached. They were 
then resuspended in fresh media (up to 10 ml final) and pipetted up and down vigorously to 
remove any clumps of cells. 1 ml of cell suspension was added into 35 ml of fresh media for a 
large flask or 15 ml for a medium flask.  
2. DNA manipulation 
a) Production of plasmid 
(i) Transformation of bacteria 
JM109 competent cells were thawed on ice. 50 µL of cells were transformed with 10 µL 
of ligation product or 0.5 µl of plasmid DNA and incubated on ice for 20 to 30 min. Cells 
were then spread on LB agar plates containing Ampicillin (100 µg/ml). Plates were incubated 
overnight at 37°C. 
(iii) Growth of single colony in suspension 
Single colonies were picked using a 200 ml pipette tip. The pipette tip was then partially 
submerged in 8 ml of LB medium containing Ampicillin at 100 µg/ml. the inoculated cultures 
tubes were incubated overnight at 37°C in a shaking incubator (200 rpm). 
(iv) Purification of plasmid DNA 
Small quantities: 4 ml of cell suspension were pelleted in 2 ml Eppendorf tubes by 
centrifugation at 8,000 rpm for 3 min. The cell pellet was then processed using the QIAprep® 
Spin Miniprep kit (Qiagen) according to the manufacturer’s instructions. 
Large quantities: 100 to 150 ml of cell suspension were pelleted in 50 ml Falcon tubes by 
centrifugation for 30 min at 4,000 rpm. The cell pellet was processed using the QIAprep 
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HiSpeed kit (Qiagen) according to the manufacturer’s instruction, ecxept that DNA was 
eluted in 500 µl of deionised water. 
(v) Quantification 
The amount of DNA present in each sample was quantified using a 2 µl drop on a 
spectrophotometer, Nanodrop (Thermo Scientitist). 
b) Amplification of DNA by Polymerase Chain Reaction 
Polymerase Chain Reactions (PCR) were performed using the KOD Hot Start polymerase 
from Merck. Reactions were set up in thin-walled 0.5 ml Eppendorf tubes according to the 
manufacturer’s instructions. Briefly, the final PCR mix was composed of 1X KOD Hot Start 
polymerase buffer, 1.5 mM MgSO4, 0.2 mM of each dNTP, 0.3 µM forward primer, 0.3 µM 
reverse primer and 0.02 U/ml KOD Hot Start polymerase. DNA template was added and the 
final volume was adjusted to 50µl with water. 
According to the manufacturer’s protocol, KOD Hot Start polymerase was added only 
after the initial denaturing step. Routine PCR cycles were performed as follows in a thermal 
cycler with heated lid: 
 
Initial denaturation 95°C 3 min  
    
Strand separation 95°C 30 sec 
x cycles Annealing According to primer’s Tm 30 sec 
Extension 70°C 10 - 25 s/kb 
    
Final extension 70°C 10 min  
Hold 10°C ∞  
 
If the PCR was performed using plasmid DNA, PCR products were digested with 10 U of 
restriction enzyme DpnI (Fermentas) in 1X Tango buffer (Fermentas) for 1h at 37°C.  
(i) Standard PCR 
Standard PCR was used to amplify specific DNA fragments. Primers were designed to 
flank each side of the fragment to be amplified in inward orientation such that the 5’-end of 
the forward primer annealed to the 5’ boundary of the fragment to be amplified and the 5’-end 
of the reverse primer annealed to the 3’ boundary of the fragment to be amplified. Primers 
were 18 to 25 nucleotides long. 0.5 µl of plasmid DNA or 2 µl of cDNA were used as 
template. 25 cycles were performed. 
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The size of the product was then checked on an agarose gel as described below.  
(ii) Excision PCR 
Specific deletions were introduced in the UTRs by excision PCR. For this type of PCR, 
we used primers flanking each side of the deletion in outward orientation such that the 5’-end 
of the forward primer annealed to the 3’ boundary of the sequence to be deleted and the 5’-
end of the reverse primer annealed to the 5’ boundary of the sequence to be deleted. Primers 
were 18 to 25 nucleotides long and 0.5 µl of plasmid pT7riboBUNX(+) was used as a 
template. 25 cycles were performed. 
Following digestion by DpnI, PCR products were purified on an agarose gel and ligated 
as described below. 
(iii) Quick-change PCR 
This technique allows the introduction of specific point mutations. Primers were designed 
to contain the mutation and to anneal to the same sequence on opposite strands of the plasmid. 
Primers were between 35 and 45 nucleotides in length with a melting temperature ≥ 70°C.  
The desired mutation(s) was located in the middle of the primer and flanked by 10 to 15 
nucleotides of correct sequence. Optimally, primers contain 40% of GC and terminate with at 
least one G or C. 0.5 µl of template was used and 18 cycles were performed.  
After digestion by DpnI (without using the Tango buffer), 10 µl  of PCR products were 
transformed into 50 µl of competent cells without further purification. 
c) Agarose gel electrophoresis and gel extraction 
DNA fragments were separated through a horizontal gel composed of 1X TAE with 0.7-
1% agarose and 0.04 µg/ml ethidium bromide. The gel was submerged in 1X TAE. Samples 
containing loading dye (1 volume in 6 volumes) were loaded in wells and a 100 V current was 
applied for 60 to 100 min.  
DNA fragments were visualised on a UV trans-illuminator and excised from the gel, if 
needed. DNA was extracted from the gel matrix using the Wizard® SV Gel and PCR Clean-up 
System (Promega) according to the manufacturer’s protocol. 
d) Ligation 
For ligation of excision PCR products, phosphate groups were added at the 5’-extremity 
by incubating 15 µL of DNA with 5-10 U of T4 Polynucleotide kinase (Promega), 4 µL of 5X 
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T4 DNA ligase buffer (Invitrogen). The mix was incubated 30 min at 37°C. Then, 1-3 U T4 
DNA ligase (Promega) was added. 
Ligations of vector and insert were set up in a final volume of 20 or 30 µL. The reactions 
contained 50 ng of vector, 50 or 150 ng of insert, 4 or 6 µL of 5X T4 DNA ligase buffer 
(Promega) and 1 or 3 U T4 DNA ligase (Promega).  
Ligations were incubated overnight at room temperature. 
When mentioned, the Quick ligation kit from NEB was used according to manufacturer’s 
instructions.  
e) Enzymatic digestion 
Endonuclease restriction digests were set up in a final volume of 15 to 30 µl. The reaction 
contained 1X of the appropriate buffer, acetylated BSA (10 µg/µl) when needed, 1 or 2 U of 
enzyme per 1 µg of DNA and was incubated at 37°C for up to 4h. 
f) Transfection of mammalian cells 
BSR T7/5 cells were used in transfection experiments. 60 mm-diameter Petri dishes were 
seeded 24h prior to transfection with a total of 4x105 cells per dish resulting in ~60% to 70% 
confluency. 
1 µg of each plasmid DNA to be transfected was added to 350 µL of Opti-MEM in an 
Eppendorf tube. For a 60-mm dish, 9 µL of Lipofectamine 2000 reagent (Invitrogen) was 
added to 350 µL of Opti-MEM in a haemolyse tube and incubated at room temperature for 5 
min. Then, the content of the Eppendorf tube was transferred into the haemolyse tube. The 
DNA/lipofectamine mix was incubated at room temperature for 20 to 30 min.  
The BSR T7/5 monolayer was washed once with 2 ml Opti-MEM before addition of the 
DNA/Lipofectamine mix. Dishes were then incubated at 37°C for 1h and rocked every 15 min. 
4 ml of GMEM – 10% FCS – 10% TPB medium were added and dishes incubated at 33°C.  
g) Mini-replicon assay 
This assay is based on the one developed by Weber et al. (Weber et al., 2001). BSR T7/5 
cells were co-transfected with expression plasmids for the N and L proteins of BUNV, pTM1-
BUNN and pTM1-BUNL, and with plasmids encoding a luciferase based mini-genome, for 
example pT7riboBUNLRen(-). The plasmid pTM1-FF-Luc, expressing the firefly luciferase 
gene under the control of the T7 promoter was transfected to serve as an internal control. 
Briefly, after transfection, pT7riboBUNXRen(-) is transcribed by the T7 polymerase 
producing viral-like RNA genome sgment. The N protein encapsidates the RNA genome to 
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form RNA-N complexes that are recognised by the L protein. The polymerase will synthesise 
antigenomic and mRNA from the genome template. Renilla luciferase mRNAs are produced 
only if the viral polymerase can perform transcription and replication. 
BSR T7/5 cells were seeded in either a 12-well plate (8.104 cells/well) or in a 24-well 
plate (4.104 cells/well). Transfections were done as described above, except that 0.3 µg/well 
of each plasmid were used to transfect a 12-well plate or 0.15 µg/well of each plasmid were 
used to transfect a 24-well plate. 24h post-transfection, cells were lysed and luciferase assay 
performed using the Dual Luciferase Reporter Assay system (Promega). 
Experiments were repeated three times with duplicate or triplicate wells. In each 
experiment, the values of the firefly luciferase were normalised to the value obtained in mock 
transfected cells, and the Renilla luciferase values were normalised to the normalised firefly 
luciferase. Then, the Renilla value of the positive control (or wt) was considered 100% of the 
relative light activity and all other values were normalised against it to give a percentage. The 
percentage values of the three repeats were used to calculate the mean and the standard 
deviation of the mean. 
3. Virus manipulation 
a) BUNV rescue 
Recombinant viruses were produced using the three-plasmid rescue system developed 
previously by A. Lowen (Lowen et al., 2004). Briefly, sub-confluent BSR T7/5 cells 
(approximately 4x105 cell in a 60 mm-diameter Petri dish) were transfected (as described 
above) with 1 µg of each plasmid pT7riboBUNL(+), pT7riboBUNM(+) and 
pT7riboBUNS(+) to rescue a wild-type virus or with the appropriate pT7riboBUNX(+) 
construct(s) to rescue mutant viruses. 
For the wild-type, supernatant was harvested five days post-transfection. In the case of 
mutant viruses, supernatants were harvested every 5 to 6 days up to 21 days post-transfection. 
Supernatant aliquots were stored at -20°C and -80°C. 
Rescue outcome was assessed either by plaque assay, Western Blotting or immuno-
staining (see method below). 
b) Plaque purification 
Unique clones of BUNV were isolated by plaque assay on sub-confluent BHK-21 cells in 
6-well plates seeded at 3.105 cell/well. Supernatants from virus rescues were serially diluted 
Chapter 2: Materials and methods  Methods 
85 
 
from 10-1 to 10-7 in PBS - 2% NCS. The media was removed from the 6-well plate and 200 µl 
of dilutions 10-3 to 10-7 were added to each well. Plates were incubated for 1h at 37°C and 
rocked every 20 min. Finally, 2 ml of overlay (final concentration: MEM 1X, agarose 0.6% 
and NCS 2%) was added. Once the overlay had set, plates were incubated at 33°C. 
After 4 to 6 days, a second overlay was added. This 1 ml overlay was the same as 
described in previous paragraph, complemented with Neutral Red diluted at 1/10 (v/v). Plates 
were incubated at 37°C for 3h to overnight until plaques were visible. A plug of agarose 
above a unique plaque was extracted using a 200 µl pipette set on 30 µl and mixed into 500 µl 
of GMEM – 10% NCS media. Samples were stored at -20°C. 
c) Preparation of virus stocks 
Virus stocks were grown in BHK-21 cells. The 500 µl of GMEM containing unique 
plaque picks was used to infect a sub-confluent 75 cm2 flask. After 1h at 37°C, 5 ml of 
GMEM – 10% NCS – 10% TBS media were added. Note that only 2% serum was use to 
grow up stock of attenuated viruses. Flasks were incubated at 33°C. Five days post-infection, 
the media was collected and centrifuged for 5 min at 1000 x g at 4°C. The supernatant was 
divided into 1 ml aliquots and stored at -20°C or -80°C. 
d) Titration of viruses by plaque assay 
The titre of virus stocks was determined by plaque assay using sub-confluent BHK-21 
cells seeded in 6-well plates (3.105 cell/well). The virus stock supernatant was serially diluted 
from 10-1 to 10-6 in PBS - 2% NCS. Media was removed from the 6-well plate and 200 µL of 
dilution 10-1 to 10-6 were added to each well. Plates were incubated for 1h at 37°C and rocked 
every 20 min. Finally, 2 ml of overlay (final concentration: MEM 1X, 0.6% Avicel and 2% 
NCS) was added. Plates were incubated at 33°C. 
After 3 to 5 days, the overlay was removed by pipetting and the monolayer fixed in a 
solution of 4% Formaledehyde (v/v). Plaques were revealed with a solution of Giemsa (1 
volume in 5 volume water) for 30 min. The stain was washed under tap water. 
The titre per ml was calculated as follows in particle forming unit (pfu): (number of 
plaques)x(dilution)x5. 
e) Detection by immunostaining 
The titre of virus stocks was determined by plaque assay using sub-confluent BHK-21 
cells seeded in 6-well plates (3.105 cell/well). The virus supernatant was serially diluted from 
10-1 to 10-5 in PBS - 2% NCS. Media was removed from the 6-well plate and 200 µL of non-
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diluted to 10-5 was added to each well. Plates were incubated for 1h at 37°C and rocked every 
20 min. The final overlay (2 ml) composition was MEM 1X, 0.6% Avicel and 2% NCS. 
Plates were incubated at 33°C. 
After 5 days, the overlay was removed by pipetting and the cells were fixed in a solution 
of 4% Formaldehyde (v/v) for 30 min. Foci of infection were detected by immunostaining.  
Cells were permeabilised and aldehyde groups blocked with 0.5 µl of permeabilising 
solution for 30 min. Cells were then incubated with 200 µl per well of primary antibody anti-
BUN N (1:1000) in blocking buffer. After 1h to 2h, plates were washed 3 times for 5 min 
with blocking buffer. Cells were incubated for 1h with 200 µl per well of peroxidase-labelled 
secondary antibody (1:1000) in blocking buffer.  
After antibody incubation, plates were washed 3 times for 5 min with blocking buffer 
before adding 200 µl of TrueBlue (InSight) precipitate-forming peroxidase substrate. Plates 
were incubated at room temperature for up to 3h. To stop the reaction, plates were washed 
with distilled water and let to dry up side down in order to minimise bleaching. 
All incubation periods were carried out at room temperature and under constant rocking. 
4. RNA manipulation 
a) Viral RNA extraction from tissue culture 
A sub-confluent monolayer of BHK-21 seeded in 6-wells plate cells was infected at an 
MOI of 1. Two-hundred µl of inoculum (virus stock in PBS - 2% NCS) was used and cells 
were incubated for 1h at 37°C and rocked every 20 min. Two ml of media were added to the 
cells and then incubated at 33°C. The supernatant was removed 48h post-infection.  
(i) Use of Qiagen kit 
The cell monolayer was lysed using 600 µl of RLT buffer and the RNA was extracted 
from the lysate using RNeasy Mini Kit (Qiagen). Samples were processed using the Qiacube 
according to the manufacturer protocol. 
(ii) Trizol extraction 
The cell monolayer was lysed using 500 µl of Trizol Reagent (Invitrogen) for 10 min at 
RT. Samples were collected in a 2 ml screw cap tube and can be stored at -80 C to be used 
later. If starting from a frozen sample, tubes were left on the bench until completely thawed, 
100 µl of chloroform was added. The different phases were mixed by inverting the tube 4 to 6 
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times. Samples were incubated at RT for 3 min and mixed before spinning at 12 000 rpm for 
15 min at 4°C. The aqueous phase was transferred to a new tube and 75% (v/v) of isopropanol 
was added and mixed. Samples were incubated for 15 min at RT before being centrifugated at 
12 000 rpm for 20 min at 4°C. The supernatant was poured off and 750 µl of 75% EtOH 
added. Samples can be stored at this point at -20°C if needed later. Samples were 
centrifugated at 7 500 rpm for 5 min at 4°C, the supernatant poured off and the pellet air-dried. 
Pellets were resuspended in 30 µl of RNase-free water. 
(iii) Quantification 
To quantify the amount of RNA present in each sample, a 2 µl drop was used on a 
spectrophotometer, Nanodrop (Thermo Scientitist). 
b) Reverse Tanscription – PCR 
To produce cDNA from RNA, 1 µg of total cellular RNA was diluted in water to a final 
volume of 12 µL, 1 µL of an appropriate primer was added. The mix was incubated at 65°C 
for 5 min. After cooling on ice, 4 µL M-MLV 5x buffer, 1 µL dNTPs 10 mM and 1µL RNasin 
were added and the mix was incubated at 42°C for 2 min. Then, 1 µL M-MLV Reverse 
Trancriptase was added and the final reaction mix was incubated at 42°C for 2.5h. All 
incubation periods were performed in a thermocycler and all reagents were from Promega. 
c) Northern blot 
(i) Preparation of the gel 
1.2 g of agarose were added to 100 ml 1X TAE and bring to the boil. The electrophoresis 
tank, the tray (11 x 14 cm), the comb and the stop-wedges were cleaned with RNaseZAP 
before pouring the gel. The gel was left to set for 1h. 
(ii) Preparation of RNA samples 
3 µg of RNA was prepared in 25 µl formamide, 2.5 µl RNA loading dye, 0.1 µl ethidium 
bromide and deionised water up to a final volume of 30 µl per well. The ladder was composed 
of 10 µl RiboRuler High Range RNA Ladder (Fermentas), 10 µl of 2X RNA Ladder 
(Fermentas) and 10 µl deionised water.  
Samples and ladder were heated at 70ºC for 5min, chilled on ice for 5min and loaded on 
the gel. 
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(iii) Electrophoresis and blotting 
The gel was run in 1X TAE at 75 V for 3 to 4 hours or until the dye reached a 0.5 cm 
distance from the bottom of the gel.  
After electrophoresis, a picture of the gel was taken in a UV transilluminator then the gel 
was washed twice in 10X SSC for 5 min under constant rocking at RT. At the same time the 
positively charge Hybond-N+ membrane was equilibrated in 10X SSC. 
The gel running tray (11x14 cm) was placed upside down on a shallow tray. A stack was 
formed on top of the gel running tray and was composed from bottom to top by: 8 cm of dry 
blotting pads (11x14 cm, VWC), 3 mm chromatography paper (11x14 cm) soaked in 10X 
SSC (11x14 cm, Whatman), the equilibrated membrane, the equilibrated gel (wells up) and 3 
mm chromatography paper (11x14 cm, Whatman) soaked in 10X SSC. Bubbles were pressed 
out of the stack using a 10 ml pipette. Two long Whatman pads (14x40 cm) were soaked in 
10X SSC and placed on top of the stack so that both ends reached the swallow tray. Two 10 
ml pipettes were placed on each side of the stack to prevent the long Whatman from touching 
the stack. The shallow tray was filled with 10X SSC. A plastic board and a 1 kg weight were 
place on top of the stack. The apparatus was wrapped in cling film and left over night to allow 
the capillary-driven transfer of RNA from gel to membrane. 
(iv) UV cross-linking of the membrane 
Once the blotting is complete, the position of the wells was marked using a ball point pen. 
The membrane was removed, rinsed in 2X SSC for 5min and hung to dry. The membrane was 
place RNA-side down on a transilluminator and the RNA was cross-linked to the membrane 
by UV (302 nm) for 3 min. The membrane was stored at 4°C until used for hybridization. 
(v) Hybridisation of DIG-labelled probes 
The lane containing the ladder was cut off and stained with a solution of 1X Methylen 
Blue. 
The membrane was placed in a hybridization tube with 4 or 10 ml (for a small or large 
tube respectively) of 50% formamide pre-hybridisation buffer (warmed to 68ºC) for 30 min 
under constant rotation at 68ºC. One-hundred and fifty ng of digoxigenin labelled probes were 
denatured by adding them to 100 µl deionised water, and then boiled for 5 min. After cooling 
on ice for 5 min, the probes were spin down briefly. The pre hybridisation buffer was poured 
off and replaced by 4 or 10 ml 50% formamide hybridisation buffer containing the probes. 
The hybridization tubes were rotated over-night at 68ºC. 
Chapter 2: Materials and methods  Methods 
89 
 
(vi) Washes and detection 
All further steps were carried out in a hybridisation tube, under constant rotation and, if 
not mentioned, at RT. The membrane was washed under increased stringency as follow: 
 twice in 2X SSC - 0.1% SDS for 15 min 
 twice in 0.1X SSC – 0.1% SDS for 30 min at 68ºC 
 in washing buffer for 5 min 
The washing buffer was replaced by 10 ml of 1X Blocking buffer. After 60 min, the 
Blocking buffer was poured off and 10 ml antibody buffer was added for 60 min. Then, the 
membrane was washed twice in 10 ml washing buffer before being incubated in 10 ml 
detection buffer for 5 min.  
The membrane was removed from the tube and placed on a translucent plastic sheet. A 
few drops of CDP-Star solution were dropped onto the membrane and the plastic was folded 
over it. Bubbles were removed to form a uniform layer of liquid. CDP-Star was left for 5 min 
before the excess was rolled out. The membrane was then exposed to X-Ray film for up to 30 
min.  
5. Protein manipulation 
a) Radio-labelling 
(i) Samples preparation 
A subconfluent monolayer of BHK-21 cells in 6-well plate was infected at an MOI of 1. 
WT or recombinant viruses, were diluted in PBS – 2% NCS. After adsorption of viruses in 
200 µl, plates were incubated at 37˚C and rocked every 20 min. After 1h, 2 ml of appropriate 
growth media was added and plates were incubated at 33˚C.  
At different times post-infection, cells were washed with DMEM methionine-free media, 
then replaced with 500 µl of DMEM methionine free containing 35 µCi of TRAN35S-Label. 
Plates were incubated for 2h at 37°C to allow labelling of newly synthesized proteins. 
During the course of the experiment, radioactivity was monitored. 
Labelling medium was removed prior to cell lysis. 300 µl of protein disruption buffer was 
added. Cells were rocked for 10min at RT until the lysate became liquid. Samples were 
collected in 1.5ml Eppendorf tubes and store and -20°C before use.  
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(ii) SDS-PAGE gel 
Lysates were boiled at 100°C for 3 min, cooled on ice and 10 to 15 µl were loaded into 
each well of a NuPAGE 4/12% Bis-Tris gel 1.0mmx12wells (Invitrogen). Electrophoresis 
was carried in 1X MES SDS running buffer at 160V until the Bromophenol Blue reached the 
bottom of the gel. 
(iii) Fixation and drying 
The gel was transferred in a fixing solution (50% methanol, 10% acetic acid, 40% H2O) 
for 10 to 15 min. The gel was rinsed twice in water and then placed into a solution of water 
with 5% glycerol (v/v) for 5 min. Whatmann paper was soaked with the glycerol solution 
before the gel was placed onto it. The wetted whatmann paper/gel was covered with cling film 
and placed into a gel dryer. The drying process was carried on at 80°C for 2h in a vacuum 
system.  
(iv) Detection 
The dry gel was inserted in a cassette and the exposure was taken overnight. The radio 
print was revealed using a Fujifilm phospho-imager and data analysed with the ImageGauge 
4.21 software. 
b) Western blotting 
(i) Samples preparation 
A subconfluent monolayer of BHK-21 cells in 6-well plate was infected with an MOI of 1. 
WT or recombinant viruses, were diluted in PBS – 2% NCS. After inoculation of viruses, 
plates were incubated at 37˚C and rocked every 20 min. After 1h, 2 ml of appropriate media 
was added and plates were incubated at 33˚C. 
At different time post-infection, cells were lysed using 300 µl of protein disruption buffer. 
Cells were rocked for 10min at RT until the lysate became liquid. Samples were collected in 
1.5ml Eppendorf tubes and store at -20°C before use.  
(ii) SDS-PAGE gel 
Lysates were boiled at 100°C for 3 min, left to cool down and 10 to 15 µl were loaded 
into each well of a NuPAGE 4/12% Bis-Tris gel 1.0mmx12wells. Electrophoresis was carried 
out in 1X MES SDS running buffer at 160V until the BPB reached the bottom of the gel. 
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(iii) Electro blotting 
The transfer of the proteins from the gel to a nitrocellulose membrane was performed 
using a semi-dry transfer apparatus (Bio-Rad Trans-Blot SD). Beforehand, the gel, two pieces 
of Watmann paper and the nitrocellulose membrane (Hybond C extra) cut to the size of the 
gel were rinsed in transfer buffer.  
First, one layer of Watmann paper was place on the blotter, the nitrocellulose membrane 
was placed on top of it. Then, the gel was carefully layered on top. A final piece of Watmann 
paper was placed on top of the stack. Possible bubbles were removed by rolling a pipette on 
top of the stack.  
The apparatus was further assembled by fitting the lid on and transfer was carried out at 
for 40 min at a constant voltage of 10 V. 
(iv) Detection 
After transfer, the membrane was taken out of the blotter. Blocking was carried out in a 
plastic box containing ~30 ml of blocking buffer for 1h at room temperature and under 
constant agitation.  
Binding of primary antibodies was carried out in a 50 ml falcon tube containing 10 ml of 
blocking solution and the appropriate concentration of anti-BUN N or anti-Tubulin antibodies. 
Primary antibodies were incubated either for 1h at room temperature or overnight at 4°C, in 
any case constant rotation was applied.  
The membrane was moved back to the plastic box, and washed 3 times in blocking buffer 
for 5 min. Then, the membrane was incubated with the appropriate secondary antibodies in a 
new 50 ml falcon tube for 1h at room temperature under constant rotation. The membrane was 
transferred back into the plastic box and washed 3 times in blocking buffer for 5 min.  
The membrane was rinsed in PBS – 0.1% Tween 20. Before placing the membrane on a 
plastic film, the remaining PBS was drained. Then, an enhanced chemiluscent substrate was 
added to the membrane. After 1 min of incubation, the membrane was transferred onto a new 
piece of plastic and placed into a cassette.  
X-ray films were used to visualise the light signal. X-ray films were exposed from 1 sec 
to 25 min according to the signal strength and reveal using Kodak automatic developer. 
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Chapter 3  
RESULTS 
 
NOTE: Throughout the results chapter, the term wt BUNV is used to refer to a recombinant 
BUNV rescued from the wt cDNA clones. 
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A. Attempt to rescue a Bunyamwera virus with a two-
segmented genome using an ambisense coding 
strategy 
1. Introduction and aims 
During BUNV replication, the NSs protein is the major interferon antagonist. NSs 
functions have been mainly studied through a virus lacking the NSs protein. Despite the fact 
that NSs is encoded in an overlapping ORF within the N protein ORF, it is possible to mutate 
the NSs start codon without introducing amino acid changes in the N protein (Bridgen et al., 
2001). Nevertheless, the range of mutations that it is possible to introduce without affecting 
the N protein is very limited. In order to delineate NSs protein domains without modifying the 
N sequence, it was attempted to express NSs as a separate ORF. Different methods have 
previously been explored in our laboratory: (1) cloning the NSs sequence after the N sequence 
and linking them with an Internal Ribosome Entry Site (IRES), expecting that the ribosome 
would be able to initiate translation after the IRES and translate both proteins; (2) introducing 
an internal promoter between the N ORF and the NSs ORF to create two independent 
transcription initiation sites; (3) cloning the sequence for a self-cleaving protease between the 
N ORF and the NSs ORF, expecting the two proteins to be translated as a polyprotein and 
then cleaved; and (4) taking the coding strategy of the phleboviruses as an example, to 
express NSs in an ambisense orientation. Of these different methods, the ambisense strategy 
was the only one to prove successful (I van Knippenberg and R Elliott, unpublished).  
 
BUNV does not use an ambisense strategy to express the NSs protein: its S-segment 
genome RNA is a template for both replication and transcription whereas the S antigenome 
can only serve as a template for replication. Replication and transcription are performed by 
the viral polymerase and are promoted by the UTRs. The terminal 25 nt of each UTR basepair 
to form a panhandle structure but not all 25 nt of the wt 3’ and 5’ termini are exactly 
complementary. It is a combination of nucleotide complementarity and nucleotide identity 
within the panhandle structure that dictates the promoter activity of the UTRs (Barr et al., 
2003; Kohl et al., 2004). Previous work with mini-genome assays showed that it was possible 
to engineer a BUNV S-segment template so that genome and antigenome cooperate to 
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promote both replication and transcription, resulting in the ability of the S segment to express 
an ORF from the ambisense orientation (Barr et al., 2005). The U residue at position 9 in the 
3’ UTR and the eight nt at positions 16 to 18, 20 and 22 to 25 in the 5’UTR were identified as 
‘essential transcription signals’. Barr et al. (2005) introduced these essential transcription 
signals in the opposite strand achieving transcription of an ORF in the reverse orientation 
(Figure 3-1). As a result, the termini were perfectly complementary and able to promote 
replication and transcription from both genomic and anti-genomic RNA species. However, 
this ambisense strategy is a compromise between optimal replication and ability to transcribe 
an ORF in antisense orientation, which resulted in lower levels of both replication and 
transcription of the S-segment mini-genome compared to the wt S-segment mini-genome. 
In the family Bunyaviridae, viruses within the genus Phlebovirus encode the N and NSs 
proteins in an ambisense orientation. In RVFV, NSs is dispensable for replication and can be 
replaced by foreign gene (Bird et al., 2008). It also proved possible to replace the NSs coding 
sequence by the coding sequences for the two glycoproteins, Gn and Gc, and obtain a 2-
segmented virus that was viable in tissue culture (Brennan et al., 2011b).  
 
The aim of this chapter was to assess if the BUNV S segment could support the 
expression of an ORF in an ambisense orientation in a virus context. To this intent, the 
termini of the S segment 3’ and 5’ UTR were mutated as described by Barr et al. (2005) and 
then the S segment structure of RVFV was mimicked by introducing the eGFP coding 
sequence in an ambisense orientation. It was speculated that if eGFP was expressed from the 
ambisense construct, the ORF of the BUNV M segment, coding for Gc, Gn and NSm, could 
be inserted in the place of eGFP and a viable virus might be rescued.  
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Figure 3-1: Schematic representing nucleotide 1 to 25 of the BUNV 3’ and 5’ UTR of the 
genomic S segment. 
The first 25 nt of the 3’ and 5’ UTR of the wt genome (A) or the ambisense genome (B) are 
represented. The positions highlighted in yellow represent nt that are essential for BUNV transcription. 
Watson-Crick base pairing are indicated by (*) and noncannonical U-G pairing by (^). (Taken from 
Barr et al. 2005) 
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2. Constructs 
a) Construct with eGFP ORF in an ambisense orientation 
The initial construct containing the eGFP ORF in an ambisense orientation was designed 
by I. van Knippenberg (unpublished data). The basis for this construct was the plasmid 
pT7riboBUNdelNSs2 (Léonard et al., 2006).  
The wt S segment can be divided into a number of domains, described from 3’ to 5’as the 
3’ UTR terminus, the remaining 3’ UTR, the N ORF, four domains within the 5’UTR (W, X 
that contains the termination signals, Y and Z) and the 5’ terminus (Figure 3-2-A).  
To make the construct pT7riboAmbiN_GFP, a fragment containing the M segment 5’ 
UTR and the eGFP ORF was inserted after the Y domain (Figure 3-2-B). This fragment is 
flanked by two restriction enzyme sites (XhoI and NcoI) and contains the restriction enzyme 
site EagI at the junction between the M segment 5’ UTR sequence and the eGFP ORF. The Y 
domain was duplicated between the eGFP ORF and the Z domain. Most importantly, the 3’ 
and 5’ termini of the S segment were mutated according to Barr et al (2005) to be able to 
promote ambisense replication and transcription.  
The construct pT7riboAmbiN/NSs_GFP is closely related to pT7riboAmbiN_GFP but 
instead of encoding only the N protein, it coded for both N and NSs proteins (Figure 3-2-B). 
The sequence coding for the NSs protein was restored by Quick-change PCR mutagenesis 
using primers in an outward orientation. Two sets of primers were necessary: the first set (Qc-
AmbiM-NSs5-For and Qc-AmbiM-NSs5-Rev) restored wt nucleotide at positions 106, 109, 
112, 115 and 118; the second set (Qc-AmbiM-NSs1-For and Qc-AmbiM-NSs1-Rev) restored 
the wt nucleotide at position 193. The sequence for these primers can be found in Table 2-4. 
b) Constructs with M ORF in an ambisense orientation 
The BUNV M ORF was inserted in the place of eGFP in the construct 
pT7riboAmbiN_GFP. Briefly, the M ORF was amplified by PCR with primers design to flank 
the coding sequence in an inward orientation. The sequence for the restriction site BsmBI was 
added upstream of the start-codon (BsmBI-MORF+) and the sequence for the restriction site 
NotI was added downstream of the stop-codon (NotI-MORF-). The sequence for these 
primers can be found in Table 2-4. The M ORF amplified by PCR was digested with the 
restriction enzymes BsmBI and NotI while the plasmid pT7riboAmbiN_GFP was digested 
with the enzymes EagI and NcoI. DNA digested with BsmBI or NcoI will have a compatible 
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Figure 3-2: Schematic of the wt S genome and of the modified genome coding for eGFP in an 
ambisense orientation. 
The UTR sequences are represented by a coloured line: in blue, the wt panhandle; in red, the mutated 
panhandle; in black, the S UTRs with the letter above indicating the domain; in grey, the M 5’ UTR; 
and in pink, the transcription termination signal. Coding sequences are represented by a box named 
according to the protein they code for. The upside-down writing signifies opposite sense coding 
strategy. (A) Representation of the wt S segment cloned into pT7riboBUNdelNSs2. (B and C) 
representation of the ambisense segment cloned into pT7riboBUN: pT7riboAmbiN_GFP encodes only 
the N protein, the absence of the NSs start-codon is indicated by Δ, whereas 
pT7riboAmbiN/NSs_GFP encodes both N and NSs.  
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overhang, while digestion with NotI leaves an overhang compatible with EagI digested DNA. 
Therefore the M ORF could be cloned in the place of eGFP. The resulting construct was 
named pT7riboAmbiN_M (Figure 3-3-A). 
The construct pT7riboAmbiN/NSs_M, where eGFP is replaced by the M ORF in the 
construct expressing NSs, was obtained by digesting pT7riboAmbiN/NSs_GFP and 
pT7riboAmbiN_M with the restriction enzymes KpnI and SapI. The fragment of the 
pT7riboAmbiN/NSs_GFP containing the sequence for NSs was ligated into 
pT7riboAmbiN_M. The resulting construct was named pT7riboAmbiN/NSs_M (Figure 3-3-
B). 
3. Detection of eGFP and M by immunofluorescence 
during rescue experiments 
In order to ensure that pT7riboAmbiN_GFP and pT7riboAmbiN_M express the protein 
from the ambisense ORF under rescue conditions, BSR-T7/5 cells were transfected with 
0.125 µg of each plasmid and were analysed by immunofluorescence assay. The wt 
combination was pT7riboBUNL, pT7riboBUNM and pT7riboBUNS; the combination to 
assess the presence of eGFP was pT7riboBUNL, pT7riboBUNM and pT7riboAmbiN_GFP; 
and the combination to assess the presence of the glycoproteins was pT7riboBUNL and 
pT7riboAmbiN_M. Cell monolayers were fixed at 48h post-transfection for the wt constructs 
and at 72h post-transfection for the ambisense constructs.  
The viral glycoproteins were detected by immunofluorescence staining in the wt rescue at 
48h post-transfection, whereas eGFP or the glycoproteins encoded in an ambisense 
orientation were only detected at 72h post-transfection. The glycoproteins expressed from the 
sense orientation localised in the Golgi area, but the glycoproteins expressed from the 
ambisense ORF seemed to have a more diffuse localisation. eGFP was diffuse in the cells 
(Figure 3-4).  
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Figure 3-3: Schematic of the genome coding for the M ORF in an ambisense orientation. 
The UTR sequences are represented by a coloured line: in red, the mutated panhandle at each 
extremity; in black, the S UTRs with the letter above indicating the domain; in grey, the M 5’ UTR; 
and in pink, the transcription termination signal. Coding sequences are represented by a box named 
according to the protein they code for. pT7riboAmbiN_M (A) encode only the N protein, the absence 
of the NSs start-codon is materialised by Δ; pT7riboAmbiN/NSs_M (B) encode for both N and NSs. 
Both constructs have the ORF of the M segment in an ambisense orientation, indicated by upside 
down writting. 
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Figure 3-4: Expression of eGFP and the BUNV glycoproteins from ambisense constructs. 
BSR-T7/5 cells were transfected with pT7riboBUNL(+), pT7riboBUNM(+) and pT7riboBUNS(+) for 
the wt; pT7riboBUNL(+), pT7riboBUNM(+) and pT7riboAmbiN_GFP for AmbiN_GFP; and 
pT7riboBUNL(+) and pT7riboAmbiN_M for AmbiN_M. Cells were fixed in formaldehyde at 48h or 
72h post-transfection, permeabilised and stained for the Gn/Gc proteins using a primary antibody 
raised against the glycoproteins and a secondary antibody coupled with TRITC. Coverslips were 
monted in Movio supplemented with DAPI. The nucleus is in blue, eGFP is in green and Gn/Gc are in 
red.  
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4. Rescue of viruses expressing eGFP in an ambisense 
orientation 
a) Virus rescue 
In order to assess if it was possible to rescue a virus expressing eGFP in the ambisense 
orientation, BSR-T7/5 cells were transfected with pT7riboAmbiN_GFP or 
pT7riboAmbiN/NSs_GFP along with pT7riboBUNL(+) and pT7riboBUNM(+). The 
expression of eGFP was detectable from 72h post-transfection and the supernatants were 
harvested at 5 days post-transfection. Presence of virus in the rescue supernatant was assessed 
by plaque assay in BHK-21 cells. The viruses were named rBUNAmbiN_GFP and 
rBUNAmbiN/NSs_GFP , or AmbiN_GFP and AmbiN/NSs_GFP for short. 
b) Infection of different cell lines 
The ability of viruses with an ambisense S segment to replicate in different cell lines was 
assessed for a range of mammalian, amphibian and insect cells. The chosen mammalian cell 
lines were BHK-21, A549-NPro, A549-V, HuH-7 and Vero E6, the amphibian cell line was 
XTC-2, and the insect cell line was C6/36. Each cell line was infected with AmbiN_GFP, 
AmbiN/NSs_GFP or wt BUNV as a control. Cell monolayers were lysed 5 days post-
infection and the presence of the N protein assessed by Western Blot. All cell lines supported 
wt BUN replication (Figure 3-5-A) but infection with AmbiN_GFP led to detectable levels of 
N protein only in the five mammalian cell lines (Figure 3-5-B). A band was also detected at 
above the N signal in the Vero E6 cell lysate; this band was also seen in mock infected cells 
(not shown). 
c) Serial passage 
In order to assess if the expression of eGFP was stable over serial passage, AmbiN_GFP 
and AmbiN/NSs_GFP were propagated in three different mammalian cell lines, A549-NPro, 
BHK-21 and Vero E6. Briefly, cell monolayers were infected with a small volume of 
supernatant from the rescue cells or from the different passages. Two or five days post-
infection, the presence of eGFP was assessed in the microscope.  
For both viruses, infection with the rescue supernatant gave good expression of eGFP in 
BHK-21 and Vero E6 cells but the expression in A549-NPro was much fainter. During serial 
passage, the expression of eGFP was lost quickly and, surprisingly, it was lost faster when 
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Figure 3-5: Western-blotting of the N protein of wt BUNV and AmbiN_GFP after infection of 
different cell lines with the rescue supernatant. 
Cells were seeded in 12-well plate in infected with rescue supernatant from wt BUN (A) or 
AmbiN_GFP (B). Mammalian cells were incubated at 33°C while amphibian and insect cells were 
incubated at 28°C. The cell monolayers were lysed in protein disruption buffer 5 days post-infection. 
The position of Tubulin and N protein signals are indicated on the left. The analysis was done on 
different gels. * indicate background signal. 
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NSs protein was present. The experiment was repeated twice and on both occasions eGFP 
expression was lost after 3 passages for AmbiN_GFP and after only 2 passages for 
AmbiN/NSs_GFP (Figure 3-6).  
 
In order to determine the cause behind the disappearance of eGFP expression, the cell 
monolayers were harvested in Trizol at either passage 0 (p0) and p2 for AmbiN_GFP or p0 
and p1 for AmbiN/NSs_GFP. Total cell RNAs were extracted and used for RT-PCR to 
determine the size of the S segment present. The RT step was performed using BUN S+ 
primer while the PCR was done with the primer pair BUN S+ and BUN S-. As a control, 
RNA was extracted from the same three cell lines infected with wt BUNV (Figure 3-7).  
RT-PCR on cells infected with wt BUNV gave a product of around 1 kb which matches 
the expected size of the wt S segment. The signal was strong for RNA samples from BHK-21 
and Vero E6 cells but faint for RNA samples from A549-NPro cells.  
RT-PCR on RNA samples from BHK-21 and Vero E6 infected with AmbiN_GFP and 
AmbiN/NSs_GFP from rescue supernatant revealed the presence of a 1.7 kb product 
corresponding to the size of the ambisense segment (Figure 3-2). It also revealed the presence 
of lesser amount of products at 1 kb and 1.2 kb, which possibly result from a truncated form 
of the ambisense segment. The same species were detected in p2 from cells infected with 
AmbiN_GFP but in lesser amounts. However no product was detected from RNA of p1 cells 
infected with AmbiN/NSs_GFP. In samples from A549-NPro cells, RNA species were hardly 
ever detected regardless of the virus or the passage. 
5. Rescue of a two-segmented virus 
a) Virus rescue 
In order to rescue a two-segmented Bunyamwera virus, plasmids pT7riboAmbiN_M(+) 
or pT7riboAmbiN/NSs_M(+) were transfected into BSR-T7/5 cells along with 
pT7riboBUNL(+). First, rescues were attempted using 1 µg of each plasmid. wt BUNV and 
viruses AmbiN_GFP or AmbiN/NSs_GFP were rescued at the same time to serve as positive 
controls. It was expected that viruses containing the M ORF in an ambisense orientation 
would be grossly attenuated, and therefore different rescue conditions were attempted: first, 
the amount of the ambisense constructs were increased to 2 µg and 3 µg, and second 1 µg of 
support plasmid pTM1-BUNM, expressing the M ORF, was co-transfected. Supernatants 
were harvested every 5 or 7 days up to 21 days post-transfection. 
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Figure 3-6: Expression of eGFP during serial passage of AmbiN_GFP and AmbiN/NSs_GFP. 
BHK-21, Vero E6 and A549-NPro cells were infected with 10 µl of rescue supernatant or supernatant 
from different passages. Autofluorescence of eGFP was observed at 48h (p0) or 4 days (p1 and p2) 
post-infection.  
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Figure 3-7: Determination of the size of the S segment by RT-PCR. 
BHK-21, Vero E6 and A549-NPro cells were infected with 10 µl of rescue supernatant or supernatant 
from different passages. Cell monolayers were harvested in Trizol at 4 days post-infection and total 
cellular RNAs extracted. The reverse transcription step was performed using the primer BUN S+ and 
the PCR was performed using the pair of primers BUN S+ and BUN S-. PCR products were run on 
agarose gel and DNA size markers are shown.  
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b) Detection of virus in rescue supernatant by 
immunostaining 
Considering the expected difficulty in rescuing these viruses, rescue outcome was 
assessed by immunostaining for the N protein. Briefly, BHK-21 cells seeded in a 12-well 
plate were infected using 100 µl of rescue supernatant, and then incubated with Avicel as the 
overlay. The monolayer was fixed 4 days post-infection and stained for the N protein.  
Anytime the positive controls appeared to be positive, I looked for N signal from a two 
segment rescue experiment but only once I did detect single cells stained for the N protein 
(Figure 3-8). This positive supernatant resulted from transfection of the plasmids 
pT7riboAmbiN_M and pT7riboBUNL(+) only and was harvested 12 days post-transfection. 
This virus was named rBUNAmbiN_M and will be referred to as AmbiN_M. Only a few 
infected cells were detected, giving a titre equivalent to 100 infectious units per ml. 
AmbiN_M did not form foci of infection as it was always a single cell that was positive for 
the N protein. It seemed possible that AmbiN_M was unable to spread to neighbouring cells. 
c) Propagation in different cell lines 
The ability of the virus AmbiN_M to replicate in different cell lines was assessed in the 
same mammalian (A549-NPro, A549-V, BHK-21, HuH-7 and Vero E6), amphibian (XTC-2) 
and insect (C6/36) cells than those tested for the propagation of AmbiN_GFP.  
Cells were infected with 100 µl of rescue supernatant for AmbiN_M. 6 days post-
infection, the supernatant was collected (p0 stock) and the cell monolayer was lysed. The 
presence of N protein was assessed by Western Blotting. All cells lines supported wt BUN 
replication (Figure 3-5-A) but infection with AmbiN_M led to detectable levels of N protein 
only in two mammalian cell lines A549-NPro, and Vero E6, and the insect cells C6/36 
(Figure 3-9-A). 
Vero E6 and C6/36 cells were selected to attempt to propagate the two-segmented virus 
AmbiN_M. Cells were infected with 500 µl of p0 stock for AmbiN_M and 5 µl for wt BUN. 
6 days post-infection, the supernatant was collected (p1 stock) and the cell monolayer was 
lysed. The presence of N protein was assessed by Western Blotting. The N protein was 
detected in both cell lines for wt BUN but was absent from the cells infected with AmbiN_M 
(Figure 3-9-B). The same experiment was repeated and again no signal for the N protein was 
detected for AmbiN_M. 
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Figure 3-8: Detection of the N protein of AmbiN_M virus by immunostaining. 
BHK-21 cells seeded in a 12-well plate were infected with 100 µl of rescue supernatant. After 1h at 
37°C, an overlay of Avicel was added and cells were incubated at 33°C. The monolayer was fixed in 
4% formaldehyde 4 days post-infection. The N protein was stained using the anti-BUN N antibody 
followed by secondary antibody coupled with peroxidase which signal was revealed using a 
precipitate-forming peroxidase substrate. Bars represent 200 µm. 
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Figure 3-9: Western-blotting to detect the N protein of AmbiN_M after infection of different cell 
lines with the rescue supernatant. 
Cells were infected with rescue supernatant of AmbiN_M (A) or with AmbiN_M p0 supernatant (B). 
Mammalian cells were incubated at 33°C while Xenopus and insect cells were incubated at 28°C. The 
cell monolayer was lysed in protein disruption buffer 6 days post-infection. The position of the 
Tubulin and N protein signals are indicated on the left. * indicate background signal. 
 
  
Chapter 3: Results  Ambisense BUNV 
109 
 
6. Discussion 
In this chapter, rescue of a two segmented BUNV was attempted. The work by Brennan et 
al. (2011) on the phlebovirus RVFV, showed it was possible to convert a three-segmented 
virus into a two-segmented virus. The strategy used for RVFV was to replace the ORF of the 
NSs protein (encoded on the S segment in an ambisense orientation) by the ORF of the 
glycoproteins, removing the need of the M segment (Brennan et al., 2011b). However, unlike 
RVFV, BUNV S segment does not use an ambisense strategy to code for its NSs protein. The 
first challenge, therefore, was to develop an S segment capable of ambisense 
transcription/replication. This was achieved by mutating the terminal sequences of the S 
segment as described by Barr et al. (Barr et al., 2005). As well as rearranging the terminal 
sequences, an intergenic region was introduced that was composed of sequences from both 
the S 5’ and M 5’ UTRs. 
 
Using this strategy, it was possible to express the eGFP protein from an ORF cloned in an 
ambisense orientation in the S segment. It was also possible to rescue three-segmented viruses 
expressing eGFP. Two viruses were rescued: AmbiN_GFP and AmbiN/NSs_GFP. The 
expression of eGFP was detected in BSR-T7/5 transfected cells and in BHK-21 or Vero E6 
cells after infection with the rescue supernatant. However, the expression of eGFP was 
rapidly lost during serial passage. One hypothesis that could explain the presence of 
fluorescence at p0 would be carryover of plasmid in the rescue supernatant. However, 
considering the volume used for infection (10 µl out of 5 ml), it seems very unlikely that this 
small volume would contain enough plasmid to render most of the cells showing 
autofluorescence. Thus, the autofluorescence observed at p0 was due to the presence of an 
infectious virus. A reason for the loss of expression of eGFP could be the excision of the ORF, 
partly or entirely. But, when trying to investigate the size of the S segment in total cellular 
RNA samples from infected cells, RT-PCR failed to detect any S segment for the 
AmbiN/NSs_GFP virus after two passages. The absence of viral S RNA suggests that the 
virus has lost its ability to replicate or that no virus particles were produced during the 
previous passage. For the virus AmbiN_GFP, the presence of S RNA was detected after 3 
passages but the amount was low suggesting poor efficiency of virus replication. A possible 
reason for the disappearance of the S segment could be caused by poor transcription 
termination efficiency, even though the transcription signals that have been identified for the 
S segment were maintained in the ambisense construct. Therefore, I think that the mRNA for 
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the N and NSs ORF should have terminated correctly at the termination signal. However, the 
presence of termination signals for the eGFP ORF was not explored, and if they are incorrect 
or absent, it is likely that the viral polymerase will transcribe the entire segment. Thus 
inefficient transcription termination could lead to the presence of a large amount of double-
stranded RNA and, hence, inhibition of viral replication. Therefore, it would be of interest to 
investigate the termination transcription signal in the ambisense segment in more detail. 
 
In parallel to creation of viruses with the eGFP ORF in the ambisense orientation, I 
attempted to rescue a virus with the M ORF in an ambisense orientation. This would results in 
a BUNV containing only two segments: the wt L segment and an ambisense S segment 
encoding N/NSs in the sense orientation and Gn/NSm/Gc in the ambisense orientation. 
Rescuing a two-segmented BUNV proved extremely difficult, though a two-segmented 
BUNV was rescued and named AmbiN_M. This virus was extremely attenuated and despite 
the fact that I could detect the N protein when cells were infected with rescue supernatant, it 
was not possible to passage it further. When observing data from immunostaining, AmbiN_M 
appeared capable of entering the cell, replicating and transcribing at least its N protein, but 
then AmbiN_M seemed unable to produce virions that would infect neighbouring cells. Many 
reasons could explain why AmbiN_M was that attenuated. 
The first reason might be related to UTR promoter strength. Indeed, the relative promoter 
strength has been shown to be M>L>S with M being the UTR that promotes the highest level 
of mini-genome expression (Kohl et al., 2004). In addition, using the ambisense strategy is 
likely to result in a lower transcription/replication activity (Barr et al., 2005). Therefore, by 
placing the M ORF in an ambisense orientation within the S segment, the production of the 
glycoprotein mRNA could have been made less efficient. Indeed, it is very likely that the 
glycoproteins were produced later in the replication cycle and in a smaller amount than in a 
wt infection. I attempted to facilitate rescue of a two-segmented BUNV by using a support 
plasmid that would express the glycoproteins independently. This strategy was unsuccessful; 
therefore the low amount of glycoproteins present in the cells cannot completely explain virus 
attenuation. 
A second reason for virus attenuation could reside in packaging issues. Indeed, to be 
infectious, a virion needs to package all three segments. Packaging mechanisms are not fully 
understood, but it is clear that signals that direct efficient packaging reside within the UTRs 
(Kohl et al., 2006). For BUNV, it was observed that a segment lacking nt 20 to 30 in the M 
segment 5’ UTR resulted in failure to rescue a virus (Kohl et al., 2006). The two-segmented 
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virus lacks the entire M UTRs, and this might explain the extreme difficulty to rescue and 
propagate it, and might suggest a role for the M UTRs in promoting or facilitating packaging 
of the L and S segment. Such a mechanism has been suggested for RVFV by Terasaki et al., 
who suggested that specific molecular interactions among genomic RNA species drive the co-
packaging of the three viral RNAs in a VLP assay (Terasaki et al., 2011). They also suggested 
that the UTRs of the M segment might be playing a central role in this co-packaging 
mechanism. However this hypothesis seems incompatible with the results of Brennan et al. 
(2011) who successfully rescued a two-segment RVFV lacking an M segment, suggesting that 
the M UTRs are not necessary for the packaging of either the L segment or the S segment. 
Nevertheless, one might speculate that RVFV genome plasticity is greater than that of BUNV, 
making the virus able to cope with the absence of the M UTRs whereas BUNV cannot. 
Brennan et al. also managed to rescue a two-segmented RVFV that packaged an extra 
segment containing the eGFP ORF flanked by the M UTRs, and despite the lack of selection 
pressure on the M-eGFP segment it was still maintained after three passages (Brennan et al., 
2011b). This finding might suggest that the M UTRs are preferentially packaged, that they 
play a role in packaging, or that virus replication is most efficient when the complete set of 
genome UTRs is present. In the case of BUNV, inefficient packaging of the L, S or both 
segments might result in the loss of the segment through passage and would explain the loss 
of AmbiN_M. It would be of interest to determine if the M segment is required for efficient 
packaging of the L and S segment. In that case, it could be attempted to rescue a two-
segmented BUNV by replacing the S UTRs on the ambisense construct with the M UTRs. 
Within the family Bunyaviridae, viruses in the Tospovirus genus possess an M segment 
capable of ambisense replication/transcription. Indeed, in this genus, the glycoproteins are 
encoded in the sense orientation while the NSm protein is encoded in the ambisense 
orientation. Therefore, mutating the termini of BUNV M UTRs to sequences that are able to 
promote replication and transcription from both the genomic and antigenomic RNA species 
might result in the expression of an ORF in an ambisense orientation.  
 
Previous work has shown that converting a three-segmented virus into a two-segment 
virus results in attenuation (Brennan et al., 2011b) and I observed that converting a segment 
to an ambisense coding strategy also causes attenuation. In this chapter, I attempted to rescue 
a two-segmented BUNV which meant that I combined two factors of attenuation within the 
same virus. The resulting attenuation appears beyond virus capacities to replicate. However, it 
would be of interest to investigate which sequence would promote replication and 
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transcription to an optimal level in an ambisense segment. 
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B. Rescue of recombinant Bunyamwera viruses 
carrying heterologous untranslated regions 
1. Introduction and aims 
The coding region of each segment is flanked by untranslated regions (UTR) that are 
partially conserved and complementary. The terminal 11 nt are conserved between each 
segment and within the genus, while internal regions of the UTRs are unique to each segment 
and show a great variability in size and sequence. For each segment, the terminal 25 nt are 
partially complementary and allow the formation of a panhandle structure (Obijeski et al., 
1980) that directs replication and transcription of the genome (Barr & Wertz, 2005), as well 
as encapsidation of the genomic and anti-genomic RNAs by the N protein (Osborne & Elliott, 
2000). UTRs are also involved in packaging of the RNPs into virions (Kohl et al., 2006). 
UTRs keep their functionality even in the absence of the viral coding region, thus, being able 
to promote transcription, replication and packaging of a foreign coding sequence such as 
Renilla (Barr & Wertz, 2004; Kohl et al., 2006).  
These observations suggest the presence of segment-specific signals within the UTRs. In 
order to answer this question, a virus containing the L coding sequence flanked by the UTRs 
from the M segment was rescued (Lowen et al., 2005). It appeared that the so called BUN 
MLM virus was attenuated in tissue culture, forming smaller plaques and growing to lower 
titres, and RNA synthesis was also affected with a relative lack of L genomic and anti-
genomic RNAs. 
 
In this chapter, I investigated further the specificity of a set of UTRs for its cognate 
coding sequence. The reverse genetic system was exploited to rescue viruses with the 
different ORFs flanked by heterologous UTRs.  
2. Virus rescues 
In order to rescue viruses in which at least one segment would carry heterologous UTRs, 
BSR-T7/5 cells were transfected with 1 µg of each plasmid with the combinations shown in 
Table 3-1. Supernatants were harvested every 5-6 days for up to 20 days post-transfection. 
First, rescues were done with two wt segments and one segment with heterologous UTRs. 
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Lowen et al. (2005) rescued BUN MLM virus but failed to rescue any other heterologous 
segment. In this studied, BUN MLM virus was also rescued but it was possible to rescue two 
more viruses with heterologous UTRs: BUN SLS, where the L coding sequence is flanked by 
the S segment UTRs and BUN MSM, where the S coding sequence is flanked by the M UTRs. 
BUN MLM and BUN MSM were rescued within 5 days post-transfection but BUN SLS took 
about 12 days to rescue. Rescue conditions were considered negative after 3 attempts when, 
under similar conditions, wt BUNV was rescued. Rescue experiments were repeated using 
different plasmid preparations. 
I also attempted to combine heterologous segments in rescue experiments, but a virus 
containing more than one segment with heterologous UTRs could not be rescued despite few 
attempts. 
 
 
Experiment 
1 2 3 4 5 6 7 8 
Pl
a
sm
id
 
pT7riboBUNL(+) - -     - - 
pT7riboBUNM(+)   - -     
pT7riboBUNS(+)     - - - - 
pT7riboBUNMLM(+)  - - - - -  - 
pT7riboBUNSLS(+) -  - - - - -  
pT7riboBUNLML(+) - -  - - - - - 
pT7riboBUNSMS(+) - - -  - - - - 
pT7riboBUNLSL(+) - - - -  - - - 
pT7riboBUNMSM(+) - - - - -    
Rescue outcome + + - - - + - - 
Table 3-1: Plasmid combinations attempted to rescue viruses with heterologous UTRs. 
Constructs names are indicated on the left and check marks notified of the use of one construct in the 
associated experiment. Positive rescue outcome was notified by a + on the bottom line. – denotes the 
absence of plasmid or a negative rescue outcome. 
3. Characterisation in tissue culture 
a) Serial passage and virus stocks 
The rescue supernatants of BUN MLM, BUN SLS and BUN MSM were used to grow a 
p0 virus stock. BUN MLM and BUN MSM p0 stocks reached titres of 106 and 105 pfu/ml 
respectively, but BUN SLS grew only to 103 pfu/ml. 
In order to increase BUN SLS titres, all three viruses with heterologous UTRs were 
serially passage 10 times. Briefly, BHK-21 cells were infected at a low MOI (0.001 pfu/cell) 
using p0 stock. The p1 supernatant was harvested after 5 or 6 days and use to infect new 
BHK-21 cells. This procedure was followed up to p10. The supernatants from p5 were titrated 
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and I observed that BUN MLM, BUN MSM and BUN SLS reached titres above 105 pfu/ml.  
I attempted to grow a plaque-purified stock of each virus after 10 passages but the plaques 
formed by BUN SLS were too small and fuzzy to be visualised with Neutral Red staining. 
Therefore, only BUN MLM and BUN MSM were plaque purified and the resulting virus 
stocks were named BUN ppMLM and BUN ppMSM. In addition, for all three viruses, a non-
plaque purified stock was grown from the p10 by infecting BHK-21 cells at a low MOI to try 
to prevent the formation of DI particles.  
b) Sequence analysis of p10 stocks 
In order to verify that viruses present in the p10 stock still carried the segment with 
heterologous UTRs, BHK-21 cells were infected at an MOI of 0.1 pfu/ml. Total cellular RNA 
species were extracted at 3 days post-infection and analysed. 
The experiment was designed to discriminate between wt and heterologous segments. To 
achieve that, a primer annealing within the coding sequence was used for the Reverse-
Transcription step. Then, the PCR were performed using a UTR specific primer and a primer 
annealing within the coding sequence. PCR products were run on an agarose gel. Primer pairs 
and PCR products are shown in Figure 3-10.  
Results obtained for the L segment are shown in figure Figure 3-10-A. Reaction 1 was 
performed with a set of primer that annealed within the L 3’ UTR and the L coding sequence 
and confirmed the presence of a wt L segment in both BUN MSM and BUN wt. It also 
confirmed the absence of a wt L segment in both BUN MLM and BUN SLS. The presence of 
the MLM segment in BUN MLM was confirmed with reaction 2 and the presence of the SLS 
segment in BUN SLS was confirmed in reaction 3.  
The presence of a wt M segment was confirmed in all three viruses with reaction 5 
(Figure 3-10-B). This reaction was performed with a set of primers annealing in the M 3’ 
UTR and the M coding region. Neither reaction 4 nor reaction 6, which were performed with 
one primer annealing into the M coding region and the other in either the L 3’ UTR or the S 3’ 
UTR, generated a PCR product.  
The presence of the appropriate S segment was confirmed with reactions 7, 8 and 9 
(Figure 3-10-C). The presence of a wt S segment only in BUN MLM, BUN SLS and BUN wt 
was confirmed with reaction 9 which was performed with a set of primers annealing in the S 3’ 
UTR and the S coding region. The presence of the MSM segment was confirmed using a set 
of primer annealing in the M 3’ UTR and the S coding region with reaction 8. All other 
primer combinations failed to generate PCR products.  
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Figure 3-10: Identification of the UTR flanking a given ORF in BUN MLM, BUN SLS and BUN 
MSM. 
The annealing positions of each primer are represented for each reaction. Primers anneal either in the 
coding region (white boxes) or in the 3’ UTR (coloured boxes) and the expected product size is 
indicated on the right. The letter inside boxes indicates to which segment it belongs. On the gel, 
viruses names are in black, the wells are marked by a thick white line and the number of the reaction 
indicated above it. Each reaction detects a different UTR/coding region arrangement: reaction 1 (L3’ 
UTR+ and L1055-) detects the wt L segment, reaction 2 (M3’ UTR+ and L1055-) detects the MLM 
segment, reaction 3 (BUNS+ and L1055-) detects the SLS segment, reaction 4 (L3’ UTR+ and M671-) 
detects the LML segment. Reaction 5 (M3’ UTR+ and M671-) detects the wt M segment, reaction 6 
(BUNS+ and M671-) detects the SMS segment, reaction 7 (L3’ UTR+ and S550-) detects the LSL 
segment, reaction 8 (M3’ UTR+ and S550-) detects the MSM segment and reaction 9 (BUNS+ and 
S550-) detects the wt S segment. Lanes loaded with marker tracker are marked with m and the sizes of 
relevant bands are given. 
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Only the identity of the 3’ UTR was checked as it was shown previously that the 3’ and 5’ 
UTRs have to belong to the same segment to promote replication and transcription (Barr & 
Wertz, 2004; Kohl et al., 2004). 
c) Plaque size 
The ability of each virus to form plaques was assessed at p0, p5 and p10 in BHK-21 cells 
(Figure 3-11). wt BUN displayed similar plaque size at each passage. BUN MLM and BUN 
MSM formed plaques from p0 and serial passage did not improve the size of the plaques. 
Indeed, compared to wt BUN, plaques were smaller and their borders were really fuzzy. The 
case was different for BUN SLS virus; at p0, the virus did not form plaques and foci of 
infection were detected by immunostaining for the N protein. Serial passage had a positive 
effect on plaque formation as plaques were seen from p5 onwards. Plaques formed by BUN 
SLS remained tiny and extremely fuzzy. 
d) Growth curve 
The growth properties of viruses carrying heterologous UTRs were analysed in a multi-
step growth curve. BHK-21 cells were infected at an MOI of 0.1 pfu/cell with p10 virus 
stocks. Cells were incubated at 33°C and virus released into the supernatant was collected at 
6h, 18h, 24h, 36h, 48h and 72h post-infection. Virus titres in the supernatant were determined 
by plaque assay on BHK-21 cells. 
Viruses with heterologous UTRs appeared to be grossly attenuated compared to wt 
BUNV. While wt BUNV reached titres up to 102 pfu/ml as soon as 6h post-infection, BUN 
MLM and BUN SLS were below limit of detection until 18h post-infection. BUN MLM was 
even slower as it was detected only from 24h post-infection. wt BUNV reached titre above 
107 pfu/ml from 18h post-infection but BUN MLS and BUN SLS just about reached 105 
pfu/ml at 72h post-infection. BUN MSM virus titre did not increased much and hardly 
reached 103 pfu/ml even at 72h post-infection. 
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Figure 3-11: Plaque phenotype of viruses with heterologous UTRs in BHK-21 cells. 
BHK-21 cells were infected with the wt BUNV or different BUNV containing a segment with 
heterologous UTRs. Cells were fixed 4 days post-infection in 4% Formaldehyde and stained with 
Giemsa’s solution or immunostained for the N protein (BUN SLS at p0). Viruses’ names are indicated 
at the top and the passage on the left. 
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Figure 3-12: Growth properties of wt BUNV and viruses with heterologous UTRs in BHK-21 
cells at 33°C. 
BHK-21 cells were infected at an MOI of 0.1 pfu/ cell and incubated at 33°C. Supernatants were 
collected at 6h, 18h, 24h, 36h, 48h and 72h post-infection. Virus titres were determined by plaque 
assays in BHK-21 cells 
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4. Viral RNA synthesis analysis 
a) Comparison between plaque-purified and non-plaque-
purified virus stocks 
Viral RNA synthesised during infection was analysed by Northern Blotting. BHK-21 
cells were infected at an MOI of 0.5 pfu/ml with BUN MLM, BUN MSM, BUN SLS and wt 
BUNV. Cells were infected with virus stocks from p0, p5 or p10. Monolayers were lysed in 
Trizol 2 days post-infection and total cell RNAs extracted. Samples were loaded in duplicate 
and subjected to electrophoresis and transfer to nylon membrane. The membranes were 
probed with DIG-labelled RNAs complementary to each of the BUNV genome segments or 
complementary to each of the BUNV antigenomes and mRNAs. wt L genome, antigenome 
and mRNA species are about 6.6 kb and wt M genome, antigenome and mRNA species are 
about 4.4 kb. Consequently the identified bands represent either the genome or both the 
antigenome and mRNA species, as these are not resolved by gel electrophoresis. wt S genome 
and antigenome are about 1 kb whereas wt S mRNA is about 100 nt smaller. Therefore, it is 
sometimes possible to separate each wt RNA species. 
 
In a first experiment (Figure 3-13), cells were infected with p0 and p5 stocks that were 
not plaque-purified. p10 stocks used were BUN ppMLM, BUN ppMSM and wt BUN from a 
plaque-purified virus, and p10 BUN SLS that was not plaque-purified. The titre of p0 stock of 
BUN SLS was too low to infect the cells at an MOI of 0.5 pfu/ml.  
For wt BUNV the pattern of synthesis of genomic, anti-genomic and messenger RNA 
species was consistent throughout passaging, and are used as a reference to compare the RNA 
levels made by the different recombinant viruses.  
The difference in the amount of L genomic RNA present in cells infected with wt BUNV 
and BUN MSM on one side and cells infected with BUN MLM and BUN SLS on the other 
side was striking (Figure 3-13-A long exposure). Indeed, L genomic RNA species could 
hardly be detected for BUN MLM and BUN SLS viruses. It seems that the presence of 
heterologous UTRs flanking the L ORF has a drastic effect on RNA levels. 
The levels of M genomic and anti-genomic/mRNAs species appeared very similar to wt 
levels in the different recombinant viruses and at the different passages. 
The S segment of BUN MSM virus is composed of the S ORF flanked by the M UTRs. 
M UTRs are shorter than S UTRs therefore the S genomic and anti-genomic RNA species of 
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BUN MSM migrated further than their wt equivalent. In cells infected with the p5 stock of 
BUN MLM and BUN MSM, I observed the presence of a band at approximately 2 kb that is 
detected with both the genomic and anti-genomic probes. The 2 kb band was not detected in 
cells with the p10 stock of BUN ppMLM and BUN ppMSM. Interestingly, in the case of 
BUN SLS, the 2 kb band appeared in cells infected with the p5 stock and was the only 
genomic and anti-genomic species present in cells infected with the p10 stock. This band was 
suspected to be the result of a duplicated S segment. In order to confirm this hypothesis, two 
samples were subjected to Northern blotting using the probes for the S genome or 
antigenome/mRNA only. In the sample from wt BUNV-infected cells RNA only a band at 
about 1 kb was detected by both probes. These bands correspond to the wt S segment 
genomic and anti-genomic RNAs species. mRNAs, slightly shorter, were also detected 
(Figure 3-14). In the RNA sample from p10 SLS, the genomic and anti-genomic probes 
detected band at 2 kb but no band at 1 kb. This observation suggests the presence of a 
duplicated S segment. 
A few extra weak bands can be visualised in Figure 3-13-A and are thought to be 
defective RNA species.  
 
In a second experiment (Figure 3-15), cells were infected with p10 stocks of wt BUNV, 
BUN MLM and BUN MSM that were not plaque-purified. The aim was to assess if the 
absence of the 2 kb S segment was an artefact resulting from using a plaque-purified stock. It 
appeared that in the case of BUN MLM, the only S genomic and anti-genomic RNA species 
detected were of 2 kb, whereas for BUN MSM, only a band at 1 kb was detected. 
Interestingly, the L genomic RNA could not be detected in cells infected with BUN MLM 
(Figure 3-15-A long exposure) and the levels of L anti-genomic/mRNAs were much lower 
(Figure 3-15-B long exposure). The M genome was not detected in extract of cells infected 
with recombinants viruses (probably due to low specific activity of the probe) but the amount 
of M antigenome/mRNA were similar for BUN MLM, BUN MSM and wt BUN.  
A strong band around 3 kb (marked with *) was detected in the MLM sample and was of 
unknown origin. 
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Figure 3-13: Northern blot analysis of RNA from BHK-21 cells infected with wt BUNV, BUN 
MLM, BUN MSM and BUN SLS viruses at p0, p5 and p10.  
BHK-21 cells were infected at an MOI pf 0.5 pfu/ml with wt BUNV, BUN MLM, BUN MSM and 
BUN SLS. For all viruses but BUN SLS, p10 stocks were from a plaque-purified virus. Total cellular 
RNA was extracted at 72h post-infection, subjected to Northern blotting and probed with DIG-labelled 
RNA complementary to the BUNV genome (A) or to the BUNV antigenome and mRNA (B). The 
boxes show a longer exposure of the top part of the membrane. Positions of viral RNAs are indicated 
on the right. 
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Figure 3-14: Detection of a band at 2 kb by the S segment-specific probes in Northern blot. 
RNAs samples from BHK-21 cells infected with p10 stocks of BUN wt and BUN SLS were subjected 
to Northern blotting and probed with DIG-labelled RNA complementary to the BUNV S genome (left 
panel) or BUNV S antigenome/mRNA (right panel). 
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Figure 3-15: Northern blot analysis of RNA from BHK-21 cells infected with wt BUNV, BUN 
MLM and BUN MSM at p10.  
BHK-21 cells were infected at an MOI pf 0.5 pfu/ml with wt BUNV, BUN MLM, BUN MSM with a 
non-plaque-purifed p10 stock. Total cellular RNA was extracted at 72h post-infection, subjected to 
Northern blotting and probed with DIG-labelled RNA complementary to the BUNV genome (A) or to 
the BUNV antigenome and mRNA (B). The boxes show a longer exposure of the top part of the 
membrane. Positions of viral RNAs are indicated on the right. 
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b) Evidence for a duplicated S segment 
I hypothesised that the 2 kb band observed in Northern blot analysis during BUN MLM 
and BUN SLS infection was the result of a duplicated S segment. To investigate that 
possibility, BHK-21 cells were infected with wt BUNV, BUN MLM, BUN SLS and BUN 
MSM. Total cellular RNA were extracted and reverse transcription was carried out using a 
primer annealing within the S segment coding sequence (S413+). Then, PCR was performed 
using primers in inward orientation, S413+ and S499- (Figure 3-16-A). PCR products were 
run on an agarose gel as shown in Figure 3-16-B and the resulting product was expected to 
size 1048 bp.  
In cells infected with wt BUNV, a band was detected at around 700 bp and is thought to 
result from non-specific amplification. In cells infected with either BUN MLM or BUN SLS 
the same four bands were detected: the lower bands were just above 1000 bp and could match 
the size of 1048 bp, expected for the hypothesised duplicated S segment; the other three bands 
were detected around 2100, 3400 and 4600 bp and could result from concatamers of more 
than two S segments. In cells infected with BUN MSM, I detected only one band slightly 
shorter than 1000 bp that could correspond to a duplicated S segment as the M UTRs are 
shorter than the S UTRs and the expected size would be 905 bp. However, none of the higher 
molecular weight bands were detected.  
In order to clarify the identity of the 1 kb band detected in BUN MLM and BUN SLS, 
these bands were extracted from the gel, purified, and the DNA was send for sequencing 
using the primers S413+ and S499-. The sequence analysis confirmed the hypothesis of a 
duplicated S segment. Indeed, it confirmed that the schematic from Figure 3-16-A was 
accurate: the S 5’ UTR is followed by the exact S 3’ UTR. Only one nucleotide was missing 
at position 17 in the second 3’ UTR of BUN MLM. When looking at the sequencing data, the 
same position in the second 3’ UTR of BUN SLS appeared to be formed by a mixed 
population of either adenine or cytosine bases (Figure 3-17). 
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Figure 3-16: Evidence for a duplicated S segment. 
(A) Schematic of a hypothetical duplicated S segment. Primers are represented above the segment and 
the expected PCR product is represented below the segment. (B) Agarose gel showing the PCR 
products when PCR was performed using S413+ and S499- primers on total cell RNA extracted from 
BHK-21 cells infected with wt BUN, BUN MLM, BUN SLS or BUN MSM. The sizes are indicated in 
bp on the left. 
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Figure 3-17: Sequencing data from RT-PCR to confirm the presence of a duplicated S segment. 
RNA was extracted from BHK-21 cells infected with BUN MLM or BUN SLS. The reverse 
transcription step was performed using primer S413+ and the PCR step using the primers S413+ and 
S499- (see Figure 3-16). PCR products were run on agarose gel and bands around 1000 bp extracted. 
DNA purified from these bands was sent for sequence analysis. The expected sequence is in black 
(5’3’) with the corresponding chromatogram for either BUN MLM or BUN SLS below. The red 
boxes mark position 17 of the second 3’ UTR.  
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5. Discussion 
The previous recovery of BUN MLM by Lowen at al. (2005) laid down the proof of 
principle that a segment carrying an ORF flanked by heterologous UTRs could be recovered, 
and thus virion particles can package two identical set of UTRs. In this chapter, I successfully 
recovered BUN MLM and two other viruses carrying one segment with heterologous UTRs: 
BUN MSM and BUN SLS. Attempt to recover viruses with recombinant segments LML, 
SMS, and LSL were unsuccessful. BUN MLM, BUN SLS and BUN MSM viruses proved to 
be grossly attenuated in tissue culture. Therefore, it seems likely that the failure to rescue 
some UTR/coding sequence combinations is due to disruption of the transcription/replication 
processes rather than packaging constraint. 
 
BUNV UTRs are composed of 11 nt conserved for each segment followed by segment-
specific sequences. Using the BUNV mini-replicon system, sequences directing RNA 
synthesis where localised to the UTRs (Dunn et al., 1995) and variation in reporter gene 
activity of mini-replicons containing different UTRs were measured as M>L>S (Barr et al., 
2003; Kohl et al., 2004). However, in the mini-replicon system each set of UTRs flanked the 
same ORF, whereas viral ORF sequences display important variation, with the most striking 
being their size. Levels of RNA species during LACV infection were evaluated by Rossier et 
al. (1988) and all three genome species appeared to be synthesised to similar levels while 
mRNA species synthesis differ such as S>M>L where S mRNAs are the most abundant 
(Rossier et al., 1988). These data support the hypothesis that each UTR regulates gene 
expression differentially to achieve optimal virus fitness. 
 
Swapping the S UTRs for the M UTRs around the S coding region has a drastic effect on 
virus fitness. BUN MSM formed small plaques and grew to titre that are 100 000 fold lower 
than wt BUNV. The reasons for such a drastic effect on virus fitness are unclear. Indeed, 
analysis of RNA species present in infected cells by Northern blotting failed to reveal any 
major difference between BUN MSM and wt BUNV. The M UTRs were shown to be 
responsible for transcription of less mRNA species than the S UTRs (Rossier et al., 1988), 
and this might be the case for BUN MSM but it is not obvious in Northern blots. However, by 
having the M UTR instead of the S UTR the start codon of the N protein is put in a stronger 
Kozak context, which might result in an increased translation efficiency of the N protein 
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balancing the lower copies of S segment mRNAs (Table 3-2). The levels of S genomic RNA 
species present in cells infected with BUN MSM are similar to wt BUNV, which suggests that 
the ratio between the amount of L and the amount of N protein is near optimal (Dunn et al., 
1995). The NSs protein of BUNV is translated in an overlapping ORF, and its start codon is 
downstream of the N start codon, so translation initiation at the NSs start codon is thought to 
occur through the mechanism of leaky scanning. Therefore, a stronger initiation context for 
the N start codon probably results in the production of less NSs protein. As NSs is known to 
play a role inhibiting the host cell transcription machinery, the synthesis of less NSs protein 
would result in a reduced host-cell protein shut-off. Thus, the host-cell translation machinery 
would not be fully available to sustain virus replication to wt levels. 
 
KOZACK sequence GCCACCAUGG 
GCCGCCAUGG 
 
 
wt S UCUUUAAUGA 
MSM UCCAAGAUGA 
 
 
wt L AGGAGUAUGG 
MLM UCCAAGAUGG 
SLS UCUUUAAUGG 
 
Table 3-2: Kozak context of the S segment start codon of BUN MSM and the L segment start 
codon of BUN MLM and BUN SLS.  
The start codon AUG is underlined. The two defined optimal Kozack sequences are shown with the 
optimal nt in bold and the critical nt in bold and underlined. The nt context of the AUG for the wt S 
segment as well as BUN MLM are represented. 
 
Replacing the L segment UTRs with either the M or the S segment UTRs results in the 
dysregulation of gene expression. Both BUN MLM and BUN SLS are attenuated in tissue 
culture, forming small plaques and growing to titres 10 000 fold lower than wt BUNV. 
However, the major difference was observed for L RNA species synthesis, both genomic and 
anti-genomic RNAs synthesis was drastically decreased. Considering the data on UTR 
strength obtained in a mini-replicon system, the L RNA species could be expected to decrease 
in BUN SLS infected cells while increasing in BUN MLM infected cells. This does not 
appear to be the case. The apparent strength of the UTRs to drive expression of a reporter 
gene (eg Renilla luciferase) does not match observations with authentic viral genome. This 
difference could be explained by the presence of a cis-acting element within the viral coding 
sequence that would function only with the correct promoter. Moreover, as the L ORF is 
about six times longer than the Renilla luciferase ORF, specific sequences within the L UTR 
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and/or cis-acting elements in the coding sequence could play a role in promoting elongation 
of a longer template by recruiting different host-cell factors or through formation of 
secondary structure. This defect in L RNA species synthesis itself can explain attenuation of 
BUN MLM and BUN SLS, indeed it reduces the availability of the L RNA genome for 
packaging. Therefore, less virion particles are likely to be produced, delaying virus growth.  
 
Interestingly, attempt to recover a virus with either the L or S UTRs flanking the M ORF 
failed. Two hypotheses could explain it: (a) the M segment might be more sensitive to 
transcription/replication dysregulation, or (b) the M UTRs might play a role in RNPs co-
packaging as suggested by a recent study on RVFV packaging signals (Terasaki et al., 2011). 
If this last hypothesis could explain the non-recovery of a virus lacking the M UTRs, it could 
not explain the failure to recover a virus with segments bearing only the M UTRs. Indeed, 
experiments to rescue viruses containing both MLM and MSM were unsuccessful. In that 
case, it is most likely that replication and transcription were too impaired to permit rescue of a 
viable virus.  
 
During serial passage, both viruses with heterologous UTRs flanking their L ORF 
accumulated a 2 kb RNA species that was specifically detected by probes targeting the S 
genome and antigenome. When I analysed the 2 kb RNA species it appeared to represent a 
concatamer of two exact copies of the S segment one after another, as follow: S 3’ UTR–S 
ORF–S 5’ UTR-S 3’ UTR–S ORF–S 5’ UTR. After 10 passages, the 2 kb specie was the 
dominant genomic and anti-genomic RNA species in both BUN MLM and BUN SLS viruses. 
Indeed a 1 kb RNA, if present, was below the detection threshold in Northern blotting assays. 
A striking observation is the correlation between the amount of L genomic RNA and the 
presence of the duplicated S segment. Indeed, when the duplicated S segment was present 
both the L genomic and anti-genomic/mRNA were hardly detected, most certainly resulting in 
a reduced amount of L protein in the cells. I speculate that the duplicated S segment could be 
an intermediate of replication that would be cleaved to unit length subsequently. However, in 
the case of BUN MLM and BUN SLS viruses, the reduced availability of the L protein would 
prevent the cleaving process. To test whether the amount of L protein plays a role in the 
appearance of a duplicated S segment, I attempted to transfect cells with the expression 
plasmid for the L protein and then to infect them with BUN MLM and BUN SLS alongside 
wt BUNV. However, I did not observe any difference in the generation of the duplicated S 
segment. This result could not rule out the hypothesis as the transfection efficiency of the L 
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plasmid could not be evaluated due to the lack of a reliable anti-L antibody. The best way to 
confirm or deny the hypothesis would be to use a cell line transiently expressing the BUNV L 
protein, however such a cell line is not currently available. Another question arises from the 
presence of this duplicated S segment: is the second ORF functional? In the case of an 
affirmative, it might be possible to use this second ORF to express a foreign gene. Indeed in 
BUN MLM and BUN SLS viruses, the generation of the duplicated S segment occurs during 
serial passage and seems to be preferentially kept over the wt 1 kb segment. Therefore, I can 
speculate that a foreign gene introduced in the second N locus might be kept at least for a few 
passages.  
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C. Mutational analysis of Bunyamwera virus L and M 
segment untranslated regions: defining the 
minimal sequences 
1. Introduction and aims 
The UTRs of BUNV have been shown to be multifunctional, containing sequences 
promoting transcription, replication and packaging (Barr et al., 2003; Kohl et al., 2006; 
Osborne & Elliott, 2000). Along with some viruses within the genus Orthobunyavirus (i.e. 
JCV, TAHV, LACV), BUNV carries long UTRs on all its segments with those on the S 
segment being the longest. UTRs of the L and M segments are shorter and similar in size 
(Figure 3-18). Despite their similarities in length, UTRs sequences are mainly not conserved 
between different members of the same genus (Figure 3-19 and Figure 3-20).  
Only the UTRs of the S segment have been characterized to date. Lowen et al. (2005) 
demonstrated than the UTRs of the S segment could be shortened to 29 and 112 nucleotides at 
the 3’ and 5’ end respectively and viable viruses rescued by reverse genetics (Lowen & Elliott, 
2005). Viruses containing shortened UTRs appear to be attenuated in tissue culture compared 
to wt BUNV. Thus, they form smaller plaques, display a delay in host-cell protein shut-off 
and grow to lower titres. 
Considering these data and the fact that AKAV, also a member of the genus 
Orthobunyavirus, has much shorter UTRs compared to BUNV, it was predicted that the non-
conserved regions of the L and M segments were also probably non-essential for virus growth. 
 
The aim of this chapter was to define the minimal L and M UTRs required for virus 
growth. To do so, deletions were introduced in the cDNA and the reverse genetic system was 
used to assess virus viability. 
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Figure 3-18: Schematic of the genomic BUNV segments. 
The coding regions are represented in black. The UTRs are to scale and represented in colour. The 
numbers above each UTR indicate its length in nucleotides. 
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Figure 3-19: Sequence alignment of the L3’ and L5’ UTR of five members of the 
Orthobunyavirus genus. 
Adenine A residues are in green, cytosine C residues in blue, guanine G residues in black and thymine 
T residues in red. The consensus sequence is in black and N denotes the absence of consensus. The 
percentage of conservation for each nucleotide is materialised by the pink bars. – are used to 
materialised gaps. Abbreviation: BUNV, Bunyamwera virus; AKAV, Akabane virus; JCV, Jamestown 
virus; TAHV, Tahina virus; LACV, La Crosse virus. Nucleotide sequences accession numbers are 
given in Table 2-1. 
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Figure 3-20: Sequence alignment of the M3’ and M5’ UTR of six members of the 
Orthobunyavirus genus. 
Adenine A residues are in green, cytosine C residues in blue, guanine G residues in black and thymine 
T residues in red. The consensus sequence is in black and N denotes the absence of consensus. The 
percentage of conservation for each nucleotide is materialised by the pink bars. – are used to 
materialised gaps. Abbreviation: BUNV, Bunyamwera virus; AKAV, Akabane virus; JCV, Jamestown 
virus; TAHV, Tahina virus; LACV, La Crosse virus; INKV, Inkoo virus. Nucleotide sequences 
accession numbers are given in Table 2-1. 
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2. Constructs  
Deletions within the non-conserved region of the UTRs of the L and M segments were 
introduced using excision PCR. Briefly, primers were designed to flank the region to be 
deleted in outward orientation. Excision PCR were carried on pT7riboBUNX(+) template as 
described in ’Materials and Methods’. 
The name of each recombinant segment follows the pattern Xa/b, where X is the name of 
the segment concerned, a is the length of the remaining 3’ UTR and b the length of the 
remaining 5’ UTR. 
a) L segment 
The wt BUNL 3’ and 5’ UTRs are respectively 50 and 108 nucleotides long.  
Deletions within either the 3’ or the 5’ UTR were introduced in pT7riboBUNL(+) using 
the primer pairs listed in Table 3-3. Deletions were introduced from the coding region toward 
the end of each UTR. The 3’ UTR was shortened to 44, 39, 22, 11 and 7 nucleotides, while 
the 5’ UTR was shortened to 85, 65, 45, 38 and 21 nucleotides (Figure 3-22). All construct 
were fully sequenced to confirm the presence of the desired deletion and the absence of 
unwanted mutations.  
 
Construct Forward primer Reverse Primer 
pT7riboBUNL44/108 LORF+ L3’44- 
pT7riboBUNL39/108 LORF+ L3’39- 
pT7riboBUNL22/108 LORF+ L3’22- 
pT7riboBUNL11/108 LORF+ L3’11- 
pT7riboBUNL7/108 LORF+ L3’7- 
pT7riboBUNL56/85 L5’85+ LORF- 
pT7riboBUNL56/65 L5’65+ LORF- 
pT7riboBUNL56/45 L5’45+ LORF- 
pT7riboBUNL56/38 L5’38+ LORF- 
pT7riboBUNL56/21 L5’21+ LORF- 
Table 3-3: Primers used to introduce deletions within the UTRs of the BUNV L segment. 
The name of the mutants follows the pattern La/b where a is the length of the 3’UTR and b the length 
of the 5’UTR. Primers sequences are given in Table 3-3. 
 
To obtain segments containing deletions in both UTRs, segments with single UTR 
deletion were digested with the restriction enzyme NcoI and SalI. The fragments containing 
the deleted UTR were ligated together (Figure 3-21). Only deletions in single UTRs leading 
to successful rescue were used to create doubly deleted segments. 
Chapter 3: Results  Minimal UTRs per segment 
137 
 
 
 
Figure 3-21: Schematic illustrating the cloning strategy used to introduce double deletions in the 
L segment. 
Plasmids containing deletions in one UTR were digested with the restriction enzymes NcoI and SalI 
(left panels). The segments containing the deletions were purified on an agarose gel and ligated 
together (right panel). UTRs are represented by a black box (wt UTR) or a red box (deleted UTR). 
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Figure 3-22: Schematic of the deletions introduced in the L segment. 
Black bars on each side represent the untranslated regions, blue bars in the middle represent the L 
coding sequence and dotted lines represent the deleted regions. Only the UTRs are represented to scale. 
The name of the mutants follows the pattern La/b where a is the length of the 3’ UTR and b the length 
of the 5’ UTR. + denotes recovery of a recombinant virus; - denotes no recovery. 
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b) M segment 
The wt BUNM 3’ and 5’ UTRs are respectively 56 and 100 nucleotides long.  
Deletions within either the 3’ or 5’ UTR were introduced by excision PCR using a 
truncated version of pT7riboBUNM(+), pT7riboBUNMdelMscI(+), as a template and the 
primer pairs listed in Table 3-4. Deletions were introduced from the coding region toward the 
end of each UTR. The 3’ UTR was shortened to 44, 33, 22 and 11 nucleotides, while the 5’ 
UTR was shortened to 80, 60, 40 and 20 nucleotides. The full length M coding sequence was 
reconstituted using directional cloning. pT7riboBUNM(+) and pT7riboBUNMdelMscI(+) 
containing the deleted UTRs were digested with the restriction enzymes ClaI and NcoI. The 
UTRs of each construct and the coding region up to the cloning site were sequenced to ensure 
the presence of the deletions and the absence of unwanted mutations (Figure 3-23). 
 
Construct Forward primer Reverse Primer 
pT7riboBUNM44/100 MORF+ M3’44- 
pT7riboBUNM33/100 MORF+ M3’33- 
pT7riboBUNM22/100 MORF+ M3’22- 
pT7riboBUNM11/100 MORF+ M3’11- 
pT7riboBUNM56/80 M5’80+ MORF- 
pT7riboBUNM56/60 M5’60+ MORF- 
pT7riboBUNM56/40 M5’40+ MORF- 
pT7riboBUNM56/20 M5’20+ MORF- 
Table 3-4: Primers used to introduce deletions within the UTRs of the BUNV M segment. 
The name of the mutants follows the pattern Ma/b where a is the length of the 3’UTR and b the length 
of the 5’UTR. Primers sequences are given in Table 3-4. 
 
Segments containing deletions within both UTRs were obtained using a cloning method 
similar to the one use for the L segment. Only deletions in single UTRs leading to successful 
rescue were used to create doubly deleted segments. The templates were digested with the 
restriction enzymes ClaI and XbaI, and vector and insert were then ligated. The UTRs of each 
construct and the coding region up to the cloning sites were sequenced to ensure the presence 
of the deletions and the absence of unwanted mutations (Figure 3-23). 
Chapter 3: Results  Minimal UTRs per segment 
140 
 
 
 
Figure 3-23: Schematic of the deletions introduced in the M segment. 
Black bars on each side represent the untranslated regions, blue bars in the middle represent the M 
coding sequence and dotted lines represent the deleted regions. Only the UTRs are represented to scale. 
The name of the mutants follows the pattern Ma/b where a is the length of the 3’ UTR and b the 
length of the 5’ UTR. + denotes recovery of a recombinant virus; - denotes no recovery. 
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3. Virus rescue 
In order to determine the minimal UTRs that supported virus replication of each segment, 
different constructs were tested in the 3 plasmid rescue system (Lowen et al., 2004). Plasmids 
containing mutated cDNAs were transfected into BSR-T7/5 cells together with plasmids 
encoding two wt segment cDNAs. All negative results were confirmed by performing at least 
one other rescue attempt under conditions where the wt virus was successfully rescued. 
For the L segment, 16 constructs containing deletions within the 3’, 5’ or both UTRs were 
made and 12 led to successful rescue of virus. The minimal UTRs for the L segment were 39 
nt left in the 3’ UTR and 38 nt left in the 5’ UTR, BUNL39/38 (Figure 3-22). 
For the M segment, 9 constructs containing deletions within the 3’, 5’ or both UTRs were 
made but only 2 led to successful rescue. One contained a deletion in the 3’ UTR and the 
other in the 5’ UTR. It was not possible to rescue a virus containing deletions in both UTRs. 
Therefore, the minimal 3’ UTR was 33 nt, BUNM33/100 and the minimal 5’ UTR was 40 nt, 
BUNM56/40 (Figure 3-23). 
An attempt to combine mutated segments was carried on with M56/40 and either L44/85, 
L44/65 or L44/45. These rescue experiments proved successful. Therefore virus rescue 
experiments combining three mutant segments were attempted and the results will be 
presented in the following chapter.  
The presence of the deletions was confirmed in all viruses by RT-PCR of either the L or 
the M segment RNA extracted from infected cells, followed by nucleotide sequencing of the 
extremities. 
4. Characterisation of virus replication in tissue culture 
Further experiments were carried out using an elite virus stock grown from a single 
plaque picked on a BHK-21 monolayer. Elite stocks were grown and titrated in BHK-21 cells. 
a) Plaque size 
The ability of each virus to form plaques was assessed in BHK-21 cells. Mutant viruses 
appeared to display a great diversity in their plaque size, however they were always smaller 
than those formed by wt BUNV. For the L segment, the size of the plaque appeared to 
correlate with the size of the deletion (Figure 3-24). The virus with the minimal L UTRs, 
BUNL39/38, showed the smallest plaque phenotype. Both viruses with deletions in either of
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Figure 3-24: Plaque phenotype in BHK-21 cells. 
BHK-21 cells were infected with the wt BUNV or different deleted BUNV. Cells were fixed 4 days 
post-infection in 4% Formaldehyde and stained with Giemsa’s solution. The name above each well 
indicates the mutant segment concerned. 
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their M UTR produced plaques of similar size that remained smaller than those of the wt 
BUNV. Viruses containing deletions in the S segment UTRs were included as a reference for 
plaque size reduction (Lowen & Elliott, 2005)  
When the M56/40 segment was combined with different L segments, L44/85, L44/65, 
L44/45, the sizes of the plaques were reduced even further. This is particularly visible for the 
virus BUNM56/40+L44/45. 
b) Virus yields 
To characterise further the growth properties of the mutant viruses, BHK-21 cells were 
infected at an MOI of 0.5 pfu/ml and virus titres in the supernatant were determined at 24h 
and 48h post-infection. 
Differences were most striking at 24h post-infection (Figure 3-25-A). Most viruses gave 
titres that were at least 10-fold lower than the wt and up to 10 000-fold lower for BUNL38/39 
and BUNM56/40+L44/45. However, by 48h post-infection (Figure 3-25-B), all viruses except 
BUNL39/38, produced yields that were within 10-fold of the wt, but all remained attenuated 
compared to the wt. Nevertheless, as a general rule, the bigger the deletions of the UTR, the 
lower the titre the viruses achieved. 
c) Protein synthesis 
wt BUNV is known to induce host-cell protein shut-off (Pennington et al., 1977) and this 
ability is lost when deletions are introduced in the S UTRs. Lowen et al. (2005) showed that 
viruses BUNS85/112 and BUNS62/112 (bearing deletions in their S UTRs) displayed a viral 
protein expression profile different from the wt. Indeed, these viruses displayed a reduced 
host-cell protein shut-off and showed a lower production of the N protein compared to Gc. 
Therefore, the effect of UTR deletions on host-cell and viral proteins synthesis was 
assessed by in vivo protein labelling. BHK-21 cells were infected at an MOI of 0.5, and 
labelled with [35]S-methionine for 2h at 24h and 48h post-infection (Figure 3-26). A higher 
MOI could not be achieved due to the low titre of some elite stocks. 
For wt BUNV, viral proteins L, Gc, Gn, N and NSm were clearly visible at 24h post-
infection while host-cell proteins were barely detected. At 48h post-infection, despite no 
visible cytopathic effect, host-cell protein synthesis was almost completely inhibited and 
essentially only viral proteins were made. On the other hand, mutant viruses, with the 
exception of BUNL44/45, displayed a delay in host-cell protein shut-off even when the 
expression of the viral N proteins  appeared similar to wt levels. This is particularly visible in
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Figure 3-25: Virus yield in BHK-21 at 24h and 48h post-infection. 
BHK-21 cells were infected at an MOI of 0.5 pfu/cell. The supernatants were harvested at 24h (A) and 
48h (B) post-infection and titrated in BHK-21 cells. 
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Figure 3-26: In vivo protein labelling of BHK-21 infected with wt BUNV or different mutants. 
BHK-21 cells were infected at an MOI of 0.5 pfu/cell. Proteins were labelled at 24h and 48h post-
infection with [35]S-methionine over 2 hours. The same volume of lysate was loaded in each lane. 
Positions of viral proteins are indicated on the right. 
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the 24h post-infection samples for BUNL44/85, BUNL44/65, BUNL39/65, BUNM33/100 
and BUNM56/40. I could also notice a lower level of Gc protein synthesis in virus 
BUNM56/40 compared to BUNM33/100 and this despite similar amount of N protein 
synthesis. 
Notably, for the virus with the shortest L UTRs, BUNL39/38, N protein could not be 
detected at 24h post-infection and was hardly visible at 48h post-infection.  
5. Discussion 
The purpose of this chapter was to define the minimal untranslated region that supported 
virus replication. The UTRs of the S segment, which are the longest, had been studied 
previously (Barr et al., 2006; Barr & Wertz, 2004; Lowen & Elliott, 2005; Osborne & Elliott, 
2000), and I extended the work to look at the L and M segment UTRs. UTR sequences are 
largely non-conserved between the L, M and S segments except the terminal 11 nt at each end. 
They are also largely non-conserved within the members of the genus Orthobunyavirus with 
the exceptions of CA- and GU-rich regions found in the 5’ UTR of the S segment (Dunn et al., 
1994). It was speculated that those non-conserved regions were non-essential and could be 
deleted. Indeed, for the S segment, UTRs could be shortened to 29 nt at the 3’ end and 112 nt 
at the 5’ end (Lowen & Elliott, 2005). Considering that some viruses within the genus 
Orthobunyavirus possess very short UTRs for their L and M segments, it was predicted that 
the “extra” sequences were non-essential for virus growth.  
 
In order to define the minimal UTRs required for the L and M segments, deletions were 
introduced within the non-conserved sequences. Using the reverse genetic system, I was able 
to recover a virus in which the UTRs of the L segment were shortened to 39 nt at the 3’ end 
and 38 nt at the 5’ end, BUNL39/38. Recovering a virus with deletions within the M UTRs 
proved more difficult. It was only possible to reduce one or the other UTR but not both at the 
same time. The minimal UTRs for the M segment were either 33 nt at the 3’ end or 40 nt at 
the 5’ end, BUNM33/100 and BUNM56/40. It is notable that constructs with the M segment 5’ 
UTR reduced to 80 or 60 nt long did not allow efficient virus rescue.  
Termination signals have not been identified for the L and M segments and it seems that 
their 5’ UTR is less sensitive to deletion. This suggests that, if present, termination signals 
might be located close to the genomic 5’ end. In the S segment, two different termination 
signals have been identified (Barr et al., 2006): one, playing a major role, 3’-GUCGAC-5’ 
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and a second one, 32 nt downstream, 3’-UGUCG-5’. The second pentanucleotide sequence is 
also present within the L segment 5’ UTR (Figure 3-19) but could not be found within the M 
segment 5’ UTR (Figure 3-20). Nevertheless, this pentanucleotide sequence was not present 
when the L segment 5’ UTR was reduced to 45 or 38 nt long. This might suggest that a 
different termination signal could be used closer to the 5’ end or that mRNAs could terminate 
by run off transcription as proposed for some segments in other bunyaviruses (Albarino et al., 
2007). 
 
The 3’ UTR provides signal for transcription and translation. Protein synthesis depends 
on the efficiency of the ribosome to recognise the ORF starting with the codon AUG. The 
‘Kozak sequence’ or optimal context for the AUG is the sequence 3’-GCC(A/G)CCAUGG-5’ 
where the nucleotide at position -3 and the one at position +4 are critical (the A of the AUG is 
designated +1 and the nucleotide just before -1), while the two Cs at position -4 and -5 are 
favourable (Table 3-5) (Kozak, 2002).  
 
KOZACK sequence GCCACCAUGG 
GCCGCCAUGG 
 
 
wt L AGGAGUAUGG 
L44/108 ACCAGUAUGG 
L39/108 AUAUAAAUGG 
 
 
wt M UCCAAGAUGA 
M33/100 CCUUUCAUGA 
 
Table 3-5: Kozak context of the start codon of different mutants.  
The start codon AUG is underlined. The two defined optimal Kozack sequences are shown with the 
optimal nucleotides in bold and the critical nucleotides in bold and underlined. The nucleotide 
contexts of the AUG for the wt L and M segments as well as for some mutant containing deletion in 
their 3’ UTR are listed. 
 
The wt L mRNA start codon is in a favourable Kozak context: 3’-AGGAGUAUGG-5’. 
The nucleotides at position -3 and +4 are respectively A and G which are the most favourable. 
When introducing a deletion of 6 nt in the L segment 3’ UTR the context of the AUG 
becomes more favourable, nucleotide at positions -4 and -5 become Cs while the ones at 
positions -3 and +4 remain the same: 3’- ACCAGUAUGG -5’. On the other hand when 
introducing a deletion of 11 nt the context of the AUG becomes less favourable, only the G at 
position +4 is conserved: 3’- AUAUAAAUGG -5’. Despite a rather different context for the 
start codon, the synthesis of the L protein does not seem to be greatly affected.  
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Concerning the wt M mRNA, the Kozak context of its start codon is suboptimal: of the 
two critical nucleotides only the one at position -3 is optimal and two Cs are found at 
positions -4 and -5, making the Kozak context 3’- UCCAAGAUGA -5'. When introducing 
deletion in the M segment 3’ UTR the context of the AUG changes, only the C at position -5 
remains: 3’- CCUUUCAUGA -5’. Despite a less favourable context, the expression of the Gc 
protein was similar in wt BUNV and BUNM33/100. Interestingly, the amount of Gc was 
drastically decreased in the mutant BUNM56/40. This mutant only contains deletion within 
its M segment 5’ UTR, so the context of the AUG is unchanged compared to the wt. The 
decrease in Gc is probably due to less efficient transcription, and hence less mRNA, rather 
than less efficient translation.  
 
Evaluation of virus yield at 24h and 48h post-infection showed that all viruses with 
shortened UTRs grew to lower titres than wt BUNV. As a general rule, the shorter the UTRs 
the slower the virus grew. The overall replication cycle of the mutant viruses appeared slower 
during the early stage of replication. This resulted in a less efficient induction of host-cell 
protein shut-off and in the formation of smaller plaques. These observations correlate with 
what has been observed when introducing deletions within the S segment (Lowen & Elliott, 
2005).  
Considering that deleted UTRs in one segment leads to virus attenuation, it was 
speculated that if a virus containing two or three segments with deletions could be rescued, it 
would be attenuated even further. When the M56/40 segment was combined with the segment 
L44/85, L44/65 or L44/45, it was possible to rescue viruses and they show reduced viral 
protein synthesis, reduced host-cell protein shut-off, lower titres and smaller plaque size than 
viruses containing only one mutated segment.  
It was of interest to investigate further genome plasticity and to what extent viruses could 
tolerate mutation in their UTRs. To that end, rescues were attempted with all the segments 
containing the minimal UTRs defined: L39/38, M33/100 or M56/40 and S29/112. It was 
speculated that such a virus would be greatly attenuated. 
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D. Rescue of Bunyamwera viruses with minimal 
untranslated regions in all three segments 
1. Introduction and aims 
Viruses within the genus Orthobunyavirus possess UTRs that are largely non-conserved 
and vary greatly in size. Reverse genetics has been used to rescue viruses with parts of their 
UTR sequences deleted. The minimal UTRs supporting virus replication have been defined 
for each segment and are as follow: L39/38, M56/40 or M33/100 (previous chapter) and 
S29/112 (Lowen & Elliott, 2005). Recombinant viruses containing one of the above mutated 
segments are attenuated compared to wt BUNV, display smaller plaques and delayed host-cell 
protein shut-off and, grow to lower titres. 
Considering that BUNV with minimal UTRs on one segment are attenuated compared to 
wt BUNV, it is a possibility that combining minimal UTRs on all three segments will not 
support virus replication. On the other hand, viruses such as AKAV naturally have shorter 
UTRs than wt BUNV on all three segments (Table 1-6). Therefore, the aim of this chapter 
was to assess if a virus carrying the minimal UTRs on each segment could be rescued, and if 
not, to determine the minimal UTRs that could support virus replication when deleted UTRs 
were present in all three segments i.e. to define the minimal BUNV genome. 
2. Virus rescue  
In order to rescue a virus containing the minimal UTRs different constructs were tested in 
the 3 plasmids rescue system (Lowen et al., 2004). The traditional way to assess rescue 
outcome is to perform plaque assays on BHK-21 using supernatant from the transfected BSR-
T7/5 cells. However, it was hypothesised that recombinant viruses might be rescued but 
would be too attenuated to form plaques in BHK-21 cells. To test that possibility, 200 µl of 
rescue supernatant were used to infect BHK-21 cells in a 6-well plate. The presence or 
absence of N protein was assessed by Western Blotting assay. Using this method, it was 
possible to detect the presence of the N protein from some of the attempted rescue 
experiments. All negative results were confirmed by performing at least one other rescue 
attempt under conditions where the wt virus was successfully rescued. 
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a) Attempt to rescue the minimal virus 
The segments with the minimal UTRs were transfected together in BSR-T7/5 cells. Two 
combinations were possible: L39/45 + M56/40+ S29/112 and L39/45 + M33/100 + S29/112. 
Transfected cells were incubated at 33°C and supernatants were harvested every 6 or 7 days 
for up to 21 days. 200 µl of rescue supernatant was used to infect BHK-21 cells in a 6-well 
plate to assess rescue outcome. The BHK-21 cells monolayer was lysed 5 days post-infection 
and the presence of the N protein was assesses by Western Blotting. 
Despite repeated attempts, the N protein could never be detected, leading me to conclude 
that it was not possible to rescue a virus with minimal UTRs (as defined for individual 
segments) on all three segments. 
b) Successful rescues 
As it was not possible to rescue a virus with the minimal UTRs, BSR-T7/5 cells were 
transfected with different combinations of plasmids expressing deleted cDNAs. Cells were 
incubated at 33°C for up to 21 days and supernatants were harvested every 6 or 7 days. 
Rescue outcome was assessed by Western Blotting for the N protein on cells infected with the 
supernatant from the transfected cells.  
Firstly, deleted segments were screened in rescue experiments where only two segments 
contained deleted UTRs and where the third segment had wt UTRs. Through this screening, 
the segments L44/38 and L39/38 did not allow efficient virus rescue with others deleted 
segments. This screening also showed that S segments with UTRs shorter than S62/112 did 
not allow efficient virus rescue when co-transfected with others deleted segments.  
 
 
Experiment 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Pl
a
sm
id
s 
L44/85     - - - - - - - - - - - - 
L44/65 - - - -     - - - - - - - - 
L44/45 - - - - - - - -     - - - - 
L39/65 - - - - - - - - - - - -     
M33/100 - -   - -   - -   - -   
M56/40   - -   - -   - -   - - 
S85/112  -  -  -  -  -  -  -  - 
S62/112 -  -  -  -  -  -  -  -  
Rescue outcome - - - - + - - + + - - - - + + + 
Table 3-6: Combinations of three deleted segments attempted in rescue experiments. 
Constructs names are indicated on the left and check marks notified of the use of one construct in the 
associated experiment. Positive rescue outcome was notified by a + on the bottom line. – denotes the 
absence of plasmid or a negative rescue outcome. 
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Deleted segments that lead to positive virus rescue during the screening are listed in Table 
3-6 and were further used in rescue experiments where each segment contained deleted UTRs. 
The sixteen different possible combinations were attempted but only six of them led to 
efficient virus rescue. A negative rescue outcome was confirmed by carrying at least three 
rescue experiments where the wt BUNV was successfully rescued each time. Interestingly, 
the L segment with the longest UTRs, L44/85, did not lead to positive virus rescue while the 
L segment with shorter UTRs, L39/65, appeared more successful. The two deleted M 
segments, M33/100 and M56/40, and two S segments, S85/112 and S62/112, were 
successfully rescued. Each of the segments leading to virus rescue was given an abbreviated 
name comprising a letter referring to the segment followed by an arbitrary number as showed 
in Table 3-7-A. The six rescued viruses and their associated abbreviated names are shown in 
Table 3-7-B. Among these viruses, three have 4 deleted UTRs (out of 6) and three have 5 
deleted UTRs (Figure 3-27). 
 
   A) 
Segments 
full name abbreviated name 
L44/65 L1 
L44/45 L2 
L39/65 L3 
M56/40 M1 
M33/100  M2 
S85/112 S1 
S62/112 S2 
        B) 
Viruses 
full name abbreviated name 
L44/65 + M56/40 + S85/112 L1M1S1 
L44/45 + M56/40 + S85/112 L2M1S1 
L39/65 + M56/40 + S62/112 L3M1S2 
L39/65 + M33/100 + S85/112 L3M2S1 
L44/65 + M33/100 + S62/112 L1M2S2 
L39/65 + M33/100 + S62/112 L3M2S2 
Table 3-7: Deleted segments and rescued viruses abbreviated names. 
The full name of the deleted segment follows the pattern Xa/b and the abbreviated name the pattern Xz 
where X indicate the segment concerned, a is the length of the 3’UTR, b the length of the 5’UTR and z 
is an arbitrary number. 
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Figure 3-27: Schematic representing the segments present in each deleted virus. 
The coding regions, not to scale, are in grey. The UTRs, to scale, are in black. For each set of three, 
the top segments represent the L genome, the middle one the M genome and the bottom one the S 
genome, with the 3’UTR on the right of the coding sequence and the 5’ UTR on the left. 
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3. Characterisation of virus replication in tissue culture 
a) Serial passage 
After rescue, an elite stock of each virus was grown in BHK-21 cells and named p0. 
Despite a few attempts, titres of p0 stocks were not high enough to allow any further 
characterisation. Thus, it was speculated that serially passaging those viruses might increase 
their fitness. Viruses with deleted UTRs, along with wt BUNV, were serially passaged in 
BHK-21 cells. To produce passage 1 (p1), a small volume of p0 was used to infect BHK-21 
cells in a medium (T 75) flask. BHK-21 growth medium supplemented with 2% NCS was 
added. Flasks were incubated at 33°C until appearance of CPE, or up to 7 days if no CPE 
were apparent, and then the supernatant was harvested. The same procedure was repeated up 
to passage 10 (p10). 
b) Effect of serial passage on plaque formation 
The ability of each virus to form plaques in BHK-21 cells was assessed from stocks p0, 
p5 and p10 (Figure 3-28). wt BUNV displayed very similar plaque sizes at every passage. For 
the deleted viruses I observed an effect of serial passage on plaque formation. Indeed, at p0, 
none of the mutant viruses formed plaques. The only way to visualise foci of infection was by 
immunostaining of the N protein. I observed two types of foci in infected monolayers; 
L2M1S1, L3M2S1 and L3M2S2 formed very small foci whereas L1M1S1, L3M1S2 and L1M2S2 
formed round, well-defined foci. This separation into two groups remained at p5 and p10. At 
p5, L2M1S1, L3M2S1 and L3M2S2 formed plaques that were hardly visible, whereas L1M1S1, 
L3M1S2 and L1M2S2 formed small and fuzzy plaques. At p10, L2M1S1, L3M2S1 and L3M2S2 
formed small and fuzzy plaques, L1M1S1, L3M1S2 and L1M2S2 formed plaques that were easy 
to visualise even if still small and fuzzy.  
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Figure 3-28: Plaque phenotype of mutant viruses at p0, p5 and p10 in BHK-21 cells. 
BHK-21 cells were infected with the wt BUNV or different deleted BUNV. Cells were fixed at 3 days 
post-infection in 4% formaldehyde and immunostained for N protein (left wells) or stained with 
Giemsa’s solution (middle and right wells). 
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c) Virus yield 
To characterise the growth properties of each mutant virus, BHK-21 cells were infected 
with viruses at MOIs ranging from 0.0001 to 10 pfu/cell from the p10 stock. In the case of 
L3M2S1 the highest MOI that could be used was 0.01 and for L3M2S2 it was 0.1. Virus titres in 
the supernatants were determined after 24h (Figure 3-29) by plaque assay in BHK-21 cells. 
At 24h post-infection, wt BUNV reached titres that were higher than those of any of the 
mutant viruses and this was observed at all MOIs. Titres produced during wt infection 
plateaued at 108 pfu/ml at MOIs of 10, 1, 0.1 and 0.01, and then reduced at lower MOIs to 106 
pfu/ml. Mutant viruses L2M1S1 and L2M1S1 behaved similarly: at MOI=10, they produced 107 
pfu/ml and then titres dropped as the MOIs decreased. At the lowest MOI, they produced only 
102 pfu/ml, which is a 40-fold decrease compared to wt. Mutant viruses L3M1S2 and L1M2S2 
also behaved similarly: they produced 107 pfu/ml at MOIs of 10 and 1. Then, I observed that 
virus production was reduced by about 10-fold every time the MOI was reduced by 10-fold.  
It was noticeable that virus L3M2S2, despite the very low titre of the elite stock, was the 
one showing the best grow kinetics. On the other hand, virus L3M2S1 whose elite stock titre 
was low as well, was among the viruses with the lowest growth kinetic. 
d) Protein synthesis 
Viral protein synthesis and the ability to induce host-cell protein shut-off were assessed 
for each mutant virus by in vivo protein labelling. BHK-21 cells were infected at an MOI of 5. 
At 24h post-infection supernatants were collected before cells were labelled with [35]S-
methionine over 2h. An MOI of 5 could not be achieved with viruses L3M2S1 and L3M2S2. 
wt BUNV is known to induce significant shut-off of host-cell protein synthesis by 24h 
post-infection in cells infected at an MOI of 5, and as shown in Figure 3-30 the synthesis of 
host-cell proteins was almost completely suppressed and the synthesis of viral protein had 
already begun to decrease. 
Viruses L2M1S1 and L3M1S2 did not induce a significant host-cell protein shut-off 
compared to non-infected cells. Viruses L1M1S1 and L1M2S2 induced an incomplete host-cell 
protein shut-off. Interestingly, the level of viral N protein did not correlate with the observed 
host-cell protein shut-off. Indeed, levels of N protein were higher in L1M1S1 and L2M1S1 than 
in L3M1S2 and L1M2S2. Levels of others viral proteins appeared similar between each mutant 
virus.  
Virus titres were determined by plaque assay in BHK-21 cells (Figure 3-30). Despite
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Figure 3-29: Yields of mutant viruses in BHK-21 cells at 24h post-infection. 
BHK-21 cells were infected at MOI of 10, 1, 0.1, 0.01, 0.001 or 0.0001 pfu/cell. The supernatants 
were harvested at 24h post-infection and titrated in BHK-21. 
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Figure 3-30: In vivo protein labelling and associated virus yield of BHK-21 cells infected with wt 
BUNV or mutant viruses. 
BHK-21 cells were infected at an MOI of 5 pfu/cell. (A) Proteins were labelled at 24h post-infection 
with [35]S-methionine over 2h. The same volume of lysate was loaded in each lane. Positions of viral 
proteins are indicated on the right. (B) The supernatants were harvested at 24h post-infection and 
titrated in BHK-21 cells.  
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differences in host-cell protein shut off and production of viral N protein, all mutant viruses 
reached similar titres. Nevertheless, those titres remained about 10-fold lower than the wt titre. 
e) Viral RNA synthesis 
BHK-21 cells were infected at an MOI of 0.01 pfu/cell and viral RNAs synthesised 
during infection were analysed by Northern blotting as described previously. The membranes 
were probed with DIG-labelled RNAs complementary to each of the BUNV genome 
segments (Figure 3-31-A) or complementary to each of the BUNV antigenomes and mRNAs 
(Figure 3-31-B). The deletions introduced in the UTRs of the L and M segments are not large 
enough to modify the migration profile of each RNA species. However, deletions in the S 
segment result in genome and antigenome that are less than 1 kb, and thus migrate further 
than the wt S genome or antigenome on the gel. As a result, antigenome and mRNA have 
similar sizes, and cannot be separated: bands represent both antigenome and mRNA species. 
The following observations can be made from the Northern Blotting results when 
comparing mutant viruses to wt BUNV: 
Viruses L1M1S1 and L2M1S1 synthesised less L genome but similar amount of M and S 
genomic RNA. Synthesis of antigenome/mRNA species were comparable to wt BUNV for 
L1M1S1 and slightly decreased for L2M1S1.  
Virus L3M1S2 displayed a similar or slightly higher level of L genome, a similar level of M 
genome and a higher level of S genome. All three antigenome/mRNA species were 
synthesised to levels similar to wt BUNV. Regarding RNA synthesis by L1M2S2, I observed 
less L genome, similar levels of M genome and more S genome. Despite differences in the 
absolute amount of genomic RNA species, synthesis of L, M and S antigenome/mRNA 
species was similar to wt. 
For viruses L3M2S1 and L3M2S2 synthesis of all genomic RNA was decreased compared to wt 
BUNV. This decrease was particularly apparent for the M genome which was hardly detected, 
even after 20 min exposure of the blot. For L3M2S2 I observed a band at 2 kb (marked with 
**) which seems to correlate with the double-sized S genome previously shown in results 
section B. Despite less genomic RNA, the levels of antigenome/mRNA species were only 
slightly decreased with the exception of the M antigenome/mRNA of L3M2S2. The band at 2 
kb was also present when probing for anti-sense RNA. 
When probing for genome RNA species, bands at 1.7 kb was detected in wt, L3M1S1 
viruses. This 1.7 kb band (marked with *) has been previously identified as defective L RNA 
species (Patel & Elliott, 1992). 
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Figure 3-31: Northern blot analysis of viral RNA species in infected BHK-21 cells. 
BHK-21 cells were infected at an MOI of 0.01 pfu/ml with wt BUNV or different mutant viruses. 
Total cellular RNA was extracted at 72h post-infection, subjected to Northern blotting and probed 
with DIG-labelled RNA complementary to the BUNV genome (A) or to the BUNV antigenome and 
mRNA (B). Positions of viral RNAs are indicated on the right. Membranes were exposed for 2 min, 
and a 20 min exposure of the upper part of the membrane is shown in boxes. * marks 1.7 kb and ** 
marks 2 kb. 
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4. Determination of the complete nucleotide sequences 
of mutant viruses 
Mutant viruses appeared to regain some level of fitness following serial passage. To try to 
define by what mechanism viruses became fitter I sequenced the complete genome of each 
mutant virus. To do so, BHK-21 cells were infected at a low MOI with p10 stocks. At 72h 
post-infection, the cell monolayer was lysed and total RNAs were extracted. Each viral 
segment was reverse-transcribed using specific primers and cDNAs were amplified by PCR. 
PCR products were purified on an agarose gel before being subject to sequence determination.  
First, I looked at UTR sequence conservation. Sequencing revealed no changes in the 
UTR sequences. Moreover, it confirmed that the introduced deletions were stable up to 10 
passages. 
Then, I looked at the coding regions. Concerning the S coding region, the sequence 
remained unchanged in all mutant viruses. For the M coding region, there were no nucleotide 
changes in viruses L2M1S1, L1M1S1, L3M1S2 and L3M2S1. I detected 1 nucleotide substitution 
in virus L1M2S2 at position 3070 (GT), leading to an amino acid (EK) change at position 
925 of the polyprotein, corresponding to position 448 of Gc.  
The L coding region of all mutant viruses, with the exception of L3M2S2, contained mutations. 
Viruses L2M1S1 and L3M2S1 had 1 nucleotide substitution each, but these did not result in an 
amino acid change. On the other hand, viruses L1M1S1, L3M1S2 and L1M2S2 all had several 
nucleotide substitutions, some of which resulted in amino acid mutations. Nucleotide and 
resultant amino acids changes are listed in Table 3-8, and the position of the mutations in the 
L protein are shown in Figure 3-32. In most cases, amino acids retained similar biochemical 
properties. In virus L1M1S1, the substitution at position 1118 replaced R by K, both amino 
acid are hydrophilic and positively charged, and the substitution at position 1945 replaced V 
by I, both amino acids are hydrophobic and non-polar. In virus L3M1S2, the substitutions 
R1800K and A2097V kept the biochemical properties of the amino acids but the substitution 
from E to Q at position 1619 converted a negatively charged amino acid into an uncharged 
one, both are hydrophilic. In virus L1M2S2, the first mutation, I122V, kept a non-polar and 
hydrophobic amino acid, whereas the second mutation, H1595P, replaced a positively charged 
and hydrophilic amino acid by a non-polar and hydrophobic amino acid. 
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Virus 
Nucleotide changes Amino acid changes 
Position Substitution Position Substitution 
L1M1S1 3375 CT 1108 - 
3403 GA 1118 RK 
5883 GA 1945 VI 
L2M1S1 6383 CT 2111 - 
L3M1S2 3545 CT 1165 - 
4905 GC 1619 EQ 
5449 GA 1800 RK 
5468 GA 1806 - 
6340 CT 2097 AV 
L3M2S1 6014 GA 1988 - 
L1M2S2 414 AG 122 IV 
3557 GC 1169 - 
4834 AC 1595 HP 
Table 3-8: List of nucleotide and amino acid substitutions in the L sequence of mutant viruses. 
Nucleotide substitutions and amino acid changes were positioned according to the wt L sequence. – 
denotes the absence of changes. 
 
5. Discussion 
AKAV, a member of the genus Orthobunyavirus, possesses much shorter UTRs in its 
genome segments than BUNV. Thus, it was speculated that BUNV UTRs could be shortened 
and still support replication. Minimal UTRs have been defined for each segment of BUNV, 
although viruses containing either L39/38, M33/100, M56/40 or S29/112 proved to be 
attenuated in tissue culture.  
 
The aim of this chapter was to rescue a virus with the minimal possible UTRs on all 
segments. To fulfil that aim, plasmids expressing the minimal segments were transfected 
together. Neither of the combination L39/38 + M56/40 + S29/112 or L39/38 + M33/100 + 
S29/112 led to successful rescue. For BUNV, having the minimal UTRs defined for each 
segment when a virus contains two wt and one mutant segment, on all three segment appeared 
to be deleterious. The next step was to attempt to rescue a virus containing UTRs as small as 
possible. Using constructs made by Lowen for the S segment (Lowen & Elliott, 2005) and 
those described in the previous chapter for L and M segments, many combinations were 
attempted but only few led to successful virus rescue. It appeared that when the number of 
segments carrying deleted UTRs increases the size of each UTR has also to be increased. 
Viruses with deletions in 4 or 5 UTRs were extremely attenuated. After rescue, the only
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Figure 3-32: Schematic of the L protein and relative positions of the amino acid substitutions. 
The endonuclease domain and the subunits of the polymerase domain are representing in yellow and 
blue respectively. Arrows indicates the relative position of the mutations. A red * denotes an amino 
acid that is conserved within the Orthobunyavirus genus. The background colour of the amino acid 
represents its biochemical properties: non-polar and hydrophobic in grey, positively charged and 
hydrophilic in blue, polar and hydrophilic in green and negatively charged and hydrophilic in pink. 
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way to detect foci of infection was by immunostaining with anti-N protein antibody and the 
viruses could not be grown to a sufficiently high titre to allow characterisation in tissue 
culture. It was speculated that serial passage in tissue culture might improve virus fitness. 
Therefore, mutant viruses were passaged 10 times in BHK-21 cells. After 10 passages, mutant 
viruses had recovered the ability to form plaques in BHK-21 cells and grew to titres sufficient 
for their characterisation in tissue culture. However, they remained attenuated compared to wt 
BUNV, forming smaller plaques, growing to lower titres, and displaying a delay in the 
induction of host-cell protein shut-off. 
Not all deleted viruses regained fitness to the same extent. Plaque sizes were small for 
L1M1S1, L3M1S2 and L1M2S2, tiny for L2M1S1 and L3M2S2, and almost invisible for L3M2S1. 
When looking at host-cell protein shut-off, it seems that the level of NSs was not the only 
factor regulating inhibition of protein synthesis. Indeed, viruses L1M1S1 and L2M1S1 both 
carried the same S segment, expressed similar amounts of N protein and are thought to 
express similar amount of NSs: however L1M1S1 induced a more pronounced protein shut-off. 
The same applies to L3M1S2 and L1M2S2, with L1M2S2 inducing more protein shut-off than 
L3M1S2. L1M1S1 and L1M2S2 induces a similar shut-off despite the fact that less NSs protein 
was synthesised by S2 (Lowen & Elliott, 2005). The M segment did not seem to be involved 
in protein shut-off as L1M1S1, L2M1S1 and L3M1S2 carried the same M1 segment but displayed 
different levels of protein shut-off. It appeared that the L segment might be involved. Indeed, 
the two viruses displaying the more pronounced protein shut-off carried the same L segment, 
L1. Viruses for which protein shut-off was poor carried either L2 or L3 segment.  
Differences in host-cell protein shut-off did not correlate with observed yields of virus. 
There appeared to be a better correlation between virus yield at low MOI and RNA synthesis. 
To compare yields and RNA synthesis, viruses L1M1S1 and L2M1S1 can be paired; L3M1S2 
and L1M2S2 can also be paired. The first two produced lower titre and overall less RNA than 
the latter two. L3M2S1 gave similar titres to L1M1S1 and L2M1S1 but a lower amount of L and 
M genomic RNA. On the other hand, L3M2S2 produced higher titres than L3M1S2 and L1M2S2 
but synthesised less of each RNA species.  
In virus L3M2S2, a band at 2 kb was detected by both the probes for genome and 
antigenome/mRNA species. In results section B-4, this band was identified as a duplicated S 
segment, and it is thought that the 2 kb band in L3M2S2 also resulted from the presence of a 
duplicated S segment. The genome probe also detected a band around 1.7 kb in BUNVwt and 
L3M2S1. This band has been identified previously and corresponds to a major L-derived 
defective segment (Patel & Elliott, 1992). 
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It is worth noting that deletions introduced within the UTR did not affect the affinity of 
the probes for the blotted RNAs. Indeed, the size of the deletion seems not significant 
compared to the size of the probes. Moreover, there is an example of a mutant segment where 
it is recognised as well if not better than its wt equivalent, i.e the L genomic RNA of L3M1S2. 
 
In order to elucidate the mechanism behind the regain of fitness, the full genome 
sequences of mutant viruses were determined, using a classic sequencing methodology. 
A previous in vitro study using a mini-genome system showed that BUNV was able to 
repair both insertions and deletions in its UTRs (Walter & Barr, 2010). Therefore, the first 
concern was to make sure that the UTRs were unchanged and the deletions were still present 
after 10 passages. In the context of infection with rescued viruses, BUNV appears to be 
incapable of repairing the deleted UTRs. Moreover, I could not detect any nucleotide 
mutations within the remaining UTRs sequence. It seems that deleted viruses did not regain 
fitness through modification of their UTRs.  
I then looked at the coding sequences. Proteins encoded by the S segment play a role in 
virus replication. Indeed, the N protein is involved in genome encapsidation (Osborne & 
Elliott, 2000) and NSs plays a role in counter-acting the host-cell interferon response and 
inhibiting host-cell protein synthesis (Bridgen et al., 2001; Léonard et al., 2006). NSs has also 
been shown to have an impact on viral polymerase activity in a minireplicon system (Weber 
et al., 2001). Despite N and NSs potentially having an important role in virus fitness, not a 
single nucleotide change was detected during sequencing of all mutant viruses. The M 
segment codes for the two glycoproteins Gn and Gc involved in entry mechanisms and NSm 
which is required for assembly and morphogenesis (Shi et al., 2006). One nucleotide mutation 
was detected in the M segment of the virus L1M2S2. However, it was on the L segment, 
coding for the polymerase protein, that sequencing revealed the generation of most mutations. 
Every deleted virus but L3M2S2, contained at least one nucleotide change, while the wt L 
segment did not accumulate any nt mutations after 10 passages. Nevertheless, not every 
nucleotide substitution led to an amino acid change. The two viruses that had only one 
nucleotide mutated, L2M1S1 and L3M2S1, did not display any amino acid mutation. 
Interestingly, when nt substitutions led to amino acid changes the vast majority of them were 
located in the C-terminal part of the L protein. To date no precise functions have been 
assigned to that part of the polymerase.  
 
There was no clear correlation between the regain of fitness and accumulation of 
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mutations within the L protein. Indeed, L2M1S1 which had no amino acid changes regained 
almost as much fitness as L1M1S1 which had two amino acid substitutions. Virus L1M2S2 had 
two amino acid substitutions as well, and after 10 passages was fitter than L1M1S1, but only as 
fit as L3M1S2 which had three changes. 
Amino acids are molecules formed by an amine group, a carboxyl group and a side chain. 
The side chain defines their biochemical properties. Therefore, changing an amino acid for 
another one might alter protein folding and activity. Protein conformation can be estimated 
using different on-line software and thus I was able to compare the predicted secondary 
structure of the mutant polymerases with the wt polymerase 
(http://bioinf.cs.ucl.ac.uk/dompred and http://bioinfadmin.cs.ucl.ac.uk/ffpred/). 
The two amino acids mutated in L1M1S1 are conserved within viruses in the 
Orthobunyavirus genus. Moreover, the mutation R1118K was in the polymerase domain 
which is thought to be critical for replication. Despite the two amino acids being hydrophilic 
and having a positive charge, both prediction programs showed a change in secondary 
structure from a coil domain to a sheet. The mutation V1945I also occurred at a conserved 
amino acid and led to a different predicted secondary structure from sheet to a coil domain. 
These differences in secondary structure might explain why L1M1S1 did not regain as much 
fitness as L3M1S2 and L1M2S2. Amino acids mutations in those two viruses do not affect the 
predicted secondary structure even if H1595P and E1619Q led to a change in the biochemical 
properties of conserved amino acids. It is interesting to note the mutation C6340T reverted the 
nucleotide present in the L cDNA to the sequence in the GenBank database and resulted in an 
A2097V change.  
I looked at the impact of the mutation on protein folding using on-line software and it 
gave us a basis to understand how deleted viruses might have regained fitness. It was of major 
interest to determine how each amino acid change impacted on polymerase activity. With data 
concerning both folding and activity of the polymerases it should be possible to get a deeper 
understanding of the complex mechanism behind virus fitness. 
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E. Impact of amino acids changes in the polymerase 
during serial passage on virus fitness 
1.  Introduction and aims 
The mini-replicon system is based on a reporter gene, such as Renilla luciferase, that is 
cloned in an anti-sense orientation between the 3’ and 5’ UTRs of the BUNV L, M or S 
segments. The mini-replicon mimics viral genomic RNA, and thus its encapsidation, 
transcription and replication can be monitored in the cell by measuring Renilla luciferase 
expression (Weber et al., 2002). The mini-replicon expressing plasmid is co-transfected into 
mammalian cells along with expression plasmids for the L and N proteins of BUNV. Upon 
transfection, the N protein encapsidates the intracellularly transcribed mini-genome to form 
RNA-N complexes (Dunn et al., 1995) that are recognised by the L protein. The polymerase 
can then perform transcription and/or replication. 
Mini-replicon systems have facilitated the study of the UTRs’ role during replication and 
transcription of the BUNV genome. The 3’ and 5’ UTR cooperate to promote and regulate 
RNA synthesis (Barr et al., 2003; Kohl et al., 2004). The strength of each segments UTRs 
have been defined (Barr et al., 2003) and the relative ability of BUNV UTRs to promote mini-
replicon RNA replication was found to be M>L>S, with M UTRs being the strongest 
promoter. Other studies showed that the signals promoting RNA encapsidation by the N 
protein are contained within the first 32 nt from the end of the viral genome (Kohl et al., 
2004; Osborne & Elliott, 2000). 
 
BUNV UTRs display great plasticity as it was possible to delete large parts of their 
sequence and still maintain viral replication (section 3-D). Viruses containing deletions in 
UTRs on all three segments were grossly attenuated compared to wt BUNV. Passaging of 
these viruses in BHK-21 cells allowed them to partially recover fitness. When I analysed their 
nucleotide sequences, I noticed that the UTRs remained unchanged, but amino acid 
substitutions appeared within the L protein.  
 
In this chapter, I used the mini-replicon system for two different purposes. First, I 
measured the impact of the deletions within the UTRs on UTR promoter strength. In this 
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assay, the relative luciferase activity measured for mini-replicons containing deleted UTRs 
would correspond to the relative efficiency of the deleted UTR to promote RNA transcription 
and replication, thus reflecting promoter strength. And second, I assessed the impact of amino 
acid mutations on polymerase activity. Mutations in the polymerase might have different 
effects: they might change the ability of the polymerase to recognise the UTRs, alter or 
increase its fidelity, or modulate its transcription/replication rate. Therefore, using mini-
replicon assays, I assessed the impact of each mutation on the overall activity of the different 
mutant polymerases compared to the wt polymerase. 
2. Plasmid construction 
a) Mini-genome expressing plasmids 
Deletions within the UTRs of pT7riboBUNZb/aRen(-) were introduced using excision 
PCR. The name of each construct follows the pattern Zb/a, where Z is the name of the 
segment to which the UTRs belong to, a is the length of the remaining 3’ UTR and b the 
length of the remaining 5’ UTR. For each construct, the viral ORF was replaced by the 
Renilla luciferase ORF in the reverse orientation (Figure 3-33). 
 
Primers were designed to flank the region to be deleted in an outward orientation and 
paired as listed in Table 3-9. Segments containing deletions in both UTRs were obtained by 
cloning as shown in Figure 3-34. The templates were digested with the restriction enzymes 
BsrGI and SapI. Vector and insert DNAs were ligated together. The UTRs of each construct 
and the coding region up to the cloning site were sequenced to ensure the presence of the 
deletions in the UTRs and the absence of unwanted mutations in the genome. 
 
Construct Forward primer Reverse primer 
pT7riboBUNL65/50Ren(-) RenORF+ Ren L65- 
pT7riboBUNL45/50Ren(-) RenORF+ Ren L45- 
pT7riboBUNL108/39Ren(-) Ren L39+ RenORF- 
pT7riboBUNM40/56Ren(-) RenORF+ Ren M40- 
pT7riboBUNM100/33Ren(-) Ren M33+ RenORF- 
pT7riboBUNS112/85Ren(-) RenORF+ Ren S112- 
pT7riboBUNS174/65Ren(-) Ren S65+ RenORF- 
Table 3-9: Primers used to introduce deletion in the UTRs of the reporter gene. 
The name of each construct follows the pattern Zb/a, where Z is the name of the segment concerned, a 
is the length of the remaining 3’UTR and b the length of the remaining 5’UTR. Primers sequences are 
given in Table 2-5. 
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Figure 3-33: Schematic of pT7riboBUNZb/aRen(-) 
The ORF of the Renilla luciferase is flanked by the 3’ and 5’ UTRs of the same viral segment to form 
the mini-genome. The mini-genome is cloned in the reverse orientation between the T7 promoter (T7 
black arrow) and the hepatitis delta ribozyme (δ black box) of the pT7ribo backbone.  
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Figure 3-34: Schematic illustrating the cloning strategy used to introduce double deletion in the 
UTRs of the reporter gene. 
Plasmids containing deletion in one UTR were digested with the restriction enzymes BsrGI and SapI 
(left panels). The fragments containing deletion in each UTR were purified on an agarose gel and 
ligated together (right panel). wt UTRs are represented by black boxes and deleted UTRs are 
represented by red boxes. 
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b) Plasmids expressing mutant polymerases 
In section 3-D-4, I identified nucleotide changes leading to amino acid mutations in the 
polymerase of viruses containing deleted UTRs. These point mutations were introduced into 
the expression plasmid pTM1-BUNL using Quick-change PCR. Primers were designed to be 
30 to 35 nt long with the point mutation in the middle. The primer pairs used are listed in 
Table 3-10. The presence of the mutation in the construct was confirmed by sequencing. To 
make sure that there were no other mutations in the L protein, the section of the polymerase 
gene containing the mutation was cloned back into pTM1-BUNL using the closest two unique 
restriction sites (Figure 3-35). 
 
Construct Forward primer Reverse primer 
pTM1-BUNL-I122V QcT407For QcT407Rev 
pTM1-BUNL-R1118K QcM3397For QcM3397Rev 
pTM1-BUNL-H1595P QcT4827For QcT4827Rev 
pTM1-BUNL-E1619Q QcN4894For QcN4894Rev 
pTM1-BUNL-R1800K QcN5498For QcN5498Rev 
pTM1-BUNL-V1945I QcM5877For QcM5877Rev 
pTM1-BUNL-A2097V QcN6329For QcN6329Rev 
Table 3-10: Primers used to introduce point mutations in pTM1-BUNL. 
The name of the mutants indicates the resulting amino acid change, where the first letter is the original 
amino acid, the number its position and the second letter the amino acid after mutation. Primers 
sequences are given in Table 2-2. 
 
Then, individual mutations were combined, using appropriate restriction enzyme sites and 
molecular cloning, to create polymerases with two and three mutations. Mutations were 
combined in pTM1-BUNL to mimic those observed in the serially passage mutant viruses 
(Figure 3-32). Mutations were associated as follows: pTM1-BUNL-R118K-V1945I mimics 
virus L1M1S1; pTM1-BUNL-E1619Q-R1800K-A2097V mimics virus L3M1S2; and pTM1-
BUNL-I122V-H1595P mimics virus L1M2S2 (see result section D-4). After cloning, the 
fragment containing the mutation was sequenced from one restriction site to the other.  
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Figure 3-35: Schematic of pTM1-BUNL with the relative positions of the unique restriction sites 
and the amino acid mutations.  
The position of the unique restriction sites are shown in dark blue. The relative positions of the amino 
acid mutations are represented by a red line within the coding sequence. In the names of the mutation 
(in red) the first letter is the original amino acid, the number its position and the second letter the 
amino acid after mutation. 
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c) Introduction of polymerase mutations into 
pT7riboBUNL 
Three mutations, E1619Q, V1945I and A2097V, were chosen to be individually 
introduced into pT7riboBUNL. 
The mutations E1619Q and V1945I were introduced into pT7ribo using available 
restriction enzyme sites. Plasmids pT7riboBUNL and pTM1-BUNL-E1619Q or pTM1-
BUNL-V1945I were digested at the two nearest restrictions site (Figure 3-36). Then, the 
fragment containing the mutation was ligated into pT7riboBUNL to form pT7riboBUNL-
E1619Q and pT7riboBUNL-V1945I.  
For mutation A2097V, cloning could not be used, and the mutation was therefore 
introduced using Quick-change PCR. The PCR template was pT7riboBUNL and the primer 
pairs used were QcN6329For and QcN6329Rev leading to the construct pT7riboBUNL-
A2097V. 
For each construct, the presence of the mutation was confirmed by nt sequencing. 
3. Analysis of the relative UTR strength in a mini-
replicon system 
To determine the strength of the deleted UTRs in comparison to the wt UTRs, BSR-T7/5 
cells were transfected with pTM1-BUNL, pTM1-N, the reporter construct 
pT7riboBUNXb/aRen and the control construct pTM1-FF-Luc. Cells were lysed 24h post-
transfection and the relative activities of firefly and Renilla luciferases were measured. For 
each sample, the value obtained for Renilla luciferase was normalised to the firefly luciferase 
activity (see result section 2.B.2.g). The experiment was repeated three times using triplicate 
wells for each experiment. 
In this experiment I wanted to compare the promoter strength of the UTRs of each 
individual virus segment. Therefore, the Renilla luciferase measurements obtained for each wt 
segment were defined as representing 100% of the activity for that UTR. The relative 
luciferase activity of the deleted segments was expressed as a percentage of the corresponding 
wt segment. 
Compared to the parental wt segment, the relative luciferase activity generated by 
segments with deleted UTRs ranged from 30% to 80% (Figure 3-37). The only exception was 
observed for pT7riboBUNL44/45Ren(-), the equivalent of viral segment L45/44 (L2), which
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Figure 3-36: Schematic of pT7riboBUNL(+) with the relative positions of the unique restriction 
sites and the amino acid mutations. 
The position of the unique restriction sites are shown in dark blue. The relative positions of the amino 
acid mutations are represented by a red line within the coding sequence. In the names of the mutations 
(in red) the first letter is the original amino acid, the number its position and the second letter the 
amino acid after mutation. 
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Figure 3-37: Comparison of the relative promoter activity of the deleted UTRs with the wt 
polymerase. 
BSR-T7/5 cells in a 12-well plate were transfected with 0.3 µg of pTM1-BUNL, 0.3 µg of pTM1-N, 
0.3 µg of the reporter construct pT7riboBUNZb/aRen(-) and 0.3 µg of the control construct pTM1-FF-
Luc. Cells were lysed 24h post-transfection and both Renilla and firefly luciferase activities were 
measured. wt luciferase activities (black bars) are considered to represent 100% activity and the 
relative luciferase activities of deleted UTRs (grey bars) are expressed in percentage of wt. Results 
shown are an average of triplicate experiments. Error bars indicate the standard deviation. 
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had an activity similar to wt. Otherwise, as a general trend, I observed that as the size of the 
deletion in the UTR increased, the efficiency of the UTRs to promote replication/transcription 
decreased. 
4. Analysis of mutant polymerases in a mini-replicon 
system 
a) Mutant polymerase activity for segments with wt UTRs 
To assess the overall activity of the different mutant polymerases for wt UTRs, BSR-T7/5 
cells were transfected with pTM1-BUNLwt or pTM1-BUNLmutant, pTM1-BUNN, 
pT7riboBUNZRen(-) and pTM1-FF-Luc. Cells were lysed 24h post-transfection and the 
relative luciferase activities of firefly and Renilla luciferase were measured. For each sample, 
the value of the Renilla luciferase was normalised to the firefly luciferase activity. The 
experiment was repeated three times with duplicate wells and for each individual experiment, 
independent plasmid preparations of the polymerases were used while all other plasmid 
preparations were the same. 
 
In Figure 3-38, the luciferase activities of the wt (black bars) measured the affinity of the 
wt polymerase for the wt UTRs and were defined as 100% activity. The relative luciferase 
activities of the mutant polymerases (grey bars) measured the affinity of the mutant 
polymerases for the wt UTRs and were expressed as a percentage of the wt.  
Mutant polymerases containing one amino acid change showed a similar activity pattern 
toward all three UTRs, and only the percentage of activity compared to wt varied. These 
polymerases could be divided in three categories: V1945I and A2097V had a better activity 
than wt; I122V, R118K and R1800K had an activity similar to wt; and H1945P and E1619Q 
had a reduced activity. At the most extreme, there was a 6-fold increase in the overall activity 
of polymerase A2097V for the L UTR and a 20-fold decrease in the activity of polymerase 
E1619Q for the M UTR.  
The picture was more complex with polymerases bearing two or three amino acid changes. 
Polymerase I122V+H1595V had an affinity similar to H1595V toward all three UTRs. 
Polymerases R1118K+V1945I and R1800K+A2097V combined a mutation that increased the 
polymerase activity and one whose activity was similar to wt, and as could be expected the 
resulting activity was an average of both. The very low activity showed by the mutation
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Figure 3-38: Measure of the overall activity of the mutant polymerases for wt UTRs. 
BSR-T7/5 cells in a 24-well plate were transfected with 0.15 µg of pTM1-BUNLwt or pTM1-
BUNLmutant, 0.15 µg of pTM1-BUNN, 0.15 µg of pT7riboBUNZRen(-) and 0.15 µg of pTM1-FF-
Luc. Cells were lysed 24h post-transfection and both Renilla and firefly luciferase activities were 
measured. wt luciferase activities obtained with the wt polymerase (black bars) are considered 100% 
and the relative luciferase activities for the L (A), M (B) and S (C) UTRs are expressed in percentage 
of wt (grey bars). Results shown are an average of triplicate experiments. Error bars indicate the 
standard deviation. 
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E1619Q was not rescued by any other mutations and the activity of polymerases containing 
the mutation E1619Q was always decreased by at least 7-fold. 
b) Mutant polymerase activity for segments with deleted 
UTRs 
To assess the overall activity of the different mutant polymerases for the deleted UTRs, 
BSR-T7/5 cells were transfected with pTM1-BUNLwt or pTM1-BUNLmutant, pTM1-BUNN, 
pT7riboBUNZb/aRen(-) and pTM1-FF-Luc. Cells were lysed 24h post-transfection and the 
relative activity of firefly and Renilla luciferase were measured. For each sample, the value of 
the Renilla luciferase was normalised to the firefly luciferase activity. The experiment was 
repeated three times with duplicate wells and for each individual experiment independent 
plasmid preparations were used for the polymerases while all other plasmid preparations 
remained the same. 
 
In Figure 3-39, the luciferase activities of the wt (black bars) measured the activity of the 
wt polymerase for the wt UTRs and were defined as 100% activity. The relative luciferase 
activities of the mutant polymerases (grey bars) measured the activity of the mutant 
polymerases for the deleted UTRs and were expressed as a percentage of the wt activity. The 
activity of each mutant polymerase was measured for the UTRs with which it was associated 
in the virus: polymerase I122V+H1595P was tested with tested with segments L1, M1 and S2, 
while polymerase R1118K+V1945I was tested with segments L1, M2 and S2 and polymerase 
E1619Q+R1800K+A2097V was tested with L2, M2 and S2. 
The activity pattern of the mutant polymerases for the deleted UTRs was similar to that in 
Figure 3-38. I observed that the activities of mutant polymerases for deleted UTRs were not 
increased compared to the activity of the wt polymerase for wt UTRs. The only exception was 
the activity of the polymerase V1945I for the L and S UTRs (Figure 3-38-A and C 
respectively). The activity of the polymerase E1619Q was again extremely impaired in 
comparison to the wt and was not rescued by any other mutations. 
c) Comparison of wt and mutant polymerase activity for 
the same deleted UTR 
In Figure 3-40, the values from Figure 3-38 and Figure 3-39 were plotted on the same 
graph. Therefore, I could compare the activities of the wt polymerases toward a given deleted 
UTR (striped bars) with the affinity of the mutant polymerase for the same given deleted UTR
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Figure 3-39: Measure of the overall activity of the mutant polymerases for deleted UTRs. 
BSR-T7/5 cells in a 24-well plate were transfected with 0.15 µg of pTM1-BUNLwt or pTM1-
BUNLmutant, 0.15 µg of pTM1-BUNN, 0.15 µg of pT7riboBUNZb/aRen(-) and 0.15 µg of pTM1-
FF-Luc. Cells were lysed 24h post-transfection and both Renilla and firefly luciferase activities were 
measured. wt luciferase activities obtained with the wt polymerase and wt UTRs (black bars) are 
considered 100% and the relative luciferase activities for the mutant polymerases and mutant UTRs 
are expressed in percentage of wt (grey bars). Results shown are an average of triplicate experiments. 
Error bars indicate the standard deviation. 
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(grey bars). Relative activities of each polymerase for the deleted UTRs are shown as a 
percentage of the wt polymerase/wt UTR affinity. 
V1945I and A2097V were the two polymerases that appeared to have an increased 
affinity toward their cognate deleted UTRs, while I122V and R1118K had a similar affinity 
compared to wt polymerase. H1595P and E1619Q both showed a loss of affinity that was not 
recovered by any other mutation. 
5. Analysis of three mutant polymerases in a wt virus 
background 
a) Virus rescue 
In order to determine if the differences in polymerase activity observed in the mini-
replicon system would be reproduced in a virus context, I attempted to rescue three different 
mutations in a wt virus background. In the mini-replicon system, mutation V1945I resulted in 
a better activity for both the wt and deleted UTRs, and mutation E1619Q resulted in a 
dramatic loss of activity. These mutations were chosen to represent polymerases with an 
increased activity (V1945I) or a decreased activity (E1619Q). The mutation A2097V also 
resulted in a better activity for both wt and deleted UTRs but to a lower extent than mutation 
V1945I and was chosen for two reasons: (a) to represent a polymerase with intermediate 
activity and (b) it matches the GenBank database sequence for BUNL (Table 2-1). 
BSR-T7/5 cells were transfected with wt pT7riboBUNM, wt pT7riboBUNS and 
pT7riboBUNLmutant. Each mutant polymerase led to successful virus rescue within 5 days of 
transfection: all showed cytopathic effect in the transfected cell monolayer, even the virus 
carrying the mutation E1619Q, despite the fact that E1619Q seemed to have lost its ability to 
replicate the mini-genome segment.  
The supernatant from the transfected cells was used to grow a p0 virus stock in BHK-21 
cells at 33°C. In order to confirm the presence of the wanted mutation and the absence of 
unwanted mutations, BHK-21 cells were infected with p0 virus stock at an MOI of 0.1 pfu/ml. 
The cell monolayer was harvested 48h post-infection. Total cell RNA was extracted and used 
to determine the nucleotide sequence of the L segment. 
In this section, viruses with an amino acid mutation in their polymerase will be named 
after that mutation, i.e. BUNV with the mutation at position E1619Q in the polymerase will 
be referred as E1619Q.  
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Figure 3-40: Comparison of wt and mutant polymerase activities for the same deleted UTR. 
The relative luciferase activities are expressed as a percentage of the wt polymerase/wt UTRs activity. 
Striped bars represent the affinity of the wt polymerase for a given deleted UTR (Figure 3-37) and 
grey bars represent the affinity of mutant polymerases for a given deleted UTR (Figure 3-39). Deleted 
UTRs are mentioned on the left, L1 (L44/65), L2 (L39/65), M1 (M56/40), M2 (M33/100), S1 (S85/112) 
and S2 (S62/112). Error bars indicate the standard deviation. 
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b) Growth properties 
(i) Plaque size 
The ability of each virus to form plaque was assessed in BHK-21 cells incubated at 33°C. 
Viruses V1945I and A2097V displayed plaques of similar sizes compared to wt BUNV, but 
virus E1619Q displayed smaller plaques (Figure 3-41). 
(ii) Growth kinetics 
The growth properties of viruses carrying a mutation in their polymerase was analysed in 
a multi-step growth curve. BHK-21 cells were infected at an MOI of 0.1 pfu/cell. Cells were 
incubated at either 33°C or 37°C and virus released into the supernatant was collected at 6h, 
18h, 24h, 30h, 48h and 72h post-infection. Virus titres in the supernatant were determined by 
plaque assay on BHK-21 cells.  
When grown at 33°C, mutant viruses showed similar growth properties to that of wt 
BUNV (Figure 3-42-A). They all grew at the same rate up to 18h post-infection. By 18h, the 
mutant viruses grew to titres within 10-fold of wt BUNV (1.4x107 pfu/ml) with the lowest 
titre being recorded for E1619Q which grew to a titre of 1.4x106 pfu/ml. At 24h and 30h post-
infection, V1945I and A2097V had grown to similar titres as wt BUNV whereas virus 
E1619Q showed around a 10-fold decrease in titre. At 48h, all viruses had grown to titres that 
were within a log of each other.  
When grown at 37°C, viruses V1945I and A2097V displayed growth kinetics similar to 
wt BUNV whereas virus E1619Q appeared to be attenuated in comparison (Figure 3-42-B). 
As early as 6h, the titre of virus E1619Q was 10-fold lower than wt and the difference kept 
increasing: E1619Q titres were 100-fold lower at 18h and 24h post-infection and 1000-fold 
lower at 30h post-infection. After 72h, the difference between wt BUNV and E1619Q titres 
was 100-fold. Thus, the mutation E1619Q appeared to lead to a mutant virus with a 
temperature sensitive phenotype. 
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Figure 3-41: Plaque phenotype of viruses containing a wt or mutant polymerase in BHK-21 cells. 
BHK-21 cells were infected with wt BUNV or different mutant polymerase viruses and incubated at 
33°C. Cells were fixed at 3 days post-infection in 4% formaldehyde and stained with Giemsa’s 
solution.  
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Figure 3-42: Growth properties of wt BUNV or viruses containing mutant polymerases in BHK-
21 cells at 33°C and 37°C. 
BHK-21 cells were infected at an MOI of 0.1 pfu/cell and incubated at either 33°C (A) or 37°C (B). 
Supernatants were collected at 6h, 18h, 24h, 30h, 48h and 72h post-infection. Virus titres in 
supernatants were determined by plaque assays in BHK-21 cells.  
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(iii) RNA synthesis 
Total cell RNA synthesised during infection was analysed by Northern blotting. BHK-21 
cells were infected at an MOI of 0.1 pfu/cell and incubated at 33°C. Monolayers were lysed in 
Trizol at 48h post-infection and total cellular RNAs were extracted. Samples were loaded in 
duplicate and subjected to electrophoresis and transfer to nylon membranes. The membranes 
were probed with DIG-labelled RNAs complementary to each of the BUNV genome 
segments (Figure 3-43-A) or complementary to each of the BUNV antigenomes and mRNAs 
(Figure 3-43-B). 
There were no major differences in levels of genomic L and M segment RNA synthesis 
(Figure 3-43-A), but the M genome was below limits of detection by the probe in each virus. 
Virus E1619Q seemed to synthesise slightly less L genome compared to viruses V1945I, 
A2097V and wt BUNV. On the other hand, all viruses with a mutation in their polymerase 
appeared to synthesize less L and M antigenome/mRNA species but similar levels of S 
antigenome/mRNA compared to wt (Figure 3-43-B). 
For virus E1619Q, 3 bands extra are detected (marked with *). Both the genome and 
antigenome/mRNA probes revealed bands around 2 kb and 3 kb, while a band around 1.7 kb 
was only detected by the probe for antigenome/mRNA. 
6. Discussion 
In the previous section, I identified mutations occurring in the polymerase of viruses with 
deletions in their UTRs when they were serially passaged. These deleted viruses also regained 
fitness through serial passage. I speculated that the accumulation of mutations within the 
polymerase might be involved in the regain of fitness. Therefore, the aim of this chapter was 
to investigate the impact of each amino acid mutation on the activity of the polymerase.  
 
In order to investigate polymerases activities, I took advantage of the mini-replicon 
system where a reporter gene is clone between the 3’ and 5’ UTRs of a viral segment. 
First, I measured the impact of the deletions within the UTRs on their ability to promote 
RNA synthesis. I showed that the UTR promoter strength decreased when the size of the 
deletion within the UTR sequence increased. The only exception was observed for the 
segment L2 (L44/45) that promote RNA synthesis with similar efficiency to the wt L segment. 
Thus, it is possible to reduce the size of the UTRs while conserving their promoter ability, 
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Figure 3-43: Northern blot analysis of the RNAs synthesised during infection in BHK-21 cells. 
BHK-21 cells were infected at an MOI of 0.1 pfu/ml with wt BUNV or different polymerase mutant 
viruses and incubated at 33°C. Total cellular RNA was extracted at 48h post-infection, subjected to 
Northern blotting and probed with DIG-labelled RNA complementary to the BUNV genome (A) or to 
the BUNV antigenome and mRNA (B). Positions of viral RNAs are indicated on the right. Membranes 
were exposed for 2 min (full size membrane) or 10 min (top part of the membrane in the box). * 
indicates 1.7 kb, 2 kb and 3kb. 
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however to achieve wt levels of replication activity the full UTR sequences are necessary. 
Then, I examined the activity of the different mutant polymerases towards wt or deleted 
UTRs. In the previous section, I identified 7 mutations that were analysed here. The mutation 
I122V located downstream of the endonuclease domain (Reguera et al., 2010) had no impact 
on the activity of the polymerase with either the wt UTRs or the deleted UTRs. The mutation 
R1118K, despite its location within the B motif of the polymerase domain (Müller et al., 
1994), had little impact on the polymerase activity. The relative luciferase activities of mini-
replicon with the different UTRs were similar to wt, only the one for the S1 (S85/112) UTR 
was lower. The other 5 mutations were located within the C-terminal domain of the 
polymerase (Figure 3-32). To date, no function has been described for this domain. By 
analogy with other polymerases, and mainly the influenza polymerase subunit PB2, it was 
speculated that it might be involved in activity such as cap recognition and/or binding 
(Reguera et al., 2010). One of these mutations, R1800K, had no impact on the activity of the 
polymerase. The other four could be separated into two groups according to their phenotype: 
H1595P and E1619Q displayed a decreased activity, while V1945I and A2097V showed an 
increased activity. Besides showing a similar phenotype, mutations in each group were 
located within the same region of the polymerase and affected amino acids that are conserved 
across the genus Orthobunyavirus (except A2097V). 
When combining mutations to mimic their combination within serially passaged viruses, I 
expected to observe a phenotype representing the average of the two activities. It was the case 
for all combinations except those including either H1595P or E1619Q. Indeed, with either of 
these mutations the activity of the polymerases remained lower compared to wt. The effect 
was more pronounced with the mutation E1619Q that seemed to ‘kill’ polymerase activity in 
the mini-genome. This observation suggests that this domain of the polymerase must play an 
important role in virus replication.  
 
In order to characterise the E1619Q, V1645I and A2097V mutations better, it was 
attempted to rescue them into a virus in a wt background. Despite the mutation E1619Q 
resulting in a loss of mini-genome replication, a virus bearing this mutation was rescued as 
easily as the wt BUNV. Viruses bearing the mutations V1645I and A2097V were also rescued 
within 5 days of transfection. When taking the mini-replicon data into consideration, I was 
expecting viruses carrying the mutations V1645I and A2097V, which result in more active 
polymerases, to replicate better than wt BUNV and the virus with the mutation E1619Q to be 
attenuated. These predictions were partly accurate for E1619Q but V1645I and A2097V 
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showed similar plaque size, growth kinetic and RNA synthesis as wt BUNV. The mutation 
E1619Q led to the formation of smaller plaque and to a slower growth kinetic, but only at 
37°C. The virus E1619Q was thus temperature sensitive, reaching a titre similar to wt at 33°C 
but 100-fold lower at 37°C. Interestingly, when I looked at the RNA species synthesised by 
the viruses with mutant polymerases, V1645I and A2097V were similar to wt BUNV but 
E1619Q synthesised additional RNA species of around 2 kb and 3 kb. Those RNA species are 
thought to be duplication of the S segment (as discussed in section B). Such a strong band at 3 
kb was not observed previously but it could be a triplicated S segment.  
 
I showed that the mutation E1619Q led to a temperature sensitive virus, and temperature 
sensitive mutants are good candidates for live-attenuated vaccines. In the 1960s, respiratory 
syncytial virus (RSV) was cold-passaged (cp) in two different cell lines to a lower 
temperature of 26°C. This cpRVS was shown to be highly attenuated in seropositive adults 
and children. Later, with the advent of reverse genetics, the basis for attenuation was studied 
in chimpanzees and the mutations accumulated in the different genes during cold-passage 
were shown to be responsible for virus attenuation (Whitehead et al., 1998a; Whitehead et al., 
1998b). More recently, the concept of cold-attenuation was applied to influenza virus: two 
different strains (A/Ann Arbor/6/60 (H2N2) and B/Ann Arbor/1/66) were attenuated by serial 
passage in chicken eggs with decreasing temperature. In the end, these strains could only 
replicate at temperature lower than 33°C, and could be combined with the relevant 
hemagglutinin and neuraminidase genes for relevant immunisation (Beyer et al., 2002).  
Vaccination with live-attenuated vaccines induces complex immune mechanism through 
activation of both the humoral and cell-mediated response. However, a concern with live-
attenuated vaccines for virus with segmented genomes is their potential ability to revert to 
virulence by genome reassortment. As a proof-of-principal, it would be of interest to 
introduce the mutation E1619Q in the polymerase along with deletion within the UTRs 
making it extremely difficult for the vaccine to regain fitness by acquiring a wt segment. To 
decrease even further the possibilities that the virus could regain fitness, temperature sensitive 
mutations could be introduced into the N protein (Eifan & Elliott, 2009) and the NSm 
sequence could be deleted (Pollitt et al., 2006). A virus carrying a combination of temperature 
sensitive mutations and deletions on all three segments would be highly unlikely to reassort, 
thus the probability of such a virus reverting back to virulence would be very low, making it a 
good vaccine candidate. 
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A. Fulfilment of the aims 
This thesis had for aims to explore BUNV genome plasticity by modifying only the 
untranslated regions. The main project was to define the minimal UTRs that would support 
virus growth. Afterward, viruses were subjected to serial passage and changes in their genome 
characterised. I choose to focus on the role played by the polymerase during forced evolution. 
Two projects were also developed on the side: one tested the possibility to engineer a two 
segmented BUNV using an ambisense coding strategy in the S segment; and the other 
explored UTR/segment specificity using viruses bearing heterologous UTRs on one segment. 
Over the course of my thesis, I took full advantage of the highly efficient BUNV rescue 
system developed previously in our laboratory (Lowen et al., 2004) and had the opportunity 
to put the efficiency of that system to the test, especially when attempting to rescue viruses 
with highly modified genomes. Indeed, some of these viruses took up to 5 times longer to be 
rescued than wt BUNV. I noticed that varying the amount of transfected plasmid or adding 
expressing support plasmid presented little advantages if any and was not of any help to 
recover viruses that failed to be rescued following the routine protocol.  
 
The ambitious attempt to create a two segmented BUNV using an ambisense coding 
strategy was the project to really push the rescue system to its limits. The ambisense strategy 
was validated using eGFP in the ambisense locus on the S segment and successful rescue of 
this virus was taken as a good omen for the success of a two-segmented BUNV. However, 
despite months of effort, numerous rescue experiments and attempts to detect virus by all 
means, a two-segmented BUNV could not be grown. The rescue system is not to blame as I 
could detect single-infected cells. It is more likely that a bipartite ambisense genome cannot 
sustain viral growth.  
 
Throughout this thesis, the generation of a remarkable genomic species was observed, 
namely a double-sized S segment (reported in sections 3-B, 3-D and 3-E). Upon investigation, 
it appeared to be an exact duplicate of the S segment. It would be of major interest to 
characterise the coding capabilities of that segment. Indeed, if the second ORF were to be 
expressed, the ‘two-segment project’ could be on the roll again. The ORF for the two 
glycoproteins and NSm could replace either the first or the second N/NSs ORF and one of the 
construct might lead to successful virus rescue. A bicistronic segment strategy could also be 
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developed to express foreign antigens in the view to engineer multivalent live-attenuated 
vaccines. The expression of the second ORF depends on the ability of the polymerase to 
initiate transcription and replication on an internal promoter. This has not been tested for 
BUNV, however in influenza A virus, an internal promoter was found to be functional but the 
second ORF was lost quickly (Flick & Hobom, 1999). The double-sized S segment found in 
BUNV mutants seems to be generated and maintained through serial passage indicating that, 
different from influenza A virus, such a construct would probably be stable. 
 
During this project, I was able to rescue viruses containing segments with heterologous 
UTRs, supporting the model of random packaging proposed previously (Lowen et al., 2005). 
Indeed, a strictly specific packaging model is not compatible with the rescue of viruses where 
two similar UTRs are present. However, a certain degree of specificity is suggested by the 
relatively low particle-to-pfu ratio observed in wt BUNV. The generation of segments 
carrying heterologous UTRs also emphasise the role of the UTRs as segment-specific 
promoters for replication and transcription. Indeed, the ratio of RNA species produced in 
heterologous viruses are different compared to wt BUNV and this is most obvious when the 
UTRs flanking the L ORF are swapped for either the M or S UTRs. In order to identify the 
sequence that directs differential transcription/replication activities only internal portions of 
the UTRs could be swap around. The role of the UTRs has been mostly studied using the S 
segment and it was found that the coding region is not involved in transcription/replication 
processes. However, considering the important size difference between the S and the L ORF, 
the presence of trans acting sequences within the L coding region cannot be rule out.  
 
The main project was to define the minimal UTRs supporting viral growth and to 
characterise the resulting virus. First, the minimal UTRs were defined for each individual 
segment (section 3-C). As a general rule, I observed that viruses with the largest deletion were 
the most attenuated. Thus, it appears that the ‘extra’, non-conserved, sequences present in 
BUNV UTRs are dispensable but not ‘useless’ and contribute to viral growth. Indeed, the 
internal portions appear to play a role in regulating the transcription/replication balance as the 
promoter strength of the UTRs decreases when deletions are introduced (section 3-E-4). 
Compared to viruses in the Simbu serogroup (i.e AKAV or Aino virus), BUNV has long 
UTRs. Both long and short UTRs seem to fulfil the same functions, thus, either the regulatory 
signals are encoded more efficiently or UTRs of viruses in the Simbu serogroup encode less 
regulatory signals. To test this, it would be of interest to construct chimeric segments 
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containing the BUNV ORF and UTRs from AKAV.  
The importance of the non-conserved regions was highlighted when trying to rescue 
viruses containing UTRs deleted in more than one segment. When combined, minimum 
segments could not support virus growth and the size of the UTRs had to be increased. 
Viruses with deletion in five of their UTRs were grossly attenuated compared to wt BUNV. 
However, after serial passage in tissue culture, those viruses were able to regain some level of 
fitness, while remaining attenuated. Serial passage can be compared to forced evolution and 
as the viruses replicate, they will accumulate point mutation in their genome. In order to 
understand the mechanism behind the regain of fitness, the entire nucleotide sequence was 
determined to assess if any mutation were ‘fixed’ during forced evolution. A classic 
sequencing method was used to define the consensus sequence present in the virus population. 
Interestingly, upon passaging, mutant viruses accumulated mutations within their polymerase, 
whereas, under similar conditions, the polymerase of wt BUNV did not accumulate any 
mutations (section 3-D-4). Those nucleotide mutations were mainly located within the C-
terminal of the L protein and a few of them led to amino acid changes at positions conserved 
across the genus Orthobunyavirus. The function of the C-ter domain of the L protein is 
unknown to date and data obtained in section 3-E-4 seems to indicate that it might play a role 
in UTR recognition. Indeed, some mutation increased the ability of the polymerase to 
promote transcription/replication in a mini-replicon system, provoking the question of the 
basis for the interaction between the polymerase and the UTRs. As well as promoting 
transcription and replication, this interaction could play a role in cap-snatching. For influenza 
viruses, the interaction of the UTRs with the PB1 subunit triggers the activation of the cap-
binding site on PB2 (Rao et al., 2003). Therefore, it would be of interest to asses if the 
introduction of a deletion within the non-conserved sequences of the UTRs resulting in a 
decrease of cap-binding activity.  
B. Integrating the project into the bigger picture 
During my PhD, I have engineered genetically modified viruses and obtained evidence 
that introducing mutations within the UTRs results in virus attenuation and most importantly 
that such mutations are conserved through serial passage. This stability represents an asset 
that could be exploited to develop live-attenuated vaccines. 
 
Recent outbreaks caused by viruses within the family Bunyaviridae highlight the 
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importance to maintain our efforts to understand virus replication and discover newer and 
safer ways to design vaccines. In addition of the existing and well-known pathogenic member 
of the Bunyaviridae, such as RVFV, OROV or HTNV, two new viruses emerged within the 
last year, SFTSV and Schmallenberg virus (SBV). SFTSV was isolated in China, is distantly 
related to RVFV and causes disease in human (Yu et al., 2011; Zhang et al., 2011). SBV was 
first isolated in Germany in October 2011 after report of an unknown disease was made to the 
veterinary services. SBV infects cattle and clinical signs include fever, reduced milk 
production and diarrhea, but the main concern is congenital defects in newborn calves and 
lambs. SBV is classified in the genus Orthobunyavirus within the Simbu serogroup. It is the 
first time that a virus from this serogroup has been detected in Europe. SBV is closely related 
to Aino virus, AKAV and Shamonda virus, that are mainly present in Eastern Asia and known 
to infect only cattle (Hoffmann et al., 2012). Thus, SBV is not, as yet, considered as a threat 
to human population. However, between the end of the summer 2011, when the first 
suspicious cases where reported, and March 2012, SBV has spread from Germany to the 
Netherlands, Belgium, northern France and has crossed the channel to cause disease in 
southern England. Similar to blue tongue virus (BTV), SBV is probably spread by Culicoides 
midges and concerns about the possibility that it will spread across Europe are real. With the 
approaching lambing season, an outbreak of SBV would have an important economic impact. 
Thus, priority should be given to the establishment of a convenient and rapid diagnostic test 
and the development of a vaccine.  
 
Knowledge acquired on orthobunyaviruses in general and on BUNV in this thesis might 
be directly transferrable to SBV and will considerably speed up the process of vaccine 
engineering. Live-attenuated vaccines confer an efficient and long-lasting immunity but are 
more difficult to design. Indeed, first they need to be attenuated, then introduced mutation 
need to be stable and in the case of segmented viruses the possibility of segment reassortment 
need to be taken into consideration. Therefore, introduction of attenuating mutations in each 
segment and combination of mutations within both the ORF and the UTRs could result in the 
production of a good live-attenuated vaccine candidate for SBV. Many options are available 
and are detailed below: 
(1) The most obvious way to create an attenuated virus is to delete the ORF of the protein 
coding for the interferon antagonist, NSs (Bouloy et al., 2001; Bridgen et al., 2001; Kohl et 
al., 2003; Vialat et al., 2000; Weber et al., 2002). The deletion of the ORF of the NSm protein 
also leads to virus attenuation (Shi et al., 2006). Importantly, a recombinant RVFV virus 
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lacking both the ORF for NSs and NSm was shown to be attenuated and to confer protective 
immunity in rats and sheep (Bird et al., 2012; Bird et al., 2008). It is worth noticing that 
BUNV could not be recovered when the NSm protein was deleted in full, however BUNV 
carrying truncated NSm were attenuated compared to wt BUNV (Shi et al., 2006). Thus, 
deletion of the S segment-encoded NSs and the M segment-encoded NSm would be a good 
foundation to a live-attenuated vaccine for SBV. 
(2) Results from published studies along with those presented in this thesis showed that 
modification of the UTRs also leads to virus attenuation; such modifications include 
swapping the UTRs around or introducing deletion within the non-conserved regions. I 
showed that both method result in attenuation of BUNV and that the introduced mutations 
were stable over 10 passages (section 3-B-3 and section 3-D-3). SBV belongs to the Simbu 
serogroup and, similar to AKAV or OROV, possess short UTRs. The 3’ UTRs are 
particularly short; however the 5’ UTRs are of reasonable sizes to envisage the introduction of 
deletions. Thus, either UTR swaps or introduction of deletions within the 5’ UTR could be 
envisaged. However, for vaccine purposes, the introduction of deletion seems a better strategy 
as they can probably be introduced in all segments at once while only one segment can bear a 
heterologous set of UTRs, meaning that two segments still carries wt UTRs. Moreover, the 
hybrid segment could be lost by reassortment with wt SBV. 
(3) Mutations leading to viruses with a temperature sensitive phenotype are of great interest 
for vaccine engineering (Beyer et al., 2002; Whitehead et al., 1998b). In this thesis (section 3-
D-4), I identified mutations generated in the polymerase during serial passage and one of 
them appeared to confer a temperature sensitive phenotype to an otherwise wt BUNV (section 
3-E-5). In the BUNV L protein, this mutation substitutes the glutamic acid (E) at position 
1619 with a glutamine (G). Interestingly, the E at position 1619 in BUN L is a conserved 
amino acid among the genus Orthobunyavirus and is indeed present in SBV (at position 1628). 
It would be of major interest to introduce the EQ mutation at position 1628 in the SBV L 
protein and define if it also causes a temperature sensitive phenotype. Previous work by Eifan 
et al. (2009) has identified mutations in the N protein that result in a temperature sensitive 
phenotype (Eifan & Elliott, 2009). Some mutations occur on amino acid that were identified 
as conserved among 51 orthobunyavirus N sequences and that are also present in SBV. 
 
All the ideas presented above could be used to design a live-attenuated vaccine against 
SBV or other members of the genus Orthobunyavirus. But, a prerequisite to the design of 
genetically modified live-attenuated vaccine is the availability of an efficient rescue system. 
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Indeed, only a rescue system can provide the liberty to push genetic engineering to its limits. 
The availability of a rescue system for BUNV and LACV and the recent success of AKAV 
rescue suggest that a rescue might be quickly established for SBV. However, reverse genetics 
systems can be tricky to develop, as proven by the lack of success for HTNV, but the 
potential rewards will be worth every effort. 
  Bibliography 
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